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ABSTRACT 
  
 2 
Bacteriophages belonging to the Siphoviridae family represent viruses with a 
non-contractile tail that function as extremely efficient bacterium-infecting 
nanomachines. The Siphoviridae phages TP901-1 and Tuc2009 infect Lactococcus 
lactis, and both belong to the so-called P335 species. As P335 phages are typically 
capable of a lytic and lysogenic life cycle, a number of molecular tools are available 
to analyse their virions. This doctoral thesis describes mutational and molecular 
analyses of TP901-1 and Tuc2009, with emphasis on the role of their tail-associated 
structural proteins. Several novel and intriguing findings discovered during the 
course of this study on the nature of Siphoviridae phages furthers a basic molecular 
understanding of their virions, and the role of their virion proteins, during the initial 
stages of infection. 
While Siphoviridae virions represent complex quaternary structures of 
multiple proteins and subunits thereof, mutagenic analysis represents an efficient 
mechanism to discretely characterize the function of individual proteins, and 
constituent amino acids, in the assembly of the phage structure and their biological 
function. However, as always, more research is required to delve deeper into the 
mechanisms by which phages commence infection. This is important to advance our 
understanding of this intricate process and to facilitate application of such findings to 
manipulate phage infections. On the one hand, we may want to prevent phages from 
infecting starter cultures used in the dairy industry, while on the other hand it may be 
desirable to optimize viral infection for the application of phages as bacterial 
parasites and therapeutic agents. 
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SECTION I A History of Bacteriophages 
In 1896, the British bacteriologist Ernest H. Hankin noted an unidentified 
substance in the Ganges and Jumna Indian rivers with antibacterial activity against 
the pathogenic bacterium Vibrio cholera. Unbeknown at the time, Hankin’s 
description of a small, heat-labile, antibacterial agent was possibly the first scientific 
observation of a bacterial virus (1, 2). However, the discovery of viruses infecting 
bacteria is accredited to Frederick W. Twort (1915) and Felix d’Herelle (1917) (3, 
4). Twort described an uncultivable ‘glassy’ bacterial appearance that when filtered 
could induce a glassy phenotype in other bacterial cells. Although uncertain in his 
conclusions of the filterable infectious agent, Twort deliberated over the possibility 
of viruses, and this work was enough to credit him with the co-discovery of 
bacteriophages. The other co-discoverer was Felix d’Herelle, who, independent of 
Twort, unravelled the mystery behind bacterial plaques. Perceiving these filterable 
infectious agents to be bacterial viruses, d’Herelle coined the term bacteriophage 
from a combination of the words ‘bacteria’ and the ancient Greek ‘phagein’ 
(meaning ‘to eat’) (5). 
Since the discovery of phages, they have been a part of many important 
milestones in molecular biology. This is attributed to their small genome size, ability 
to work with their bacterial hosts, ease of experimental manipulation and relatively 
minimal replication complexity. Outlined below are several examples of how phages 
have contributed to our understanding of molecular biology. 
Evolution, a concept now taken for granted (by many), previously required 
scientific debunking. Salvador Luria and Max Delbruck (1943) demonstrated 
evolution by challenging a population of bacteria, all originating from a common 
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ancestor, with phages. Within a few hours, the media, cloudy from bacterial growth, 
returned clear. However, if Luria and Delbruck incubated the now-cleared media 
further, the culture sometimes regrew. This was due to the growth of a sub-
population of phage-resistant bacteria that arose within the population of bacteria. 
Through mathematical modelling, Luria and Delbruck calculated these heritable 
changes, or mutations, in the bacterial phage-sensitivity phenotype over time. These 
mutations occurred independent of the phage, during bacterial growth, as the number 
of resistant bacteria did not increase in stationary phase cells (6). Natural selection, 
at a microscopic level, was therefore first demonstrated by Luria and Delbruck using 
phages. 
In 1952, Alfred Hershey and Martha Chase used phages to demonstrate, 
beyond any reasonable doubt, that nucleic acid encoded proteins. By analysing 
radioactively labelled phage DNA and phage proteins, Hershey and Chase 
demonstrated that phage proteins directed DNA injection, while only radio-labelled 
DNA was passed on to progeny phage (7). 
Norton Zinder and Joshua Lederberg (1952) demonstrated that a Salmonella-
infecting phage could carry DNA, encoding a selectable marker, between bacteria. 
This process, different from sexual recombination in bacteria, was termed 
transduction (8). Many years following on from this discovery, transduction has 
remained an important tool in molecular biology and represents one of the main 
routes by which bacteria achieve horizontal gene transfer. 
Three years after James D. Watson and Francis Crick deciphered the 
structure of DNA, two scientists, Elliot Volkin and Lazarus Astrachan (1956) 
discovered the missing link between DNA and protein. At this time, it was known 
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that there had to be some correlation between hereditary genetic material and 
proteins, however, conclusive experimental evidence was lacking. Volkin and 
Astrachan noted that soon after bacterial infection by a phage, the infected bacterium 
started to produce phage proteins. While the majority of the cellular RNA remained 
unchanged, a small portion of the cellular RNA was observed that had a similar base 
composition to that of the infecting phage DNA. They called their discovery ‘DNA-
like-RNA’ (9). Like most scientists who accidentally discover something 
monumental, they did not realize the significance of their find. It was only later that 
François Jacob and Jacques Monod realized this ‘DNA-like-RNA’ was in fact a 
cytoplasmic message for protein synthesis; hence its name as messenger RNA 
(mRNA). Jacob and Monod later received a Nobel Prize (1965) for their 
contributions to the understanding of certain regulatory processes that occur in cells, 
while Volkin and Astrachan were never acknowledged for their contribution to 
molecular biology (10). 
Bacteriophage T4 has served as an important molecular tool for 
understanding the triplet nature of the genetic code. Francis Crick, Leslie Barnett, 
Sydney Brenner and R.J. Watts-Tobin (1961) used the acridine dye proflavin to 
introduce or remove bases into T4’s gene rII. They demonstrated that the addition or 
deletion of nucleotide bases, and complementary additions or deletions of bases, 
were deleterious, but not if they were in multiples of three. Overall Crick and 
colleagues used phage T4 to demonstrate that three nucleotide bases, a codon, 
encode one amino acid (Fig. 1). Crick et al. further speculated at the degeneracy of 
the genetic code, as there were 64 possible codons and only 20 amino acids (11). 
However, it was Marshall Warren Nirenberg (1961) who deciphered the first codon, 
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UUU, which encodes phenylalanine, marking a major milestone in understanding 
molecular biology (12). 
 
Figure 1. Circular genetic code table. The four nucleotide bases of mRNA are: A, 
Adenine; U, Uracil; G, Guanine; C, Cytosine. An individual codon, as demonstrated 
by Crick et al. (1961), is composed of 3 nucleotides. The circular codon table above 
shows the first codon position in the centre, with the names of the 20 encoded amino 
acids radially located around their respective third codon positions. As predicted by 
Crick and colleagues, the 20 amino acids are encoded by 61 codons, in addition to 
three codons that represent translational termination signals (11). This can be seen 
with the amino acid phenylalanine, deciphered by Nirenberg as UUU (12), and 
which is also encoded by UUC (figure sourced from the following web link: 
http://www.millerandlevine.com/). 
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During the 1950’s and 60’s, it became apparent that the transcription of 
genetic material was regulated. Jacques Monod, who was studying the lac operon, 
showed that the lactose-degrading enzyme β-galactosidase was produced following 
the addition of lactose to the media. When the scientists Andre Lwoff, François 
Jacob and Jacques Monod (1961) teamed up, they also began to look at the genetic 
regulation of phage λ lysogeny (λ was discovered by Joshua Lederberg’s wife, 
Esther). In genetic maps of E. coli, they showed lysogenized λ always occurred at a 
defined place. Also, when the DNA encoding a prophage λ entered a female E. coli 
through conjugation, the λ lysogen was induced. Lwoff et al. speculated that it was a 
cytoplasmic factor of the male E. coli maintaining the dormant phage (13). The 
scientific discoveries by Lwoff, Jacob and Monod, ultimately leading to the operon 
model of genetic regulation (Fig. 2), whereby regulatory genes encode proteins that 
interact with operator sequences to control sets of co-located structural genes, earned 
them a Nobel Prize (1965). 
A few years later, Mark Ptashne (1967) demonstrated that phage λ repressor 
protein maintained the lysogenized phage within the chromosome (Fig. 2). The λ 
repressor also fulfilled Jacob and Monod’s operon model, as it was shown to bind 
tightly to the operator sequences, blocking transcription and thus maintaining the 
lysogenic phage (14). 
Allan Campbell (1962) demonstrated DNA integration into genomes using 
phage λ. While phages such as Mu are capable of transposition (random genome 
insertion), λ integrates by site-specific recombination. Campbell focused on the 
chromosomal sequences specific for recombination, identifying the need for specific 
sequences and enzymes to catalyse the reaction (15). Campbell’s model went a long 
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way towards understanding the insertion of foreign DNA into a genome and also the 
ability of viruses to remain dormant until activated. 
 
 
Figure 2. Phage λ genetic switch obeys the operon model of Lwoff, Jacob and 
Monod. (A) Leftward transcription from the divergent genetic switch of phage λ 
produces the repressor protein, cI. Protein cI forms a homodimer and binds to 
operator sequence 1. Repressor binding to operator sequence 1 recruits a second cI 
dimer to bind operator sequence 2, which in turn enhances production of additional 
repressor proteins. (B) Induction conditions result in the degradation of cI protein 
and rightward transcription from the genetic switch producing the anti-repressor 
protein, Cro. The anti-repressor protein stimulates the transcription of factors 
required for λ lytic growth (figure sourced from (16)). 
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Those working with phages observed a phenomenon whereby phages 
infecting a particular strain did so more effectively in the second generation of 
propagation. It was Daisy Dussoix and Werner Arber (1962) who proposed a model 
by which a host endonuclease could degrade susceptible foreign phage λ DNA, 
restricting infection (hence the name restriction enzyme). The host strain, by 
modifying its own DNA, was protected from this endonuclease. Dussoix and Arber 
postulated that, at low frequency, susceptible phage λ DNA during infection also 
became modified, which subsequently increased their infection efficiency in the 
second generation (17). Several years later, Martin Gellert (1967) demonstrated that 
E. coli extracts could close the cohesive ends of λ phage DNA into a closed circle 
(18). When taken together, the ability to digest DNA at specific sequences, by 
restriction enzymes, and repair these cuts, via a ligase, are amongst the most 
important tools in DNA manipulation and molecular engineering. 
Costa Georgeopoulos, Roger W. Hendrix, Sherwood R. Casjens and A. D. 
Kaiser (1973) isolated host mutants incapable of supporting bacterial colonies at 43 
oC and assembling the phage λ capsid. These mutants were mapped to groE and 
could be complemented (19). However, it was years after the description of groE 
that its function as a chaperone molecule became apparent. Reginald John Ellis 
(1987), who was working on Rubisco in chloroplasts, demonstrated a chaperone 
function of a Rubisco-binding protein. Ellis argued molecular chaperones were 
common in nature, assisting in folding and unfolding of macromolecular structures, a 
notion that was strongly supported by the Rubisco-binding protein’s homology to 
GroEL, known to be important for the production of various different bacteriophages 
(20). 
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Recent advances in DNA sequencing have resulted in biologists requiring 
massive computational power to interpret the generated data. However, the first 
attempts to sequence genetic material (such as Maxam and Gilbert’s chemical 
degradation) were laborious, required numerous dangerous chemicals, and generated 
relatively little data (21). The major breakthrough in sequencing was the method of 
chain-termination developed by Frederick Sanger (1977). The chain-termination 
method uses dideoxynucleoside triphosphates (ddNTPs) capable of being 
incorporated into an extending DNA sequence, yet upon incorporation they 
themselves cannot facilitate further DNA extension. By analyzing four nucleotide 
reactions in parallel, each containing a small proportion of a particular ddNTP in 
with the corresponding dNTPs, a number of different molecular weight products are 
produced. By comparing the sizes of terminated DNA sequences and correlating 
them to the incorporation of the dideoxy -adenines, -guanines, -thymines, and -
cytosines, the genetic sequence could be determined (22). The single-stranded DNA 
genome of phage φX174 (5,386 nt), the first genome to be sequenced by chain-
termination, represented a major milestone in molecular biology. The ability to 
sequence DNA is an important analytic tool and has been pivotal in advances in 
multiple life-science fields. 
Phages continue to contribute to discoveries in molecular biology and the 
fundamental nature of DNA, not all of which have been discovered despite modern 
advances. Mark Ptashne, who demonstrated the repressor protein and lysogenic 
switch of phage λ, has shown that genetic regulation is a much more complex system 
than initially perceived. Ptashne’s book ‘A Genetic Switch’ (2004) demonstrated 
epigenetic control of phage λ DNA by the persistent expression of λ lysogeny genes 
in the absence of the original signal, without a change in DNA sequence (23). The 
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scientific advances that have been made through phage research, such as epigenetics, 
have had major consequences in molecular biology and other branches of science, 
and phage research will hopefully continue to significantly contribute to our 
understanding of molecular biology.  
 14 
SECTION II Lactic Acid Bacteria and Bacteriophages 
Lactic acid bacteria (LAB) represent a diverse group of Gram-positive, low-
GC genomic content, non-spore forming, coccoid or rod-shaped bacteria that 
produce lactic acid as the major end-product of fermentation. Species of 
Lactobacillus, Lactococcus, Leuconostoc, Pediococcus and Streptococcus 
thermophilus form the core LAB representatives and are economically important in 
the dairy industry for their fermentation of milk to produce dairy products, such as 
yogurts and cheeses, with desirable tastes and textures (24, 25). For example, in 
2012 the Irish dairy industry exported fermented dairy products and ingredients with 
an estimated value of €2.66 billion (26), making it one of Ireland’s most important 
agri-food sectors. The metabolic activities of LAB have been exploited for thousands 
of years to ferment carbohydrates in foods for human consumption. With few 
exceptions, such as Enterococcus faecalis, LAB are deemed generally regarded as 
safe (GRAS) organisms and their presence in food is considered harmless or even 
adventitious as many are claimed to possess health-promoting probiotic properties 
(27). 
 
SECTION II.I LAB Cell Envelope 
The exposed surface of a microorganism represents a rather unique molecular 
signature that allows interactions with its environment. Particular surface 
components of certain probiotic LAB are known to interact with the human 
gastrointestinal tract and have been demonstrated to exclude or inhibit pathogens 
through enhancing the intestinal epithelial barrier and modulating the host immune 
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response (28). The cell envelope of LAB is composed of an inner phospholipid cell 
membrane surrounded by a thick cell wall of peptidoglycan (PG) decorated with 
various proteins, teichoic acids and carbohydrates. 
The majority of cellular life is covered in a cell wall to resist turgor; animal 
and protozoal cells being notable exceptions (29). PG (peptidoglycan or murein) of 
bacterial cells forms a macromolecular sacculus, composed of long glycan strands of 
repeating N-acetylglucosamine (GluNAc) and N-acetylmuramic acid (MurNAc) 
sugars cross-linked to neighbouring glycan strands through short peptide stems 
protruding from the D-lactyl moiety of MurNAc. The consensus peptide stem of 
most Gram-positive bacteria, including LAB, is a pentapeptide of L-Ala-γ-D-Glu-L-
Lys-D-Ala-D-Ala (Fig. 3). Interspecies variations in PG are observed in the glycan 
strands, peptide stems, and interpeptide bridges which can be present to link peptide 
stems. Variations in murein also occur in a given bacterium depending on growth 
conditions and phase of growth, thus highlighting its dynamic nature (30, 31). 
The glycan strands of most Gram-positive bacteria are cross-linked indirectly 
via an interpeptide bridge in their peptide stems. The size of the interpeptide bridge 
can range from one to seven amino acids, and its composition can be quite diverse. 
The interpeptide bridge of lactococci and several lactobacilli are composed of a 
single dicarboxylic amino-amino acid, typically D-Asp (31). As peptide stems are 
theoretically distributed regularly along the glycan strand, the number of interpeptide 
bridges directly correlates with glycan strand length. However, the thickness of PG 
in the cell envelope and glycan strand length do not necessarily correlate, as thick 
cell-walled Staphylococcus aureus and Bacillus subtilis have short and long glycan 
strands, respectively (32). 
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A PG hydrolase (PGH) enzyme exists for every chemical bond that is present 
in the PG muropeptides (Fig. 3). Muramidase and glucosaminidase enzymes cleave 
glycosidic bonds between MurNAc-GluNAc and GluNAc-MurNAc, respectively. 
Amidase enzymes (more specifically N-Acetylmuramyl-L-alanine amidases) 
hydrolyze the peptide stem from the MurNAc of the glycan strand, while certain cell 
wall-active peptidases cut within the peptide-stem and peptide-bridge of PG (33). 
Bacterial PGHs are necessary for normal bacterial growth as the cell wall is 
constantly recycled and expanded to accommodate cell growth and division. Lysis of 
bacteria by their own PGHs, termed autolysis, is particularly important with regards 
LAB, as it facilitates the production and ripening of cheeses (34). 
 
 
Figure 3. Peptidoglycan structure of lactic acid bacteria with the chemical bonds 
targeted by various hydrolase enzymes indicated (figure sourced from (35)). 
 
Three architectural models of peptidoglycan are debated amongst biologists 
(Fig. 4). Either the PG glycan strands run parallel to the bacterial membrane, in the 
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classical layered model or the disorganised layered model, or the PG is perpendicular 
to the bacterial surface and the cell wall cross-linkage is parallel to membrane, as in 
the ‘scaffolding’ model (36). Gan et al.’s (2008) study of frozen-hydrated 
Escherichia coli cell walls using cryo-tomographic electron microscopy showed a 
single 2.5 nm layer of PG comprising the sacculus, supporting the disorganized 
layered model (37). 
 
 
Figure 4. Models for PG structure. (A) The layered model, (B) the scaffold model, 
and (C) the disorganized layered model. MurNAc and GluNAc disaccharides are in 
green while PG proteinaceous cross-linkages are in blue (figure sourced from (37)). 
 
The PG architecture of B. subtilis is possibly the best studied Gram-positive 
bacterium and (predominantly) supports the layered model. The following paragraph 
is a summary of a detailed description by Hayhurst et al. (2008) regarding the 
current understanding of the Gram-positive cell wall (38). Muropeptide glycan 
strands have a right-hand helical twist, and under certain physiological conditions B. 
subtilis grows helically. A number of glycan strands are cross-linked to form a 
helical PG ‘rope’, and PG ropes are then coiled into a helix (of 50 nm width) to form 
‘cable’ structures. Turgor pressure on the cell causes PG cables to flatten, resulting 
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in characteristic 25 nm cross striations observed in the PG cables when observed by 
atomic force microscopy (AFM). The PG of B. subtilis runs circumferential to the 
rod shaped bacterium, and PG cables are stabilized by inter/intra glycan strand 
linkages. New peptidoglycan cables are inserted into the cell wall by cross-linkage 
with existing cables by enzymes protruding from the cell membrane into the 
bacterial periplasmic space. 
AFM images of live lactococcal cells show a smooth surface, while mutants 
defective in a surface-coating cell wall polysaccharide (CWP) show 25 nm periodic 
bands running parallel across the bacterium (Fig. 5) (39). Whether these bands are 
analogous to the coiled cables of the glycan strands observed in B. subtilis is yet to 
be determined, but it strongly suggests a common structural arrangement of PG 
amongst these Gram-positive bacteria. 
 
 
Figure 5. Atomic force microscopy showing the nanoscale organization of 
lactococcal PG. (A) Division of an L. lactis mutant lacking its CWP. (B) Detection 
of peptidoglycan molecules found they were arranged parallel around the short cell 
axis (red lines). (C) Cartoon representation of PG periodic cables (blue) lying on top 
of the cell membrane (green) and underneath the natural CWP coating (brown) 
(figure sourced from (39)). 
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Proteins, teichoic acids and carbohydrates present on the surface of LAB 
fulfil multiple functions during the complex life cycle of these microorganisms; 
therefore, their discussion in this review is limited to their pertinence with regard 
phage infection (for more information, see reviews (40-43)). Proteins on the surface 
of bacteria represent specific targets for phage adsorption. Surface-layer (S-layer) 
proteins found on the surface of some lactobacilli have been reported to act as targets 
for phage to facilitate adsorption and subsequent infection (44) and the phage 
infection protein (Pip) on the surface of lactococcal cells serves as a receptor for c2 
species phages (45). 
Teichoic acids are long anionic polymers composed largely of glycerol 
phosphate, glucosyl phosphate, or ribitol phosphate repeats. Teichoic acids can be 
associated with the bacterial cell wall (wall teichoic acids) or anchored to the 
bacterial phospholipid membrane (lipoteichoic acids) (46). Teichoic acids were 
demonstrated as the surface-recognised receptor of Lb. delbrueckii and Lb. 
plantarum phage LL-H and Phi2, respectively (47, 48). Teichoic acid is also a 
candidate receptor for S. thermophilus phage 0BJ, as adsorption to its host is strongly 
inhibited by the carbohydrate ribose (49). 
A surface-coating CWP of L. lactis MG1363 was recently described (50). 
This CWP is composed of hexasaccharide repeating units, containing rhamnose, 
glucose, galactose and GluNAc, linked by phosphodiester bonds. The saccharidic 
composition of lactococcal CWPs differs amongst strains, and appears to correlate 
with the observed genetic diversity of their encoding regions (51) (Ainsworth et al., 
unpublished results). CWPs on the surface of S. thermophilus have also been 
reported, although they have not been studied in as much detail as their lactococcal 
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counterparts. Similar to the CWPs of Lactococcus, S. thermophilus CWPs were 
demonstrated to contain carbohydrates rhamnose, glucose and GluNAc, and affect 
the adsorption of streptococcal phages (49, 52). LAB CWPs are believed to be 
covalently connected to PG and contribute to the ecological properties of the strain, 
as they were demonstrated to affect the recognition of lactococci by phagocytes and 
phages (50) (Ainsworth et al., unpublished results). 
 
SECTION II.II Disruption of LAB Fermentations 
Prokaryotic viruses are ubiquitous and abundant in seemingly all ecological 
niches (53), industry notwithstanding. The first report of phages affecting an LAB-
mediated fermentation was by Whitehead and Cox in 1935 (54). Since then, 
numerous procedures have been implemented to prevent, control or reduce the 
incidence of failed fermentations as a result of phage infection, as slow or dead 
fermentations result in disruption of the production schedule and low quality produce 
(for reviews, see (55-57)). However, infection of starter cultures remains the single 
greatest cause of fermentation failure and a significant challenge to the fermentation 
industry. 
Strategies used by the dairy industry to limit phages within their production 
facilities include: thermal and biocidal treatments, strain selection and rotation, and 
the application of bacteriophage-insensitive mutant strains (BIMs) (58, 59). 
However, phages appear to have become more resistant to pasteurisation 
temperatures and sanitation procedures (60). Therefore, phages enter, and 
contaminate, dairy plants through incoming milk. To further complicate matters, 
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robust phages which manage to enter dairy factories were demonstrated to persist on 
various work surfaces and spread through the production facility as airborne particles 
(61). 
Strain rotation is a simple, yet efficient, phage control procedure. Phages of 
LAB typically have narrow host ranges (51), and the rotation of starter cultures 
prevents the amplification of a specific infecting phage (56). In addition to strain 
rotation, the selection of starter cultures with phage-resistant properties is important 
to avoid fermentation problems. For instance, L. lactis-infecting phages of the c2 
species require a proteinaceous receptor, Pip, to successfully recognise and initiate 
infection of their hosts. The generation of lactococcal BIMs lacking the Pip-encoding 
gene, through evolutionary pressure and natural selection, results in strains resistant 
to phages belonging to the virulent c2 species (62-64). 
 
SECTION II.III Phage Diversity and Classification 
The high cost associated with phage-mediated problems in the dairy industry 
has in turn resulted in significant scientific research efforts, which is crucial to the 
understanding of the phage problem and to finding solutions for the affected 
industrial processes. In addition, with cheaper and more advanced DNA sequencing 
technologies available, the number of fully sequenced genomes of LAB and their 
phages has dramatically increased (Table 1). Taken together, a considerable wealth 
of knowledge has been generated regarding the diversity and genomic content of 
dairy phages, their ecology, their replication cycle, the responses of bacteria to 
phages, and host-encoded phage-defence mechanisms (for reviews, see (65-67)). 
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Taxonomic classification is an important procedure to create a compilation of 
members with shared characteristics. Categories can be scrutinised for many 
purposes, including: (i) the determination of inter-/intra-relatedness amongst 
collections, (ii) identification of similarities and unique aspects, (iii) and predicting 
the ecological and evolutionary significances. The International Committee on the 
Taxonomy of Viruses (ICTV) is primarily charged with the classification of viral 
orders, families, and genera, and then designating the particular level of 
nomenclature in the form of the suffixes -virales, -viridae, and -virus, respectively 
(68). 
 
Table 1. Overview of the number of fully sequenced and published LAB and LAB-
infecting phage genomes. Best approximate of bacterial and phage genomes were 
sourced from (www.genomesonline.org) and (www.ebi.ac.uk/genomes/phage.html), 
respectively. Table updated from Mahony et al. (2012) and accurate as of October 
2013 (69). 
 
No. of sequenced 
genomes 
Bacteria  
 Lactobacillus spp. 48 
 Lactococcus spp. 10 
 Leuconostoc spp. 8 
 Pediococcus spp. 2 
 S. thermophilus 6 
Phages  
 Lactobacillus spp. 21 
 Lactococcus spp. 77 
 Leuconostoc spp. 5 
 Pediococcus spp. 1 
 S. thermophilus 12 
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In contrast to the success of bacterial classification by a universally present 
taxonomic unit, 16S rRNA, determining the phylogenetic relationship of phages is 
not as straightforward. Comparative genomic analysis on the ever-increasing number 
of sequenced phages is facilitating the determination of evolutionary relationships to 
a greater resolution. However, one of the major requirements for classifying viruses 
is the application of the ‘polythetic species concept’. This means a species may be 
defined by a set of properties some of which may be absent in a given member (70). 
As a consequence, the primary feature for classification of phages remains the 
morphology of phages as defined by electron microscopy. 
Bradley (1967) referred to several types of phages as resembling a ‘tadpole’, 
possessing a head-structure, called a capsid, attached to a tail that is capable of 
changing shape (71). The phylogenetic order Caudovirales was consequently 
established to represent the ca. 96 % of phage virions that possess a tail structure 
(72). The capsids of these phages can be icosahedral (round), prolate (slightly 
extended), or elongated in shape. Based on tail morphology, replication and 
assembly, it is recognised that the order Caudovirales can be subdivided in three 
familial groups of tailed, double-stranded DNA phages: (i) Myoviridae, for phages 
with long contractile tails, (ii) Podoviridae, phages with short non-contractile tails, 
and (iii) Siphoviridae, phages with long non-contractile tails. The remaining 4 % of 
non-tailed phages possess polyhedral, filamentous, and pleomorphic morphologies 
(Fig. 6). These phages have no taxonomic rank at the level of order assigned, but 10 
families are recognised (73). 
Phages infecting LAB typically possess a double-stranded DNA genome 
encased in a virion with a long non-contractile tail, characteristic of the phage family 
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Siphoviridae from the order Caudovirales (72, 74). However, a small number of 
tailed Podoviridae and Myoviridae phages, also of the order Caudovirales, have 
been found to infect L. lactis species and the genus Lactobacillus, respectively. As 
lactococcal phages represent one of the best studied groups of bacterial viruses 
infecting a single bacterial species, 10 distinct phage species have been characterized 
(75). The most frequently isolated L. lactis phages that disrupt milk fermentations 
are Siphoviridae belonging to the 936, c2 and P335 species (75). While 936 and c2 
species phages are strictly virulent, P335 species phages can be virulent or 
temperate. Two Podoviridae and five additional Siphoviridae species are known to 
infect L. lactis; however, these species are considered rare (Table 2). 
 
 
Figure 6. Phage classification as based (primarily) on the morphological 
characteristics of phages as observed under an electron microscope. While 96 % of 
all phages to date display only three morphologies (Myoviridae, Podoviridae and 
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Siphoviridae), many other phage morphologies have been described (figure sourced 
from (73)). 
 
Investigators Rohwer and Edwards (2002) proposed an alternative system of 
classifying phages compared to that currently employed by the ICTV. This was 
termed the phage ‘Proteomic Tree’, based on DNA sequencing and comparative 
analyses of the predicted proteome. The advantages over the ICTV mechanisms are 
as follows: firstly, ICTV requires visualization of free phage particles under an EM, 
limiting classification only to those that can be propagated; secondly, prophage 
sequences are omitted; thirdly, metagenomic studies that generate large amounts of 
sequence data, by their very nature, do not attempt to work with the host bacterium 
or phage in question. Due to the limitations imposed by the ICTV, the number of 
unclassified phages will increase as more (complete) phage genome sequences 
become available (76). While no single conserved sequence is present in the 
genomes of all phages, the phage proteomic tree created by Rohwer and Edwards 
produced a phage phylogenetic tree similar to that produced by the ICTV-supported 
classification scheme (Fig. 7). 
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Table 2. Diversity and classification of lactococcal phages. 
a 
Scale bar represents 50 
nm (table sourced from (75)). 
 
 
Rohwer and Edwards (2002) also propose a new nomenclature system, where 
the suffix ‘-phage’ replaces ‘-viridae’ when referring to computational classification 
and not morphological. Other suggestions to phage nomenclature provided by 
Rowher and Edwards include that the first mention of the phage should reference the 
host organism (or else left as ‘unknown’) and using the symbol φ (phi for phage) 
followed by the first designation of the phage from its original source (the example 
used was E. coli φX174) (76). 
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Figure 7. Phage phylogenetic tree constructed using the predicted proteome of phage 
sequences. The tree consists of 105 completed genome sequences, generated by 
length-corrected protein distances, with a penalty score for missing proteins. Each 
genome is coloured according to their ICTV classification as shown in the key. For 
ease of reading the large Siphophage group has been moved away from other phage 
groups (as indicated by the dotted line) (figure sourced from (76)). 
 
 
 28 
SECTION II.IV Phage Replication 
Incapable of self-proliferation, phages require the inadvertent contribution of 
a host’s DNA replication and protein synthesizing machinery to complete their life 
cycle. The lytic cycle of phages is frequently divided into 5 main stages; adsorption, 
penetration, synthesis, assembly and release. In addition, temperate phages can 
integrate their genome into the genome of their host and replicate in situ, before 
excising and proceeding to replicate through the lytic cycle (Fig. 8). 
Phage recognition of a cognate bacterial host has important consequences, as 
it will determine the fate of both the phage and the bacterium. Several phages seem 
to target two different receptors on the surface of the bacterium to adsorb to: a 
reversible adsorption to a bacterial generic moiety, allowing the phage to ‘walk’ 
along the bacterium surface in order to find a second, specific receptor that mediates 
irreversible adsorption (77). As discussed above, a variety of surface-exposed 
moieties are adsorption targets for LAB-infecting phages, such as proteins, teichoic 
acids and carbohydrates. 
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Figure 8. A simplified schematic representation of a phage replication cycle. The 
phage lytic cycle follows: adsorption, penetration (injection), synthesis, assembly 
and release. The lysogenic switch marks the ‘decision’ by temperate phages to 
integrate into, or induce from, their host (figure sourced from (78)). 
 
Irreversible adsorption commits the phage to infection, whereby its genetic 
material must gain entry into the host’s cytoplasm. However, the bacterial cell 
envelope consists of multiple barriers preventing easy access of the phage genetic 
material into the bacterium. Extracellular bacteriophage must penetrate the PG-
containing cell envelope to infect a bacterium and produce progeny that is 
subsequently released into the environment. The parasitic replication cycle of many 
phages is facilitated by virion-associated PGH (VAPGH) enzymes to locally degrade 
PG at the initiation of infection (for morphologically distinct phage-type examples, 
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see (79-83)). The thicker PG sacculus of Gram-positive bacteria, relative to Gram-
negative bacteria, is likely a more considerable physical barrier to phage infection. In 
accordance with this, Moak and Molineux (2004) found that five LAB-infecting 
Siphoviridae, representative of four different lactococcal-infecting phage species, 
possess a virion-associated PGH activity (84). VAPGH domains are often associated 
with large, essential phage structural proteins, often encumbering functional 
characterisation of such proteins. The covalent association of VAPGH domains with 
these large key proteins has been proposed to prevent diffusion of the potentially 
lethal, PG-degrading enzymes (84). Several phages require PGH domains only under 
certain physiological conditions (for examples, see (85-87)), and thus studying PGH 
domains and their localization often reflects on the infection mechanism of such 
particular phages. 
The challenge of traversing the bacterial cell envelope, including lipid 
membranes and the peptidoglycan cell wall, may well have been a major catalyst in 
driving the observed diversity of phage morphologies. The virion structures of 
specific phage classes, such as Myoviridae, Podoviridae and Siphoviridae, represent 
extremely efficient DNA-delivering nano-machines, and members of each 
morphology appear to utilize a unique mechanism to penetrate the bacterial cell 
envelope and inject their genetic material into their particular host (88). Discussed 
below are prototypical examples of Myo-, Podo- and Sipho-viridae phages; LAB-
infecting phages with these morphologies are expected to penetrate their hosts in a 
similar manner. 
Myoviridae, with long contractile tails, are often described to employ an 
injection mechanism similar to a ‘syringe’ (89). After irreversible adsorption, 
 31 
contraction of the Myoviridae tail sheath drives the tail tube through the bacterial 
envelope. The genetic material of the phage is then ejected from the phage capsid, 
directed through the phage tail tube, thereby facilitating its exit at the tail tube tip and 
directly in the bacterial cytoplasm. The best studied Myoviridae and accepted 
prototype of this phage family is T4 (Fig. 9). Comprehensive reviews of the structure 
and function of T4’s virion are available (90-92). T4 adsorbs to the terminal glucose 
of lipopolysaccharide (LPS), in combination to the outer membrane protein OmpC, 
on the surface of its enterobacterial host through its long tail fibres (93, 94). T4 
infection can occur, albeit at lower efficiency, in the absence of either the terminal 
glucose of the LPS or OmpC (95). However, binding by at least three long tail fibres 
is required for T4 to be infectious (96). The signal generated by T4’s long tail fibres 
adsorbing to the host’s receptors results in tail tube contraction, which in turn pushes 
the cell-puncturing device, composed of a trimer of gp5, through the bacterial cell 
envelope (97). The gp5 syringe-complex of phage T4 also possesses lysozyme 
domains facilitating the degradation of the bacterial cell wall during host penetration 
(98). 
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Figure 9. Host penetration by bacteriophage T4. Long tail fibres reversible adsorb to 
LPS and OmpC on the surface of Enterobacteriacaea. If three long tail fibres 
recognise the bacterial receptors, T4’s tail sheath contracts, driving the cell 
puncturing syringe through the bacterial envelope. The phage DNA can then exit the 
phage tail tip directly into the host’s cytoplasm. Penetration of the bacterial cell wall 
is facilitated by VAPGH domains associated with the cell-puncturing device’s tip 
(figure sourced from (89)). 
 
Podoviridae, with their short non-contractile tails, have been shown to eject 
proteins from their capsids that form a channel to bridge the cell envelope. The 
channel from the phage virion to the bacterial cytoplasm both directs the phage 
genetic material and protects it from nucleases present in the bacterial cell-
envelope’s periplasmic space (99). The penetration of the bacterial cell envelope by 
Podoviridae has been demonstrated for several phages, however, the best example is 
phage T7 (Fig. 10). Phage T7 ejects the capsid core proteins corresponding to gene 
products 14 (gp14), gp15 and gp16 from its capsid to span the bacterial cell 
envelope. Protein gp16 also possesses a lytic transglycosylase domain to degrade the 
peptidoglycan cell wall of its enterobacterial host, facilitating the penetration stage of 
phage T7’s infection process (86, 100). 
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Figure 10. Host penetration by phage T7. Phage T7 binds to its host through side tail 
fibres, before ejecting the capsid core, composed of proteins gp14, gp15 and gp16, to 
span the bacterial envelope. Protein gp14 anchors in the outer membrane, while the 
lytic activity of gp16 degrades the bacterial PG layer. The phage DNA is partially 
ejected into the host, whereby the host polymerase inadvertently pulls the remainder 
of the phage DNA into the bacterial cytoplasm resulting in phage infection (figure 
sourced from (99)). 
 
Siphoviridae, with their long non-contractile tails, are presumed to create a 
channel traversing the bacterial cell envelope by ejecting the Tape Measure Protein 
(TMP) from the core of their tail tube (101-103). While several experiments have 
indicated that the TMP of Siphoviridae, which dictates the length of their tails, also 
creates a channel for DNA injection, there is as yet no concrete evidence to support 
this hypothesis. This is due to the large diversity of Siphoviridae and complexity 
surrounding this stage of replication. The most compelling example for Siphoviridae 
TMPs forming the channel for DNA ejection into their host is from phage T5 (Fig. 
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11). The tip of Enterobacteriaceae phage T5 TMP protein, Pb2, was shown to have 
pore-forming activity in vitro (102). Further work, using cryo-tomographic electron 
microscopy, demonstrated T5 DNA injection into membrane vesicles possessing 
T5’s proteinaceous receptor FhuA (104). In addition, Pb2 of T5 possesses a C-
terminally located muramidase domain which facilitates degradation of the host PG 
layer (105). 
Upon penetrating a bacterium, the phage genome replicates either through the 
lytic cycle, during which phage-encoded functions force the host to dedicate its 
metabolic and biosynthetic activities to the procreation of progeny phages, or to 
establish lysogeny, whereby the phage genome integrates into the bacterial genome 
and replicates in situ as a consequence of the bacterial division process. Phages 
capable of a lytic life cycle only are considered virulent phages, while phages that 
can undergo a lysogenic life cycle (in addition to lytic propagation) are referred to as 
temperate phages. Lysogenic phages are referred to as prophages when they are 
present in a dormant state within the genome of their bacterial host.  
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Figure 11. Adsorption and penetration of phage T5 into proteoliposomes containing 
FhuA, the phage’s proteinaceous receptor. Panel (c): electron micrograph of phage 
T5, displaying the tail tip, which is approximately 50 nm long and 2 nm wide; Panel 
(b), multiple subpanels: upon adsorption to FhuA containing proteoliposomes, T5’s 
tail tip decreases in length to approximately 23 nm and widens to 4 nm Panels (a), 
(d) and (e): de-noised single particle analysis reconstructions showing the tail tip of 
phage T5 penetrating the lipid vesicle (figure sourced from (104)).  
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Phages which possess the necessary genes to establish lysogeny can integrate 
into a bacterial chromosome via random transposition (eg. phage Mu) or via site-
specific recombination (e.g. phage λ). Transposition is catalysed by transposase 
proteins that bind specific sequences at the transposon ends, and then coalesce these 
ends into a transposome complex. Mu phage transposition into the host genome 
occurs via a non-replicative integration mechanism, whereby the transposome 
complex catalyses DNA cleavage of the host genome and the strand transfer steps 
inserting Mu’s genome randomly into the host chromosome (106, 107). Site-specific 
recombination by phages such as λ occurs through particular attachment sequences 
present on the bacterium (attB) and on the phage (attP). The recombination reaction 
is driven by an integrase or recombinase enzyme (108). 
The genetic switch controls the transcription of genes required to establish 
and maintain phage lysogeny or proceed to produce phage progeny via the lytic life 
cycle. One promotor of this genetic switch controls the expression of a repressor 
protein, which binds to, and interferes with, a second promotor sequence that 
controls transcription of genes required to proceed to lytic replication (Fig. 2). Upon 
entering a host bacterium, the initial phage ‘decision’ to establish lysogeny or 
proceed through a lytic life cycle is based on the host cell’s physiological state, 
influenced by various environmental conditions (23). When a temperate phage is 
integrated as a prophage, it often imparts beneficial traits to its host. Prophages can 
encode phage defence mechanisms to prevent super-infection (109), and even 
pathogenicity factors to increase the host’s fitness (110). The expression of a 
repressor protein, a lysogenic conversion factor, also prevents homologous phages in 
the environment from ‘super’-infecting the bacterium. 
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Prophage induction, such as phage λ, occurs following DNA damage. E. coli 
RecA protein recognises DNA damage and becomes activated, which stimulates 
autoproteolytic activity in the LexA repressor that results in the E. coli SOS 
response. LexA repressor and λ repressor protein (cI) are structural homologues and 
RecA also stimulates λ cI proteolysis, signalling to λ that physiological conditions 
within its host are unfavourable (111). 
The chromosomes of phages are organized into specific functional modules 
and their expression proceeds in a controlled manner (112). Each module controls a 
distinct functional activity of the phage, and commonly encountered modules include 
the lysogenic module (as discussed above), synthesis module, structural module, and 
lysis module. This specific order ensures careful control of lysogeny (if applicable), 
production of multiple copies of the phage genome, packaging and protection of the 
phage chromosome within a capsid, production of the completed virion (that is 
specialised in finding a new host), and production of proteins to lyse the bacterial 
host cell and release phage progeny into the environment. 
Phage progeny production and assembly is a complex process which varies 
considerably between different phages. Many phage genomes encode the necessary 
factors required to completely synthesize a new virion, while other phages are 
heavily dependent on host factors (113). The assembly of tailed phages, for which 
much is known, predicts that the phage’s capsid structure and tail structure assemble 
independently and are subsequently joined to form a functional virion (114). 
Proteins encoded by the phage lysis module, typically a holin and endolysin, 
are responsible for rupturing the host bacterium and releasing mature phage progeny 
(Fig. 12). Endolysins accumulate into the cytoplasm of the host bacterium, and are 
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conformationally ready to degrade the bacterial cell wall. However, holins are 
produced and accumulate in the membrane until a specific ‘programmed’ time. At a 
critical point, holin oligomers form, creating pores that function to permeabilize the 
bacterial membrane and release the endolysins to complete the phage infection cycle 
(115). 
 
 
Figure 12. Example of bacterial lysis and phage progeny release (figure sourced 
from R. Bijlenga, Biozentrum, University of Basel though web link: 
www.sciencephoto.com/media/249780/view). 
 
Phages released from the infected bacterium typically kill the host, releasing 
newly formed infectious virions. These phage particles are inert, non-living entities, 
but are primed to adsorb to a host bacterium should they collide, initiating another 
round of the phage infection process. 
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SECTION II.V LAB Phage-Resistance Mechanisms 
Advances in our understanding of LAB and their infecting phages have 
helped in the rational selection of phage starter cultures, their rotational 
implementation and management, and the development and design of dairy factories. 
These modern practices have industrialized the dairy industry from what was 
traditionally an artisan process. Probably the clearest examples demonstrating why 
phages remain problematic for the dairy industry is demonstrated by studies 
examining bacterial-encoded phage-resistance mechanisms and subsequent phage 
circumvention thereof. 
Bacterial acquisition of a phage-resistance mechanism represents a key 
innovation, which can render the majority of phages unable to replicate. For a period, 
this emergent bacterial population multiplies unchecked by phage infection. 
However, while phage replication produces predominantly homogeneous 
descendants, a minority of the population will accrue point mutations, genomic 
deletions, insertions, or combinations thereof. Many, if not most, of these mutations 
may negatively affect phage replication fitness; however, if one of the mutated phage 
descendants is capable of infecting a previously phage-resistant bacterium, this 
genetic variant becomes the fittest and thus repopulates the ecological niche. As 
before, this phage produces a heterogeneous mix of descendants whose evolutionary 
trajectory is determined, in part, by numerous complex phage-host interactions. 
Bacteria have evolved systems to block phage attack at numerous stages of 
the infection process, while phages in turn have developed solutions to evade such 
bacterial defences (116). Naturally occurring L. lactis phage-defence mechanisms 
have been identified and characterized that act at virtually every stage of phage 
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development: from cell surface modification that prevents phage adsorption (50, 63, 
69), superinfection exclusion (Sie) systems that prevent phage DNA injection (117, 
118), restriction-modification (R/M) systems which target the phage DNA for 
degradation (59, 119), clustered regularly interspaced short palindromic repeat 
(CRISPR) systems which provide a memory of, and immunity to, previous phage 
infections, to abortive infection (Abi) systems that protect the bacterial population 
via suicide of the infected bacterium (119, 120). The section below focuses on 
phage-resistance mechanisms encoded by LAB, highlighting, where pertinent, 
systems that target the different stages of phage replication. 
The first stage of phage infection, as discussed above, requires a phage virion 
to successfully recognise and adsorb to a cognate host bacterium. The selective 
pressure of phage infection often results in natural bacterial mutants that alter their 
cell surface composition, and such LAB mutants are commonly utilized by dairy 
industries as bacteriophage-insensitive mutant, or BIM, starter cultures. However, 
lactococcal BIMs with changes in their cell surface are often negatively affected in 
their growth properties compared to the parental strain (69) (Ainsworth et al., 
unpublished results). 
During the 1980’s and 90’s, several plasmid-encoded phage adsorption 
inhibition systems were identified in L. lactis strains (121-124). Strains harbouring 
these plasmids were reported as producing a more ‘fluffy’ pellet upon centrifugation. 
This was attributed to a cell surface coating, which could be observed under electron 
microscopy, which apparently blocked or masked the phage receptor and prevented 
phages from efficiently adsorbing to the surface of lactococcal strains. Recently, cell 
surface coatings of lactococcal strains conferring phage resistance were described as 
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an exopolysaccharide (EPS) layer (125, 126). Whether the original lactococcal 
adsorption inhibition systems were due to EPS production is currently unknown, as 
there exists a number of other mechanisms utilized by bacteria to avoid phage 
adsorption (for a comprehensive review, see (119)). However, similar to EPS layers, 
the LAB surface-coating layers described in the initial phage adsorption inhibition 
system studies could be easily removed by mild alkali treatment. When strain 
SK110, possessing a plasmid which was shown to encode a phage adsorption 
inhibition system, was given a mild alkali treatment the phage adsorption efficiency 
returned to levels comparable to the plasmid-free strain (123). 
Host-encoded defence mechanisms have been characterized in several LAB 
that prevent phage host-penetration. The best studied example in a lactococcal strain 
is the Sie protein of phage Tuc2009 (Sie2009), produced during lysogenic replication 
of the P335 species phage. Sie2009 is encoded by Tuc2009’s lysogenic module and 
situated between the genes encoding the repressor and integrase proteins, which is a 
common gene constellation found in genomes of lactococcal phages that belong to 
the P335 species. Sie2009 is a membrane-associated protein that was shown to 
interfere with phage DNA injection, but not phage adsorption. Sie2009, expressed in 
vitro, is capable of protecting its host bacterium from superinfection by several 936 
species phages, and was shown to prevent phage infection even when the host 
bacterium was challenged with 10
9
 phage per ml (118). 
Similar to Sie2009, the temperate S. thermophilus phage TP-J34 encodes a 
lipoprotein, Ltp, within its lysogeny module which is believed to be directed to the 
cell surface through signal sequence secretion. This is consistent with its detection 
on the surface of L. lactis protoplasts, which had been stripped of their cell wall 
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layer, by immunogold labelling. Interestingly, when Ltp is expressed in an L. lactis 
host, it protects L. lactis from infection by a 936 species phage P008 (127). Recently, 
the crystal structure of LtpTP-J34 was solved. While the N-terminus of Ltp anchors the 
superinfection exclusion protein to the cytoplasmic membrane, the soluble C-
terminus is formed by a tandem of three-helix helix-turn-helix (HTH) domains. 
Mutants of phage P008 which could overcome the protective effect of Ltp were 
sequenced, and mutations were identified within the phage TMP. The TMP of phage 
P008 has a strong positive charge (pI > 9.0), while the C-terminal surface charge of 
Ltp is highly negatively charged. These results are congruent with Ltp interacting 
with P008 TMP, thereby interfering with normal phage host-penetration and DNA 
injection processes (128). 
R/M systems are ubiquitous in bacteria and are an important mechanism 
employed by bacteria to control the acquisition of foreign DNA (129). A typical R/M 
system requires three components: (i) a specific DNA sequence, (ii) an restriction 
enzyme which recognizes the specific DNA sequence if it is unmethylated thereby 
targeting such DNA for its endonuclease activity, and (iii) a cognate methylase 
which methylates a base in the recognition sequence, thereby preventing the 
corresponding DNA from being recognized and cut by the endonuclease (130). R/M 
systems are designed to degrade foreign DNA entering the cytoplasm of a bacterium. 
Bacterial DNA is protected from its own R/M system, even after synthesis of a new 
DNA strand, as at least one strand is methylated (i.e. hemi-methylated). Methylases 
are more specific for hemi-methylated DNA. This is important as both the methylase 
and restriction enzyme are active in the cell at the same time, and their relative 
activity is important in determining the fate of foreign DNA, as phage DNA which 
 43 
becomes methylated before an endonuclease degrades it could result in phage 
replication and bacterial death. 
As soon as a phage successfully infects an R/M system-possessing bacterium, 
the DNA of its progeny becomes methylated. Phages infecting a bacterial population 
possessing an R/M system may also evolve point mutations to avoid endonuclease-
recognition (131, 132), while phages have also been described that have acquired a 
methylase gene from the host chromosome and can thus alter between infecting 
bacteria possessing or lacking a specific R/M system (133, 134). 
As highlighted above, the protection provided by R/M systems is 
fundamentally dependent on specific DNA sequences. Phages which evolve point 
mutations in their recognised sequences become resistant and avoid nuclease 
degradation. The mutation rates for dsDNA organisms were observed by Drake et al. 
(1998) as remarkably similar in diverse microbes. A mutation rate per genome per 
replication (m/g/r) of approximately 0.0034, or 1 bp change per 10
10
 nt, was 
observed for bacteria (and temperate phages) (135). However, lytic dsDNA phages 
possessed an m/g/r under laboratory conditions of ~0.004 (~1 bp change per 10
8
 nt). 
The increased mutation rate is probably because a lytic virus is replicated numerous 
times per infection (135, 136). This explains how, under successive rounds of 
replication, phages so quickly acquire the necessary point mutations to overcome 
sequence-specific bacterial defence mechanisms such as R/M systems. 
The accumulation of point mutations throughout a phage genome to avoid 
R/M systems is often evident by the lack of the relevant restriction sites in their 
genome. For example, L. lactis 936-type phages jj50 and sk1 possess 14 and 11 
LlaAI restriction sites (GATC) in their 27.5 kb and 28.5 kb genomes, respectively, 
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while the rare emerging lactococcal phage P087 possesses only 2 LlaAI sites in its 
entire 60.1 kb genome (reference, this work). This requires evolutionary selection 
over multiple generations, which is facilitated by the inherent leakiness of R/M 
systems (130). 
The genes encoding many R/M systems of LAB have been identified on 
plasmids (137). While LAB plasmids encoding R/M systems are still being 
identified and characterized (138-140), the number of chromosomally encoded R/M 
systems detected in LAB is increasing due to advances in genome sequencing (141-
143). 
Approximately 40 % of all bacteria possess one or more CRISPR loci and 
CRISPR-associated (cas) genes (144). The following outline of the CRISPR/Cas 
system is taken from the extensive reviews on this bacteriophage-resistance system 
(145, 146), except where indicated. A CRISPR locus is composed of 2 to 375 DNA 
repeat sequences (21-48 bp), each separated from the next by a unique DNA 
sequence called a spacer (21-72 bp). Following entry of foreign genetic material into 
the bacterial cell, such as an unsuccessful phage infection, part of the invading DNA 
can be incorporated into the 5’ end of the CRISPR locus as a new spacer. The 
incorporation of such a new spacer, flanked by repeat sequences, is facilitated by the 
so-called Cas proteins. 
The CRISPR locus is transcribed from a promoter in an upstream leader 
region (20-534 bp). This leader region is also believed to be important in the 
acquisition of new spacer sequences, as new spacers were observed to be orientated 
in a conserved manner next to the leader region (147). The CRISPR transcripts are 
processed into CRISPR RNA (crRNA) at the repeat sequences to yield individual 
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spacer sequences with part of a repeat sequence at its 5’ end. The spacer sequences 
of the crRNA direct Cas proteins to protect the bacterium against invasion by foreign 
genetic material containing complementary sequences to the crRNA. Both DNA and 
RNA have been observed as the target of different CRIPSR/Cas systems, 
highlighting the mechanistic diversity of the system (148, 149). 
The various CRISPR/Cas subtypes all contain two universal cas genes (cas1-
2), four conserved cas genes (cas3-6) and one or more of nine subtype-specific cas 
gene-sets, that may function as nucleases, helicases, RNA binding proteins, etc., in 
various organisms (150, 151). Additional cas genes, loosely associated with the 
CRISPR loci, are also observed in genomes containing a given CRISPR/Cas system. 
These are called repeat associated mysterious proteins (RAMPs) and are only present 
in genomes with a CRISPR/Cas system (152). The different cas genes facilitate both 
the acquisition of new spacers (adaptation stage) and the neutralization of invading 
genetic elements (interference stage) (145). 
CRISPR cassettes are frequently spread via horizontal gene transfer (HGT) 
(153, 154). A number of sequenced megaplasmids (> 40 kb) contain CRISPR loci 
and cas genes, and similarly several chromosomal CRISPR loci have been located 
near plasmid-associated genes (153). When published, Horvath et al. (2009) 
observed only one sequenced LAB CRISPR locus that was present on the E. faecium 
pHT beta plasmid (155, 156), although at least one other was discovered since then 
(see below). 
CRISPR elements were not detected in the sequenced genomes of 
Lactococcus, Leuconostoc, or Pediocococcus (156). It was highlighted that the 
absence of CRISPR in these bacteria may have been strain-specific and not 
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indicative of the species. This may indeed be the case, as recently a strain of 
Lactococcus was discovered to possess a plasmid-borne CRISPR system. However, 
CRISPRs are not common in L. lactis strains, as this plasmid-borne CRISPR system 
was identified as the only positive from a screen of 383 other industrial strains (157). 
Barrangou et al. clearly showed that the adaptation of S. thermophilus to 
virulent phages is via the acquisition of new spacers at the leader end of the CRISPR 
locus (158). The phage genomic sequences which became spacers, called proto-
spacers, were not randomly selected. Proto-spacer adjacent motifs (PAMs) were 
identified flanking the proto-spacer (159). In S. thermophilus, different CRISPR loci 
were clearly shown to have different PAM sequences: the PAM sequence of locus 1 
(Sthe1) was shown to be AGAAW, while that of locus 3 (Sthe3) is GGNG (156, 
160). 
LAB possessing CRISPR elements may still become sensitive to phage 
infection. A single point mutation in the phage proto-spacer or neighbouring PAM 
sequence was shown to result in S. thermophilus reversion to a phage-sensitive 
phenotype (159, 161). This knowledge of CRISPR/Cas systems and phage resistance 
has allowed the rational design of BIMs of LAB for industrial application (159). 
As previously mentioned, certain LAB strains do not possess CRISPR 
elements which would greatly improve their phage resistance. Recently, research has 
shown that the S. thermophilus Sthe3 CRISPR locus can be transferred to E. coli and 
retain its ability to provide interference against incoming plasmids and phages. The 
engineered plasmid could successfully interfere with plasmid transformation by 
more than five orders of magnitude and λ infection by three orders of magnitude. 
The authors noted how this potential allows for the development of phage-resistant 
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strains, and strains that are much less likely to incorporate and disseminate 
undesirable plasmids (162). In lactococcal dairy strains, however, many desirable 
technological properties (lactose utilization, peptidases, phage resistance 
mechanisms, etc.) are plasmid-encoded, and perhaps this is why lactococcal strains 
used in the dairy industry as a general rule do not possess CRISPR/Cas systems. 
The CRISPR/Cas system, which is ironically spread via HGT, is a host 
defence mechanism against invading genetic material (such as phages, plasmids and 
transposons). As spacers in the CRISPR loci nearest the leader sequence are the most 
recently acquired, this provides a historical account of recent phage infections in the 
ecosystem. Loss of spacers, likely via homologous recombination, limits the size of 
the CRISPR loci (163). The CRISPR/Cas phage-defence mechanism reflects host-
prey interactions that drive an evolutionary race between bacteria and phage, through 
the maintenance and renewal of CRISPR spacer sequences in the case of the 
bacterial host and the acquisition of mutations in the phage genome that allow escape 
from the CRISPR system. As mentioned, the CRISPR system acquisition of new 
spacers is believed to require an unsuccessful phage infection. Thus, the 
CRISPR/Cas system may work in tandem with other host defence mechanisms to 
limit phage infection. 
Abi systems are found in a diverse range of organisms (164, 165); however, 
they have been extensively studied in L. lactis. The dominance of research pertaining 
to lactococcal Abi systems may have been influenced by the following factors: (i) L. 
lactis is an economically important bacterium for the production of various cheeses, 
(ii) phage infection of starter strains in dairy fermentation plants is an ever-persistent 
problem (57), (iii) significant data is available relating to the three main species of 
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lactococcal phages, c2, 936, and P335 (64), (iv) lactococcal strains often possess 
multiple plasmids that possess technologically desirable properties related to 
industrial production of cheeses (lactose utilization, proteases, bacteriocins, etc.), 
including Abi systems, which may readily transfer by conjugation, and (v) plasmid 
localization of many Abi systems has facilitated the relatively easy identification of 
the gene, or genes, involved in phage-resistance phenotype (120). 
Abi systems, also called phage exclusion systems, refer to a broad collection 
of protein-mediated anti-phage mechanisms, which function to provide host 
protection by preventing normal phage multiplication. In several cases, Abi systems 
have been shown to inhibit phage proliferation by prematurely killing the infected 
cell. This altruistic nature of Abi systems sets them apart from other phage-defence 
mechanisms. Furthermore, unlike R/M systems, Abi systems are effective against 
phages regardless of prior phage-host interactions (i.e. phages become resistant to 
R/M systems after a single propagation due to methylation). Abi systems typically 
result in a drop in efficiency of plaque formation, burst size, and efficiency of 
formation of centres of infection (130). 
If the action of a particular Abi system results in death of such an Abi-
encompassing bacterial cell, it complicates the characterization of the mode of action 
of the system. Twenty three different Abi systems have thus far been identified 
against lactococcal phages (166). With just a few exceptions, they have been named 
alphabetically AbiA through to AbiZ (there is an AbiD but also an AbiD1; while 
there are no Abi systems that have (yet) been assigned the names AbiM, AbiW, 
AbiX, or AbiY). The majority of the characterized Abi systems operate through a 
single protein; however, Abi protection may be mediated by two proteins (in the case 
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of AbiE, AbiG, AbiL, AbiT, AbiU) or by multi-component systems (AbiR). The 
lactococcal Abi systems characterized to date highlight that almost all aspects of 
phage multiplication can be targeted; DNA replication, transcription, and synthesis 
of structural proteins (for a review, see (120)).  
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SECTION III Siphoviridae Tail Structure and Function 
Bacteriophages are the most abundant biological entities in the biosphere, 
with 10
31
 prokaryotic viruses estimated on earth, outnumbering bacteria by an order 
of magnitude (53). Siphoviridae, referring to phages with a dsDNA genome and a 
long non-contractile tail, are the dominant viral morphotype (73). The abundance of 
Siphoviridae may be indicative of their efficiency at infecting bacteria. 
Siphoviridae tails are multi-proteinaceous complex machines that act in a 
pre-programmed and coordinated manner to distinguish and adsorb to their host’s 
receptor, penetrate the bacteria’s cell envelope, and direct DNA ejection into their 
host’s cytoplasm. Several Siphoviridae phages have been analysed in depth with 
respect to their tail structure. Enterobacterial phages λ and T5, lactococcal phages 
Tuc2009, TP901-1 and p2, and Bacillus subtilis phage SPP1 have all served as 
models to advance our understanding of Siphoviridae tail structure and function. 
Here we review Siphoviridae tail machines, with emphasis on these model phages, 
so that the structural and functional significance of their tail structures can be 
interpreted and applied to other Siphoviridae phages, despite divergent DNA 
sequences. 
 
SECTION III.I Tail Length Determination 
The length and flexibility of Siphoviridae tail structures may increase host 
recognition efficiency. In support of this hypothesis, a correlation between tail length 
and environment levels of biological activity was noted for various phages in aquatic 
ecosystems, with oligotrophic waters containing phages with longer tails than meso- 
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and eu-trophic waters (167). Ackermann (1998) reported that Siphoviridae tails 
range from 79-539 nm, although recently Siphoviridae with tails greater than 800 nm 
have been described (74, 168). 
The length of a Siphoviridae phage tail is determined by the phage tape 
measure protein (TMP) (169-171), which acts as a molecular ruler, whereby specific 
repeating sequences are believed to act as a scaffold for the assembly of the final 
phage tail tube. Analysis by Belcaid and colleagues (2011) highlighted that many 
Siphoviridae TMP proteins possess specific repeat motifs, with the amino acids (aa) 
tryptophan or phenylalanine occurring either every 11 residues or following a pattern 
of 11-11-18 residues (172). 
In-frame deletions and duplications of the TMP have been shown to 
proportionally decrease or increase the length of λ and TP901-1 tails (Fig. 13; (170, 
171)). The TMP of phage λ measures 32 Major Tail Protein (MTP) disks. Katsura 
and Hendrix (1984) calculated that one amino acid of the TMP template protein 
roughly correlates to 0.15 nm length of the phage tail (169). Notably, ten 40 aa 
repeating motifs with regularly spaced aromatic residues within the TMP of 
lactococcal phage p2 are present and predicted to adopt a curved alpha-helix, which 
is assumed to determine the length of the lactococcal 936 phage tail (173). 
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Figure 13. Tail length determination by phage λ TMP. The number of major tail 
protein rings, from left-to-right, are; 13, 21, 25, 26, 30 and wild type 32 (figure 
sourced from (174)). 
 
Phages often possess a six-fold symmetry of their tail tube and also contain 
six copies of their TMP per mature phage particle (175, 176). Proteolytic processing 
of E. coli phage λ TMP occurs before the assembled head and tail structures are 
connected (177, 178). Maturational cleavage of the TMP also seems to take place in 
the L. lactis phage Tuc2009, although apparently processed and unprocessed proteins 
were detected in the mature virion (179). 
 
SECTION III.II Initiating Tail Assembly 
The tail tips of Siphoviridae phages frequently possess a long tail fibre, 
which plays an important role in tail morphogenesis. For example, the association of 
three copies of phage λ’s gpJ tail fibre protein represents the first requisite step for 
the formation of a so-called initiator complex that acts as a hub for tail assembly 
(Fig. 14). The gpJ trimer is further complexed with proteins gpI, gpL and gpK (180), 
followed by the addition of six copies of TMP, or gpH, which are associated with 
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two chaperone proteins, gpG and gpGT (181, 182). The initiator complex is 
completed by gpM addition and stabilization (180). 
Lactococcal phages Tuc2009 and TP901-1 share ~78-97 % identity in the 
proteins that make up their respective distal tail structure (176). These high levels of 
homology, both in terms of gene synteny and corresponding amino acid 
composition, have allowed extrapolation of the experimental data obtained for 
Tuc2009 and TP901-1, which in turn has resulted in a very comprehensive model 
regarding the tail structure and function of either of these phages (183). Tuc2009 and 
TP901-1 both possess a 135 nm tail (171), and morphogenesis of these respective 
tails, like phage λ, is believed to be dependent on the C-terminal portion of the TMP, 
the Distal Tail protein (Dit) and the N-terminal portion of the tail fibre or Tail-
Associated Lysin (Tal) protein (184), as these three proteins are proposed to form a 
so-called initiation complex (171, 185). In agreement with this notion, it has been 
shown that phages deficient in any of these three proteins produce tail-less DNA-
containing capsids (184). Recent work suggests that the N-terminal domain of Tal 
may not be necessary for assembling the baseplate of phage TP901-1 (see below), 
although it may be required for anchoring the assembled Dit-baseplate structure to 
the tail tip (186). 
The TMP C-terminus, Dit and tail fibre N-terminus of TP901-1 and Tuc2009 
share 24 %, 32 % and 26 % amino acid identity to its equivalents encoded by 
Bacillus subtilis phage SPP1, respectively, implying structural and functional parity 
between these phages. Veesler et al. (2010) have shown that the Dit protein is a 
central docking component in many Gram-positive phages (187). The SPP1 Dit 
equivalent is a donut-shaped hexamer, forming an internal central channel 
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approximately 40 nm wide. The internal diameter and negative surface charge of Dit 
are both congruent with DNA egression through Dit. The model for SPP1 initiation 
complex assembly proposes that several copies of the TMP bind at their extremity to 
the internal surface of the Dit hexamer, and protrude towards the capsid, while a 
dome-shaped trimer of gp21 N-terminus (the SPP1 tail fibre protein) associates with 
the Dit hexamer’s tail tip exposed surface, capping the tail tube channel (187). 
 
SECTION III.III Tail Tube Formation 
Following the formation of a Siphoviridae initiator complex, the TMP is 
assumed to serve as a scaffold for tail tube formation. The proteins gpG and gpGT 
are not associated with mature Siphoviridae, but are proposed to function as 
chaperones for tail morphogenesis and major tail protein (MTP) polymerization. The 
ratio of gpG to gpGT is believed to be an important factor in controlling tail 
formation, with gpGT produced at an approximate ratio of 1:30 relative to gpG 
production (188). Controlling the relative abundance is achieved by means of a –1 
ribosomal frameshift during mRNA translation at a specific slippery sequence 
located at the 3’ end of the gpG gene, causing translational coupling to the gpT ORF 
to form protein gpGT. Production of gpGT analogues using sequence-specific 
translational frameshifts is conserved amongst many long-tailed bacteriophages 
(188, 189). 
Recent publications on gpG and gpGT of phage λ have shown that both 
proteins are essential for correct assembly of its tails. Plasmid-induced 
complementation assays showed the abundance of gpG:gpGT was essential for 
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efficient tail production, which explains the important conservation of the frameshift 
mechanism for gpGT production in Siphoviridae (190). In a separate publication Xu 
et al. (2013) demonstrated that the “G” region of gpGT binds to the TMP of phage 
lambda, gpH, while the “T” domain of gpGT binds the MTP, gpV. Protein gpG 
binding to gpH (and also binding of the “G” domain of gpGT) is apparently evenly 
distributed across the whole length of λ TMP. However, the gpH-gpG and gpH-
gpGT-gpV interactions remain poorly understood and structural analysis of the TMP 
protein is likely a key requirement to elucidating more of the tail tube assembly 
process (191). 
The crystal structure of lactococcal phage p2 ORF12 shows that it is an 
orthologue of gpG. ORF12 crystallizes to form side-by-side spirals in solution (173). 
The spiral structure of tail-associated chaperone proteins was recently shown to be 
conserved in the enterobacterial phage HK97 (192). Regularly occurring 
hydrophobic pockets in the ORF12 oligomer of phage p2 correspond to the predicted 
positions of repeating aromatic residues along the curved α-helical region of TMP. It 
is predicted that the ORF12-TMP complex maintains the TMP hydrophobic helix in 
its correct shape and in solution until the MTP tail tube is formed (173). 
For some phages it has been shown that MTP subunits form hexameric rings 
encircling the TMP, with such rings stacking along the length of TMP towards the 
capsid (for examples, see (175, 179, 193)). The polymerization process of phage λ 
MTP, gpV, possibly displaces the chaperones gpG and gpGT bound to the TMP; 
although there is currently no direct evidence for this. Current knowledge indicates 
that gpV polymerization on the gpH TMP scaffold pauses when the N-terminus of 
TMP is reached. The tail terminator protein of phage λ, gpU, which forms a 
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hexameric structure in phage λ and SPP1 (194, 195), is known to associate with the 
top ring, thereby preventing aberrant tail tube polymerization (196, 197). The tail 
tube of phage λ is completed by proteolysis of gpH to gpH*, changing the molecular 
weight of this protein from 90 to 78 kDa, and by the addition of protein gpZ whose 
function is currently unknown (182, 194, 196). The completed λ tail structure can 
spontaneously assemble with a completed λ capsid structure to form an infectious 
virus (Fig. 14; (114)). 
 
 
Figure 14. Cartoon representation of phage λ tail assembly (figure sourced from 
(190)). 
 
The enterobacterial phage T5 possesses a 250 nm long flexible tail. Five or 
six copies of the 121 kDa protein, Pb2, form both the TMP and straight tail fibre 
(105). The 40 Pb6 MTP rings encircling T5 TMP are unusual amongst long tailed 
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phages as they are reported to have a trimeric and not a 6-fold symmetry, the 
significance of which is currently unknown (198). 
The tail tube of phage SPP1 is the product of two MTPs, gp17.1 and gp17.1*. 
Both MTP proteins possess the same amino terminus, however, gp17.1* is the 
product of a +1 translational frameshift at a programmed sequence, adding 
approximately 9.1 kDa to the carboxyl terminus of gp17.1. This translational 
frameshift produces gp17.1 and gp17.1* at a ratio of approximately 3:1. Both gp17.1 
and gp17.1* can solely be used in the production of tail tubes. However, tail tubes 
produced simply of gp17.1 are smooth and featureless, while gp17.1* only tail tubes 
are ‘hairy’ (199). 
Plisson et al. (2007) reported on the structure of the MTP tail tube of SPP1 
before and after phage receptor recognition. SPP1 MTP is composed of four 
domains, D1-D4. The signal generated by the phage anti-receptor causes MTP 
domains D1 and D4 to rotate clockwise by 14
o
 toward the tail axis, and D2 to bend 
slightly towards the tail axis. The alterations observed in D4 causes significant 
changes in D3 of the same MTP subunit, causing D3 to tilt to a vertical orientation. 
The movement of D3 reduces the tail internal diameter by 25 %, from 56 to 42 Å. 
Each ring of MTP is rotated approximately 21
o
 to the previous ring, and the 
movement of D3 induces an alteration in D4 of the next MTP ring. Signal 
transmission following receptor binding proceeds via each of the six MTP subunits 
per ring in a domino-cascade away from tail tip, opening the head-to-tail connector 
for DNA expulsion (193). 
The tail tube of phage TP901-1 is composed of 33 stacked MTP rings. Like 
SPP1, each MTP ring of TP901-1 is composed of six subunits, however, each MTP 
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ring is rotated relative to the previous ring by 22.4
o
 (200). While the bacterial 
receptor recognized by TP901-1 has recently been elucidated (Ainsworth et al., 
unpublished results), no comparison of the pre- and post-DNA ejection states for 
phage TP901-1 is available. 
 
SECTION III.IV Phage Host-Recognition 
The C-terminus of phage λ tail fibre, gpJ, functions as a receptor binding 
protein (RBP). For DNA injection by wild type phage, λ requires the bacterial outer 
membrane protein LamB, involved in maltose uptake to the periplasmic space (201), 
and the inner membrane maltose phosphoenolpyruvate phosphotransferase proteins 
IIC and IID (202). Homotrimers of LamB produce an outer membrane porin, 
although λ-ejected DNA does not pass through the pore (202). Phage λ gpJ binds in a 
two-step process; reversible adsorption is followed by an irreversible binding which 
commits the phage to DNA ejection and inactivation (203). A gap between the phage 
tail tube tip and LamB receptor, approximately equivalent to the length of λ tail fibre 
(21 nm), is observed in reversibly bound phage. Irreversibly adsorbed phages are 
seen to be in direct contact with the receptor and their capsids are largely emptied of 
DNA (204). 
Phage side tail fibre (stf) proteins increase the efficiency of phage adsorption. 
The chaperone protein, Tfa, is required for phage λ stf assembly and is present in the 
mature virion. The common laboratory isolate of phage λ, designated λ-PaPa, and 
isolated in the 1950’s, is missing its stf proteins due a frameshift mutation. The 
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original isolate of phage λ, Ur-λ, possesses stf proteins and has been shown to absorb 
faster and more efficiently (182, 205). 
Binding of enterobacterial phage T5 to its proteinaceous receptor FhuA is 
mediated through Pb5, a protein forming the conical structure at the end of the tail 
tube (206, 207). The addition of FhuA to T5 phages in vitro causes DNA ejection 
and phage inactivation, and the addition of recombinant Pb5 to cells competes and 
blocks T5 adsorption. The interaction of Pb5 with FhuA results in a strong 
irreversibly bound complex, and separating Pb5 bound to FhuA required protein-
denaturing conditions stronger than were needed to denature either Pb5 or FhuA in 
isolation (208, 209). Pb5 binding to FhuA is thus believed to cause conformational 
changes in Pb5, and can be observed to cause major conformational changes in Pb2 
straight tail fibre, shrinking it from 50 to 23 nm and doubling its width from 2 to 4 
nm (Fig. 11; (104)). 
A baseplate-like structure, almost twice the diameter of the tail tube, is 
situated between the terminal MTP ring and conical tip of phage T5 (Fig. 15; (198)). 
Two putative proteins, Pb3 and Pb4, are believed to form this structure (105, 210). 
Three L-shaped tail fibre (LTF) proteins, encoded by Pb1, are attached to the tip of 
the T5 tail at this baseplate structure (211). These L-shaped tail fibres of phage T5 
are responsible for the adsorption to E. coli LPS, and, although non-essential for 
infection, this interaction facilitates efficient host adsorption and thus infection (198, 
212).  
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Figure 15. T5 tail and tail tip structure analysed by cryo-electron microscopy (EM). 
Images (a) and (b) show the surface of an 11-disc segment of the 40-disk tail with 3-
fold symmetry, while (c) shows a longitudinal section. The image (d) shows the 
relative rotation of two major tail protein disks. Image (e) represents a cross-
sectional view of the density map corresponding to the centre and edge of a disk, 
apparent in the banded appearance of the tail tube in (f) T5 micrographs. Picture (g) 
is a negatively stained EM image where the tail tip and fibres are evident. Image (h) 
shows a single particle analysis reconstruction of the tail tip with baseplate. Scale 
bars represent 50 Å (figure sourced from (198)). 
 
 61 
The RBP of lactococcal phage p2 (belonging to the 936 species), represented 
by ORF18, was crystallized and structurally examined. The RBP was, similar to 
TP901-1, dissected into three domains: the N-terminal shoulder domain involved in 
anchoring the RBP to the phage tail tip, the linker or neck region, and the C-terminal 
host-recognizing head domain. The p2 RBP heads were, like TP901-1, found to be 
associated with a glycerol molecule in their crystal structure (107). The RBPs of p2 
were also characterized in detail by examining antibodies which neutralized phage 
infection. These antibodies were effective in neutralizing 12 out of 50 tested 936 
species lactococcal phages, and bound to head domains of phage p2 ORF18 at the 
cleft between the RBP trimer subunits (107, 213, 214). 
Interestingly, addition of the cation calcium, known to be essential for many 
infecting lactococcal phages (215), was observed in crystal structures and EM 
density maps of phage p2 baseplate to cause conformational changes at the phage tail 
tip by rotating the RBPs by approximately 200
o
 to a ‘heads-down’ active 
conformation (Fig. 16; (216)). The baseplate is composed of two back-to-back 
ORF15 hexamers of the Dit protein, a trimeric assembly of ORF16 (orthologous to 
the N-terminus of TP901-1 Tal protein and SPP1 gp21), and six trimers of ORF18 
RBPs. Phage p2 requires ORF16 for in vitro oligomerization of ORF15. The C-
terminus of p2 ORF15 has an extended galectin-fold, creating 6 protrusions around 
the periphery that do not contact each other. Each extension, termed an ‘arm’, 
projects a three-digit ‘hand’ clear of the ORF15 hub. The arms of the upper ORF15 
ring differ as they are in contact with each other, forming a continuous volume. In 
the inactive model of p2, the galectin hand of the lower ORF15 ring associates with 
the shoulder domain of a RBP homotrimer, and the upper ORF15 ring arms and 
 62 
hands are in lateral contact with the head domains of RBP heads. Interpreting this 
inactive model, the RBPs are in a ‘heads-up’ orientation. 
The reorientation of p2’s RBP direction during calcium activation causes the 
dome-shaped tail tube cap, composed of the N-terminus of three ORF16, to 
outwardly rotate and create an approximately 32 Å channel for DNA ejection. The 
N-terminus of the ORF16 proteins, previously not in any contact with RBPs, now 
shares a large contact area, keeping the RBPs in a heads-down conformation. A 
model for initiation of infection by the lactococcal phage p2 speculates that the 
primary interaction with the host cell surface LTA and/or cell wall polysaccharide 
(see (50) for information related to L. lactis cell wall polysaccharides), both of which 
are known to contain phosphate groups (and thus function as cation ‘sponges’), 
release calcium that triggers conformational changes in the baseplate to an activated 
form (Fig. 16; (216)).  
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Figure 16. Crystal structure of lactococcal phage p2 baseplate and activation. 
ORF15 is green, ORF16 is pink, and ORF18 is blue. (A) Side view of p2 baseplate 
in a ‘heads-down’ active conformation. (B) Top-down view of p2 baseplate in a 
‘heads-down’ active conformation. (C) Side view highlighting the rotation of p2 
RBPs, ORF18, in their inactive ‘heads-up’ conformation (dark blue) and active 
‘heads-down’ conformation (light blue) (figure sourced from (216)). 
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Phages such as Tuc2009 and TP901-1 recognize their bacterial hosts by a 
large proteinaceous complex, termed a baseplate, located at their tail tip (Fig. 17). 
The baseplate of TP901-1, with a calculated molecular weight of 1.8 MDa (217), 
constitutes a large part of the overall tail structure (estimated at 6.4 MDa by 
modifying Sciara et al.’s 2006 calculation for Tuc2009 tail structure, taking into 
account recent advances in our understanding on the baseplate (176)). The baseplates 
of Tuc2009 and TP901-1 are composed of six tripod or baseplate protein (Bpp) 
structures, associated around the periphery of a Dit hexamer structure formed during 
the initiator complex morphogenesis (184). The baseplate tripod assemblages of 
Tuc2009 and TP901-1 are both composed of upper baseplate proteins (BppU), 
forming the apex of the tripods, and the lower baseplate proteins (BppL), forming 
the three ‘legs’ of the tripods. The quaternary structure of each TP901-1 tripod is 
composed of a trimer of BppU and three trimers (one trimer for each leg of the 
tripod) of BppL (176, 213). The tripods of Tuc2009 differ slightly, as a BppU 
subunit is substituted by two copies of an associated baseplate protein, BppA (218).  
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Figure 17. EM images of (A) TP901-1 BppU-BppL tripods, (B) TP901-1 Dit-BppU-
BppL baseplates, and (C) p2 ORF15-ORF16-ORF18 baseplates. Scale bar is 500 Å. 
Inset images are computer-generated class averages of several observed structures 
(figure sourced from (186)). 
 
The lower baseplate protein (BppL) of Tuc2009 and TP901-1 functions as 
the RBP. Both phages possess 18 homotrimers of BppL, representing the 18 tripod 
legs (three for each tripod, with six tripods present on each baseplate), providing 
each phage with a total of 54 RBP molecules. All characterized RBPs of lactococcal 
phages are modular in nature (219, 220). The N-terminal ‘shoulder’ domain of BppL 
connects the RBP to the upper baseplate protein BppU. A ‘neck’ domain links the 
shoulder to the ‘head’ domain (176, 220). The C-terminal head domain of 
lactococcal phage RBPs is responsible for recognizing saccharidic receptors on the 
bacterial surface (50, 213). The unique host ranges of Tuc2009 and TP901-1 could 
be experimentally swapped by exchanging BppL901-1 and BppL2009 (179). In addition 
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to BppL, it was recently demonstrated that the accessory baseplate protein BppA of 
phage Tuc2009 increases the host-affinity of the phage RBP tripods, facilitating 
efficient host recognition (183, 218). 
Crystallization of the TP901-1 RBP, BppL, revealed that a glycerol molecule 
was co-crystallized at the presumed substrate binding site of BppL, while tryptophan 
fluorescence quenching experiments indicated that BppL also was able to bind to 
specific saccharides in solution with high affinity (213). The region of the TP901-1 
RBP actively involved in host recognition was further characterized by specific 
designed ankyrin repeat protein (DARPin) binding-proteins and camelid antibodies 
which both bound to the tip of the RBP head domain. The interactions between 
camelid antibodies and DARPin molecules with lactococcal RBPs are specific and 
strong enough to prevent phage infection (214, 221, 222). 
The topology of Tuc2009 and TP901-1 RBPs in the baseplate structure 
suggests they are in an infection-ready orientation to recognise their host bacteria. 
Unlike activation of phage p2 by calcium (or other divalent cations), which results in 
dramatic morphological alterations, calcium is not required for infection by TP901-1 
and only partially required for infection by Tuc2009. Thus, the phage activation 
mechanism for these P335 species phages likely requires more subtle morphological 
rearrangements (215). Currently, the best candidate for generating the signal for 
phage genome ejection upon correct host recognition was the observation of subtle 
morphological alterations in the tripods of TP901-1. Electron microscopy of purified 
TP901-1 tripods showed two class-averages, with the distance between tripod legs 
differing by 20 Å in ‘packed’ and ‘open’ conformations (185). 
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The tail fibre of phage SPP1, encoded by gp21, is bi-functional. The N-
terminus of gp21 functions as a tail tube cap capable of opening for DNA ejection, 
while the C-terminus acts as a RBP. A hinge region in gp21, located downstream of 
the N-terminal cap domain allows for a high degree of flexibility, measuring angles 
as great as 50
o
 (193). SPP1 reversibly adsorbs to teichoic acids on the surface of B. 
subtilis (223), yet gp21 recognizes and irreversibly binds to the exposed ecto-domain 
of the membrane protein YueB (224, 225). The C-terminus of gp21 is not predicted 
to contain a channel for DNA egression. Vinga and colleagues (2012) have indicated 
that following gp21 C-terminus interacting with YueB, the tail fibre’s C-terminus is 
still present and not cleaved from the virion structure (226). Therefore, the gp21-
YueB interaction may result in a conformational change in gp21 such that it does not 
obstruct DNA egression following the opening of the tail tube cap represented by the 
N-terminus of gp21. At the initiation of infection, the TMP of SPP1 is expelled from 
the tail tube volume, presumably through the opened tail tube cap, before the capsid-
released DNA is directed along the tail tube into the host bacterium (193). 
In several instances, phage structural proteins such as the major capsid 
protein or major tail protein are reported as incorporating domains to enhance host 
adsorption (227). The C-terminus of phage lambda MTP, gpV, has an Ig-like fold 
believed to facilitate adsorption to enterobacterial cell-surface carbohydrates (228). 
As mentioned, the tail tube of SPP1 is predominantly composed of gp17.1; however, 
a +1 frameshift can also result in a C-terminal extension, producing protein gp17.1*. 
The C-terminal extension of gp17.1* is proposed by Auzat and colleagues (2008) as 
facilitating the phage infection cycle through weak interactions with the cell surface 
of bacteria and contributing to the phage scanning for a specific receptor on a 
potential host (199). The tail tube of lactococcal phage p2 is composed of 31 MTP 
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rings and a ring formed by the tail terminator protein. The MTP of phage p2 also 
possesses a C-terminal domain described as ‘decorating’ the tail tube, which may 
similarly fulfil an adhesion-like role (229). 
 
SECTION III.V Host Penetration and DNA Injection 
Phage λ gpK, a protein required for initiator formation, possesses a putative 
PGH domain. However, the cell wall-hydrolysing role of gpK was initially 
indeterminate as detecting gpK in mature virions proved difficult (182). Recent work 
has shown that gpK possesses two domains, and N-terminal Mov34 domain and a C-
terminal NlpC/P60 domain. The N-terminal Mov34 domain is essential in tail 
morphogenesis. Mov34 domains are often involved in proteolysis, and this domain 
may be involved in the proteolysis of gpH and tail activation. The C-terminal 
NlpC/P60 domain of gpK is a PGH essential for phage activity, as mutagenesis of 
the catalytic Cys121 of gpK was shown to result in inactive phage particles (230). 
Protease sensitivity of gpH and gpJ changes during λ’s transition from 
reversible to irreversible adsorption, which is concomitant with the transition from 
type 1 to type 2 complexes, respectively. Protein gpJ is protease resistant in 
dispersed λ particles and type 1 complexes. However, gpJ becomes sensitive to 
proteolytic degradation following formation of type 2 complexes. It was proposed 
that a conformational change in gpJ tail fibre occurs, such that it does not enter the 
cell but is in an exposed configuration. Protein gpH in type 2 complexes becomes 
markedly more proteinase resistant. Uncharged amino acid residues at both ends of 
gpH, and the change to a protease resistant conformation, led to speculation that the 
 69 
TMP gpH is involved in membrane penetration and anchoring, or in creating a 
transmembrane channel (231). 
Phages penetrating their host can proceed via pore-forming or fusogenic 
proteins (29). As discussed above, the tip of enterobacterial phage T5 TMP protein, 
Pb2, possesses pore forming activity in vitro (102). This is due to two fusogenic 
alpha-helical transmembrane segments present in the area between the TMP region 
and its straight tail fibre region of phage T5 Pb2 protein (105). These regions allow 
T5 tail fibre to cross two lipid bilayers and inject DNA into proteoliposomes 
containing T5’s protein receptor FhuA (104). Penetration and DNA injection by T5 
is facilitated by Pb2 possessing a C-terminally located muramidase domain which 
degrades the host PG layer, enabling the TMP to traverse this obstacle so that it can 
form a channel in the bacterial cell envelope (105). 
The tail fibres of phages Tuc2009 and TP901-1, in addition to the role of 
their N-termini in phage morphogenesis, possess a C-terminal cell wall-degrading or 
lytic domain, and were thus named Tal2009 and Tal901-1, respectively (for Tail-
Associated Lysin of Tuc2009 and TP901-1). The virion-associated lytic domain was 
predicted by Kenny et al. (2006) as an M23 peptidase, involved in degrading the 
lactococcal cell for initiation of phage infection (232). Endopeptidases of the M23 
peptidase family were characterized in Staphylococcus as glycyl-glycine hydrolases, 
cleaving the cross-linkage of the bacterial cell wall (233). In Bacillus prophage SP-β 
the M23 peptidase possesses DD-endopeptidase activity, degrading the peptide-bond 
between D-Ala and diaminopimelic acid in the peptidoglycan cross-linkage (234). 
While the lytic activity of Tal2009 was not observed against staphylococcal cell walls, 
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it was proposed to degrade the cross-linkage of lactococcal cell walls like other 
members of this protein family (232). 
An interesting observed phenomenon of Tal2009 and Tal901-1 is the 
incorporation of two forms of their tail fibres in the mature virions, both the full 
length ~100 kDa Tal protein and a truncated derivative lacking the C-terminal lytic 
domain. The stoichiometry and mechanism by which the full length and truncated 
Tal proteins are incorporated is still unknown, but Kenny and colleagues identified 
the proteolysis site in Tal2009. Since the amino acid region around the proteolytic site 
of Tal2009 and Tal901-1 is glycine-rich (GGSSG*GG for Tuc2009 and GGNSG*GG 
for TP901-1; position of the proteolytic cleavage is marked by *), and several M23 
peptidase enzymes cleave glycyl-glycine bonds, it was speculated that the Tal 
proteins may undergo self-mediated proteolysis (232). However, although the Tal 
proteins are proteolytically processed in vitro, the proteolysis of the Tal proteins is 
now known not to be autoproteolytic (see Chapter 2). The proteolysis of the Tal 
proteins of Tuc2009 and TP901-1 is now determined to be important in the efficient 
adsorption of the phages to their hosts and infection of cells with increased cell wall 
cross-linkage (235).  
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SECTION IV Concluding Remarks 
Phages are remarkable biological entities which have been a part of many 
important milestones in microbiology and molecular biology. Phages continue to 
provide, and aid our understanding of, many complex molecular interactions. The 
structures of phage virions represent extremely efficient nano-machines, and due to 
the conserved nature of their component proteins, a ‘blue skies science’ approach to 
understanding lactococcal phages is applicable across multidisciplinary phage-
related topics. 
 
Chapter 2 of this thesis is dedicated to examining the lytic activities 
associated with phage virions and understanding their role during infection. This 
chapter demonstrates a remarkable strategy utilized by certain tailed phages to 
ensure successful infection under different circumstances. 
 
Chapter 3 presented in this thesis is a broad assessment of the structural 
module of a Siphoviridae phage, and sought to specifically determine the role of 
proteins in the assembly and infection processes of phages. Through a variety of 
molecular techniques, it is apparent that phage virions have evolved from a 
conserved ancestral origin, as many phage proteins, despite divergent sequences, 
fulfil identical roles. Lactococcal Siphoviridae phages characterized here 
demonstrate how viruses are extremely efficient in a number of aspects, including 
the utilization of a compact genome and the ability to assemble into complex 
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quaternary structures both spontaneously and through specific chaperone 
interactions. 
 
Chapter 4 of this thesis describes the investigation of the most characteristic 
feature, and a fundamental question, of Siphoviridae – why do they possess long 
non-contractile tails? Through specific deletions, regions of the phage tape measure 
protein were scrutinized to determine the role of this protein in Siphoviridae 
structure assembly and its function during the infection process.  
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CHAPTER II 
 
The Lactococcal Phages Tuc2009 and TP901-1 Incorporate Two Alternate 
Forms of their Tail Fibre into their Virions for Infection Specialization 
 
 
Notes: 
Purified NZ9000 peptidoglycan was supplied, and analysed by RP-HPLC and 
MALDI-TOF MS following enzymatic digestion, by Dr. Pascal Courtin and Dr. 
Marie-Pierre Chapot-Chartier. 
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ABSTRACT 
Lactococcal phages Tuc2009 and TP901-1 possess a conserved tail fibre, 
called a Tail-Associated Lysin (referred to as Tal2009 for Tuc2009, and Tal901-1 for 
TP901-1), suspended from their tail tips that projects a Peptidoglycan-Hydrolase 
(PGH) domain towards a potential host bacterium. Tal2009 and Tal901-1 can undergo 
proteolytic processing mid-protein at the glycine-rich sequence GG(S/N)SGGG, 
removing their C-terminal structural lysin. In this study, we show that the PGH of 
these Tal proteins is an M23 peptidase which exhibits D-Ala-D-Asp endopeptidase 
activity, and that this activity is required for efficient infection of stationary phase 
cells. Interestingly, the observed proteolytic processing of Tal2009 and Tal901-1 
facilitates increased host adsorption efficiencies of the resulting phages. This 
represents, to the best of our knowledge, the first example of tail fibre proteolytic 
processing that results in a heterogeneous population of two phage types. Phages 
which possess a full length tail fibre, or a truncated derivative, are better adapted to 
efficiently infect cells with extensively cross-linked cell wall, or infect with 
increased host-adsorption efficiencies, respectively. 
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INTRODUCTION 
It is predicted that 60% of the estimated 10
31
 phages in the biosphere belong 
to the Siphoviridae (1, 2). Yet despite their prevalence, the molecular details 
surrounding the initiation of infection by such Siphophages are not fully resolved. 
The Siphoviridae tail tip is a multi-proteinaceous structure responsible for host 
recognition and the initiation of phage infection. Siphoviridae often possess a central 
tail fibre suspending from their tail tip known to be essential for various aspects of 
phage infection, such as tail morphogenesis, bacterial adsorption, cell envelope 
penetration, and directing DNA ejection (3-11). 
Coliphages lambda and T5, and Bacillus phage SPP1, are arguably the best 
studied models for understanding the various roles that central tail fibre proteins 
fulfil during Siphoviridae infection. Lambda possesses a central tail fibre, composed 
of three copies of gpJ protein, which forms a hub around which the tail organelle 
assembles (3). The C-terminus of gpJ functions as a receptor-binding protein, 
attaching to LamB on the surface of E. coli (5, 12). The tail-tube tips of reversibly 
bound lambda particles are approximately 17 nm from the cell surface, while the tail-
tube tips are in direct contact with the bacterial envelope when this phage is 
irreversibly bound to its host (13). The transition from reversibly to irreversibly 
bound phage lambda coincides with conformational changes in gpJ (detected through 
proteinase-sensitivity) and the appearance of a transmembrane channel proposed to 
be formed by the Tape Measure Protein (TMP) gpH (10, 14). 
The tail protein Pb2 of Siphoviridae phage T5 serves both as the TMP and 
straight tail fibre. Insertion of purified Pb2 into black lipid bilayer membranes results 
in the formation of pores of ca. 2 nm diameter (15). The C-terminus of Pb2 possesses 
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a PGH domain which promotes the penetration of the E. coli cell envelope (9). 
Located between the TMP and tail fibre region domains of Pb2 are two 
transmembrane domains. These have been shown to insert T5’s tail fibre into a lipid 
layer containing T5’s proteinaceous receptor FhuA. Insertion of Pb2 into FhuA-
containing liposomes causes conformational changes in Pb2, shortening its length 
while simultaneously doubling its width from 2 to 4 nm (9, 17). 
The central tail fibre of Bacillus subtilis phage SPP1 is composed of three 
copies of gp21 (11). The N-terminus of gp21 forms a cap at the distal end of the tail-
tube, which has been shown to open at the onset of infection (18). The C-terminus of 
gp21 acts as a receptor binding protein attaching to the membrane-spanning protein 
YueB (19-21). Irreversible adsorption of SPP1 to YueB initiates infection, and is 
accompanied by conformational changes transmitted across the full length of the tail-
tube to the portal protein by means of a cascading rotational-movement of the 
Siphophage’s major tail protein (11). 
Siphoviridae phages infecting Lactic Acid Bacteria (LAB), and in particular 
Lactococcus lactis, are the single largest cause of industrial milk fermentation 
problems and result in significant economic losses (22). The P335 phage species is 
one of the three major lactococcal-infecting phage species which cause regular 
problems for the dairy industry (the other species being c2 and 936) (23, 24). 
Scientific efforts to understand and control this particular problem in the dairy 
industry have allowed lactococcal phages to become one of the most intensely 
studied phage groups, and one of the model systems for understanding how 
Siphoviridae phages infect their host (25). 
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The tail fibre of lactococcal phages Tuc2009 and TP901-1 is composed of a 
trimer of the so-called Tal protein, which between them share 95% amino acid 
identity (26). Tal2009 and Tal901-1 are predicted to possess a C-terminally located M23 
peptidase PGH domain, which distally protrudes from the large host-recognizing 
baseplate structure of each of these phages (27-29). The N-terminus of Tal2009 and 
that of Tal901-1 both share 26% amino acid identity with the N-terminus of SPP1 tail 
fibre protein gp21 (30). The N-terminal portion of Tal2009 and Tal901-1 is therefore 
expected to fulfil an analogous role at the initiation of infection, opening to facilitate 
ejection of the TMP and DNA. Located between the predicted C-terminal M23 
peptidase domain and the N-terminal tail-tube cap of Tal2009 and Tal901-1 is a glycine-
rich sequence, GG(S/N)SGG. Interestingly, GGSSG*GG has been shown to undergo 
proteolysis in vitro and in vivo (cleavage location indicated by *), which results in 
mature Tuc2009 virions that have incorporated both full-length and truncated Tal 
proteins (31). 
Here we present the biochemical and mutational analysis of Tal to further 
understand the role of tail fibre proteins during infection. The importance of the cell 
wall-degrading activity and proteolytic processing of Tal2009 and Tal901-1 for host 
penetration and adsorption is discussed, and placed within the context of current 
knowledge on host penetration by Siphoviridae phages. 
  
 106 
MATERIALS AND METHODS 
Bioinformatic analysis. Relevant DNA sequences were downloaded from 
NCBI and manipulated using the DNAstar software package (DNASTAR Inc., 
Madison, WI). Protein domains were identified using EMBL-EBI’s InterProScan 
(http://wwwdev.ebi.ac.uk/interpro/). Multiple sequence alignments were generated 
online using EMBL’s ClustalW program 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The amino acid percentage identity 
between protein sequences was estimated by BLAST2p 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Bacterial strains, culture conditions, phage preparations and plasmids. 
Bacteria, phages and plasmids used in this study are listed in Table 1. L. lactis strains 
were grown at 30
o
C in M17 (Oxoid) broth or agar supplemented with 0.5% (w/v) 
glucose (GM17). Erythromycin and chloramphenicol were used as necessary at 
concentrations of 5 and 10 µg/ml, respectively. L. lactis strain NZ9000 carrying the 
TP901-1erm prophage was isolated by simultaneously inoculating 2% (v/v) NZ9000 
from a fresh overnight and 2% (v/v) TP901-1erm from a 10
10
 PEG-precipitated 
lysate, followed by 6 hours incubation, before selecting for erythromycin-resistant 
colonies. Large-scale phage preparations of TP901-1erm and mutant derivatives 
were performed as described previously (4) by inducing 1.6 L of the lysogenized 
NZ9000 host with mitomycin C. TBT buffer (100 mM NaCl, 50 mM CaCl2, 10 mM 
MgCl2, 20 mM Tris-HCl [pH 7.0]) was used as the phage resuspension buffer. 
Recombineering and oligonucleotides. All oligonucleotides used in this study 
are shown in Supplementary Table 1. Recombineering was performed as previously 
described (32). However, specific modifications optimized for L. lactis, such as 
 107 
phosphorothioate linkages and transforming 500 µg of oligos, were also employed 
(33). Recombineering oligonucleotides were ordered from IDT (Leuven, Belgium), 
while all other oligonucleotides were ordered from Eurofins MWG (Ebersberg, 
Germany). 
Protein expression and purification. The terminal 501 bp of the 3’-end of 
tal2009, was overproduced in E. coli using the pQE60 vector construct named 
pTal2009-5ΔN as previously described (31). The 501 bp 3’-end of tal2009 was also 
used to fuse it in-frame with the DNA encoding two LysM Cell-wall Binding 
Domains (CBDs) of Tuc2009’s endolysin by SOEing PCR (34, 35). The resulting 
amplicon, which specified a Tal2009M23peptidase-LysM fusion protein, and 
designated TalM23-LysM, was cloned into pNZ8048 using standard techniques, to 
generate plasmid pTalM23-LysM. The TalM23-LysM protein was overproduced in 
NZ9000 using the NICE expression system (36), and required purification using a 
denaturing-renaturation procedure as described in the QIAexpressionist handbook 
(QIAGEN). 
The terminal 501 bp regions of TP901-1’s tail fibre, amplified using TP901-
1erm and mutant TP901-1ermHis892Ala lysates as DNA templates, were cloned into 
pQE60 as described for pTal2009-5ΔN, and the corresponding proteins, named Tal901-
1-5ΔN and Tal901-1-5ΔNHis892Ala, respectively, were overproduced and purified as 
described above. 
Assay for lytic activity. L. lactis UC509.9 cells were autoclaved and the 
insoluble material was washed twice with water, once with 10 mM sodium 
phosphate buffer (pH 6.5), and finally resuspended in the latter buffer to produce a 
suspension with an OD600 of 0.450. All lysis experiments were performed in 
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triplicate at 30
o
C. While only water was added to the negative control, mutanolysin 
(Sigma), at a concentration of 0.1 U/ml, was used in all samples to hydrolyse the 
glycan strand linkages of the lactococcal cell wall. Tal2009-5ΔN and TalM23-LysM 
were added at 1.0 and 1.7 µg/ml (equimolar concentrations), respectively, to achieve 
further degradation of the cell wall. This combined degradation of the cell wall 
results in lysis and in a reduction in OD600. Cell wall hydrolysis using Tal901-1-5ΔN 
and Tal901-1-5ΔNHis892Ala was performed in a similar manner, except that autoclaved 
cells were prepared from the TP901-1 host L. lactis 3107. Tal901-1-5ΔN and Tal901-1-
5ΔNHis892Ala were assayed at equal concentrations of 1.75 µg/ml. 
Determination of hydrolytic specificity on pure peptidoglycan (PG). L. lactis 
MG1363 PG was prepared and hydrolysed by mutanolysin as outlined previously 
(37). The resulting soluble muropeptides were reduced with sodium borohydride. 
Following this pre-digestion step and prior to the addition of TalM23-LysM, the 
samples were adjusted to pH 6.5 by the addition of NaOH. TalM23-LysM-mediated 
digestion of MG1363 PG-derived muropeptides was carried out for 16 hours at 30 
o
C 
with gentle agitation, using 0.04 mg/ml of enzyme. Samples were then analysed by 
RP-HPLC with an Agilent UHPLC1290 system using ammonium phosphate buffer 
and methanol linear gradient as described previously (34). All the peaks of the 
mutanolysin digest and most of the peaks (peaks 4 to 12) of the mutanolysin plus 
TalM23-LysM digest were analysed without desalting by MALDI-TOF mass 
spectrometry (MS) using a Voyager-DE STR mass spectrometer (Applied 
Biosystems) as reported previously (37). Structural identification of the 
muropeptides was deduced from the previously published reference profile (37). 
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Phage assays. Phages used in this study were induced from their lysogenic 
host by the addition of 3 µg/ml mitomycin C (Sigma) to a liquid culture of the 
relevant strain when it had reached an OD600 of 0.1. Phage lysates were sterilized by 
filtration (0.45 µm pore filter) and stored at 4
o
C. Phage titres were determined in 
triplicate by plaque assay employing three independent lysates using the standard 
double agar method (38) against the TP901-1 sensitive host L. lactis 3107. All 
GM17 media contained 5 g/l glycine and 10 mM CaCl2. 
Adsorption assays were performed against host 3107 at an OD600 of 0.3 with 
a phage-host Multiplicity of Infection (MOI) of 0.01. Phages were allowed to adsorb 
for 10 minutes at 30 
o
C in the presence of 10 mM CaCl2. The adsorption assay 
control without bacterial cells (i.e. media only) allowed enumeration of the initial 
phage titre. The percentage of phage which adsorbed was calculated as [(initial 
phage titre-final phage titre)/initial phage titre]*100 (39). 
To compare the ability of TP901-1 and its Tal protein mutant derivatives to 
infect exponential phase or stationary phase cultures, Centre Of Infection (COI) 
assays were performed. Phage infection of L. lactis 3107 was performed using an 
MOI of 0.01 at 30 
o
C in the presence of 10 mM CaCl2. Phages were added to 
exponentially growing 3107 strain at OD600 ~0.3 (host 1), or to stationary phase cells 
of 3107 following culture dilution to OD600 ~0.3 using cell-free ‘spent’ GM17 
medium (host 2). After 10 minutes, cells were washed twice in GM17 to remove free 
phage, and subsequent dilutions were plaque assayed against an uninfected 3107 
culture to determine the COI values of host 1 and host 2, after which the Efficiency 
of COI (ECOI) formation was calculated as [(COIhost 1)/(COIhost 2)] (40). 
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Competition assays between Tal901-1 mutants TP901-1ermGly>Arg, which 
possesses a full length tail fibre, and TP901-1ermGly603*, which has a truncated Tal 
protein, were performed to directly compare the biological significance of the tail 
fibre and associated lytic domain. An equal volume of freshly prepared phage lysates 
of TP901-1ermGly>Arg and TP901-1ermGly603* were mixed together, and the phage 
cocktail was diluted 1:10 into both an exponential and stationary phase culture of L. 
lactis 3107 as described above, except the phages were allowed only 5 minutes to 
establish infection. 
Western blots. Phage proteins, from CsCl-purified phage particles, were 
separated on a pre-cast 12 % SDS-PAGE gel (Thermo Scientific) using a 0.1 M Tris-
HCl, 0.1 M HEPES, 3.0 mM SDS (pH 8.0) running buffer. Proteins were transferred 
to a nitrocellulose membrane (Hybond-C Extra, Amersham) in a electrotransfer unit 
(BioRad) for 2 hours at 100 V, in a 10 % methanol, 10 mM CAPS (pH 11.0) transfer 
buffer, which was kept cool by placing the unit on ice. The two primary antibodies 
for Western blots, recognizing the N-terminus of the Tal protein or the baseplate 
protein BppU, had previously been described (41), and shown to interact with the 
relevant protein of both Tuc2009 and TP901-1 (4). Western blot secondary 
antibodies, IRDye 680RD goat anti-rabbit antibodies (Li-Cor Biosciences), and pre-
stained protein molecular weight ladder (11-250 kDa; Li-Cor Biosciences), were 
detected in the 700 nm channel using an Odyssey CLx infrared imager (Li-Cor 
Biosciences). 
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RESULTS 
Analyses of P335-species structural proteins to identify virion-associated 
PGH domains. Kenny and colleagues previously demonstrated that the P335-species 
phage Tuc2009 possesses a tail-associated lytic activity (31). Although analysis of 
the phage genomes of two c2-type and forty 936-type phages did not reveal PGH 
domains associated with tail proteins (data not shown). The genomes of the eleven 
publicly available P335-species phages (23) all contain a gene that encodes an easily 
recognizable (due to its large size) TMP, followed by two genes that specify the 
Distal Tail protein (Dit) and tail fibre protein (Fig. 1) (25). ClustalW alignments of 
the presumed TMP, Dit and tail fibre protein sequences resulted in four closely 
related P335-species phage with a lysozyme-like domain associated with their TMP, 
five closely related P335-species phages with M23 peptidase domains associated 
with their tail fibre proteins, and two P335-species phage with no recognizable PGH 
domain (Fig. 1). 
Tal2009 PGH activity against lactococcal cells. The constructs Tal2009-5ΔN 
and TalM23-LysM both generate proteins with the same the C-terminal M23 
peptidase of Tal2009 tail fibre, however, the latter contains two additional LysM cell 
wall binding domains (Fig. 2A). In order to verify the cell wall-degrading activity of 
Tal2009-5ΔN and TalM23-LysM proteins, the lytic activity of these purified 
recombinant enzymes was assayed on autoclaved bacterial cells as outlined in the 
Material and Methods. Neither the addition of water (negative control) nor the 
addition of mutanolysin at low concentrations (0.1 U/ml) resulted in significant lysis 
of autoclaved cells, as measured through OD600 reduction of the PG-containing 
suspension (Fig. 2B). In contrast, a combination of mutanolysin plus Tal2009-5ΔN or 
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TalM23-LysM resulted in a clear reduction in OD600. TalM23-LysM was 
significantly more effective at hydrolysing PG relative to Tal2009-5ΔN over 20 hours 
(Fig. 2B), which is consistent with other reports where the addition of cell wall 
binding motifs were used to increase the lytic activity of PGH catalytic domains (42-
44). TalM23-LysM was therefore used in subsequent analyses. 
Characterization of Tal2009 PGH hydrolytic specificity. The PGH catalytic 
domain of Tal2009 is located at its C-terminal extremity, as previously reported and 
confirmed here, and contains an M23 peptidase domain (31). The M23 peptidase 
family includes endopeptidases that target the interpeptide bridge of PG. In order to 
confirm this prediction, it was necessary to identify the specific chemical bond 
targeted by the purified TalM23-LysM. PG was extracted from L. lactis MG1363 
and first degraded by mutanolysin, a muramidase, as previously described by 
Courtin et al. (37). The resulting soluble muropeptides were further incubated with 
TalM23-LysM recombinant protein. Muropeptides obtained after mutanolysin 
digestion (Fig. 3A) and after mutanolysin plus TalM23-LysM digestion (Fig. 3B) 
were separated by RP-HPLC. Comparison of the two obtained profiles revealed that 
the higher molecular weight muropeptides obtained by mutanolysin digestion of PG, 
such as dimers (peaks 16-30), trimers (peaks 31-36) and tetramers (peaks 37-39), 
were degraded by TalM23-LysM to its constituent monomers (peaks 1-15; 
Supplementary Table 2). This pattern of degradation shows that the PGH catalytic 
domain of Tal2009 acts as an endopeptidase that hydrolyses the lactococcal 
peptidoglycan within the interpeptide bridge at D-Ala-D-Asp/Asn bond. Thus, like 
other M23 peptidases (45-47), Tal2009 is a DD-endopeptidase able to hydrolyse PG 
cross-bridges. 
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Construction of NZ9000-TP901-1erm for Tal901-1 mutagenesis. In order to 
investigate the precise role of lactococcal Tal proteins during infection, mutagenesis 
was attempted on the gene encoding the Tal2009 protein. However, no mutagenesis 
system was found to be compatible with Tuc2009’s host strain UC509.9 (results not 
shown). As Tal2009 and Tal901-1 share 95% amino acid identity, and since mutagenesis 
of the TP901-1 genome has previously been successfully employed (4, 48-50), 
mutagenesis was instead performed on the Tal901-1 genome. However, rather than 
using the rather laborious pGhost mutagenesis method (51), we decided to employ 
recombineering, a mutagenesis system that has recently been adopted for L. lactis 
(32, 33). 
For the purpose of achieving TP901-1 mutagenesis by recombineering, we 
constructed a derivative of L. lactis strain NZ9000 that harboured the TP901-1erm 
prophage (this phage is a derivative of TP901-1 carrying an erythromycin marker; 
(50)), which was designated NZ9000-TP901-1erm (see Materials and Methods). The 
integration of TP901-1erm, via attB-attP recombination (52), was confirmed by (a) 
the lack of a PCR product with primers which flanked NZ9000s attB sequence, and 
(b) by generating PCR products from the primers flanking NZ9000s attB sequence to 
TP901-1 chromosomal sequences (results not shown). TP901-1erm phages induced 
from NZ9000 with mitomycin C were still capable of infecting L. lactis 3107 at 
levels of approximately 10
7
 pfu/ml. 
Employing the NZ9000-TP901-1erm strain, we introduced three different 
mutations in the tal901-1 gene, which resulted in three mutant TP901-1erm phages, 
designated TP901-1ermGly>Arg, TP901-1ermHis892Ala and TP901-1ermGly603*, and 
discussed in detail below. 
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Characterization of Tal901-1 mutants. Specific mutations were made in 
TP901-1erm Tal protein in order to investigate the role(s) of the various conserved 
features observed in Tal2009 and Tal901-1 during infection. Mutant TP901-1ermGly>Arg 
was based on previous work (31), which had shown that altering the DNA sequence 
of 3 glycine codons, corresponding to Tal2009’s proteolytic processing site 
GGSSGGG, to arginine codons, GRSSRRG, prevented in vitro proteolysis. The 
desired mutation was introduced into the TP901-1erm genome, and one such mutant 
prophage was selected and its genome sequenced to verify the genotype of the 
generated mutant phage. Western blots detecting the N-terminus of Tal901-1 protein 
verified that the mutated Tal protein of mutant TP901-1ermGly>Arg was unable to 
undergo proteolysis as only a single band corresponding to the full length Tal901-1 
protein (102.1 kDa) was detected, in contrast to the Tal protein of TP901-1erm (Fig. 
4). 
Western blots using primary antibodies directed against the Upper Baseplate 
Protein, BppU, which immediately succeeds tal901-1, was performed on all mutants to 
verify that there were no downstream effects caused by mutating tal901-1 (results not 
shown). 
The second mutation in tal901-1, generating mutant prophage TP901-
1ermHis892Ala, was designed to inactivate the M23 peptidase domain, as demonstrated 
for the Bacillus subtilis prophage SP-β (45). The histidine at position 892 (His892) 
of Tal901-1, underlined in TP901-1erm’s M23 peptidase sequence PHLHF, was 
targeted for mutation to an alanine residue as this is the first histidine in the HxH 
motif characteristic of zinc metallopeptidases (53). In order to verify the M23 
peptidase of mutant TP901-1ermHis892Ala was inactive, recombinant proteins of 
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TP901-1’s C-terminal M23 peptidase domain were created. Constructs Tal901-1-5ΔN 
and Tal901-1-5ΔNHis892Ala, representing the same C-terminal regions of their respective 
tail fibres as construct Tal2009-5ΔN, were assayed against autoclaved cells of L. lactis 
3107 (Fig. 2C). As expected, recombinant enzyme Tal901-1-5ΔN derived from 
TP901-1erm showed lytic activity, while Tal901-1-5ΔNHis892Ala, constructed from 
mutant TP901-1ermHis892Ala, showed no activity (Fig. 2D). Western blots determined 
that the Tal protein of mutant TP901-1His892Ala still undergoes proteolytic processing. 
This is evident as the full length and truncated Tal901-1 proteins (102.1 and 67.4 kDa, 
respectively) are detected (Fig. 4). These in vivo results show that the M23 peptidase 
domain Tal901-1 is not involved in the proteolytic separation of the Tal protein N- and 
C-terminus. 
The third mutant TP901-1 derivative, TP901-1ermGly603*, was designed to 
introduce a stop codon into the coding sequence of tal901-1 at the position where it is 
known to undergo proteolysis. This mutation would be expected to result in a 
homogeneous population of phages, the reverse of TP901-1ermGly>Arg, with all the 
Tal901-1 proteins of the TP901-1erm phage population truncated at the sequence 
GGNSG*GG (position of stop codon highlighted by *). TP901-1ermGly603* also 
allows a comparison with mutant TP901-1ermHis892Ala, whose Tal protein is also 
expected to be incapable of degrading peptidoglycan. Western blots verified the 
truncated TP901-1ermGly603* protein (67.4 kDa), which runs slightly below its 
expected position on the SDS-PAGE gel (Fig. 4). As expected, no full length Tal901-1 
protein (102.1 kDa) was detected in the Western blots of TP901-1ermGly603* in 
contrast TP901-1erm. 
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Efficiency of plaque formation of TP901-1erm and its Tal901-1 mutant 
derivatives. In order to determine the effect of the various mutations of tal901-1 on the 
efficiency of plaque formation of its corresponding TP901-1erm-derived phages, the 
ability of these mutant phages to infect lactococcal host 3107 was tested by plaque 
assay analysis. Plaque assays of TP901-1erm and its mutant derivatives were 
performed in triplicate on three independently produced lysates. The EOPs of 
TP901-1ermGly>Arg, TP901-1ermHis892Ala and TP901-1ermGly603*, relative to TP901-
1erm phage, were thus determined to be 0.408, 0.050 and 0.062, respectively (Fig. 
5A). The plaque morphologies of the Tal901-1 mutant phages were also noticeably 
different from those produced by wild type TP901-1erm: TP901-1ermGly>Arg 
produced plaques that were slightly smaller and hazier compared to TP901-1erm, 
while TP901-1ermHis892Ala and TP901-1ermGly603* both formed pinprick-sized 
plaques (results not shown). 
Adsorption assays of TP901-1 and Tal901-1 mutant derivates. Due to the 
location of Tal901-1 in the TP901-1 virion, i.e. suspending directly below the host-
recognizing baseplate organelle (26), we were curious about the effects of the Tal901-
1 mutations on adsorption. We therefore performed adsorption assays on the TP901-
1erm and its derived mutant phages, and expressed the obtained data as the 
percentage of phages which bound to the bacterial host cells in 10 minutes (Fig. 5B). 
The MOI for the adsorption assays, 0.01 phage per bacterial cell, was optimized 
based on conditions that yielded >95 % of unmutated TP901-1erm adsorbing to its 
host L. lactis 3107 within 10 minutes (data not shown). The obtained phage 
adsorption efficiencies for the various phages were as follows: TP901-1erm, 98.01 
+
/- 2.04 %; TP901-1ermGly>Arg, 87.24 
+
/- 1.36 %; TP901-1ermHis892Ala, 93.28 
+
/- 2.74 
%; and TP901-1ermGly603*, 99.56, 
+
/- 0.44 %. These results demonstrate that mutants 
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TP901-1ermGly>Arg and TP901-1ermHis892Ala significantly differ in their host 
adsorption efficiencies compared to TP901-1 (p-value < 0.05), while mutant TP901-
1Gly603* does not (Fig. 5B). 
Efficiency of Formation of Centres of Infection. The M23 peptidase domain 
associated with Tal2009 and Tal901-1 is expected to facilitate cell wall penetration and 
genome delivery, particularly during conditions where the cell wall is extensively 
cross-linked, as would be expected for stationary phase cells (8, 54). To compare the 
ability of TP901-1erm and mutant derivatives to infect stationary phase cells 
compared to exponentially growing cells, the phage ECOIs were calculated (see 
Materials and Methods). The ECOI for TP901-1erm was calculated as 0.41 
+
/- 0.02, 
TP901-1ermGly>Arg as 0.56 
+
/- 0.05, TP901-1ermHis892Ala as 0.22 
+
/- 0.005 and TP901-
1ermGly603* as 0.27 
+
/- 0.03. The difference in the mutant phage’s abilities to infect 
stationary phase cells, relative to TP901-1erm, is considered to be statistically 
significant (p-value < 0.05; Fig. 5C). 
Competition assays between TP901-1 mutants with and without tail fibre. In 
order to compare and contrast the biological significance of TP901-1 proteolytic 
processing of Tal901-1, the TP901-1 mutants permanently possessing or lacking the 
tail fibre were mixed together and simultaneously allowed to infect. The number of 
COIs established could be calculated due to distinguishing plaque morphologies 
formed by these phages. TP901-1ermGly>Arg, which possesses the C-terminus of 
Tal901-1 and thus the M23 peptidase domain, forms more COIs in stationary phase 
cells than TP901-1ermGly603*. In contrast, TP901-1ermGly603*, which lacks the C-
terminus of the tail fibre and the PGH motif, is more efficient at establishing COIs in 
exponentially growing cells (Fig. 5D).  
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DISCUSSION 
The proteolysis of Tuc2009 and TP901-1 Tal protein represents a molecular 
‘bet-hedging’ mechanism to produce a naturally mixed population of phages, which 
are simultaneously adapted for efficient host adsorption and host penetration. Many 
phages have evolved sophisticated strategies to efficiently infect their hosts, 
however, to our knowledge, the proteolytic processing step of Tal2009 and Tal901-1 
represents a novel phage mechanism. 
Not all phages appear to require PGH domains to facilitate host penetration 
and infection, as many phages lack any recognizable PGH domain associated with 
their structural proteins. However, there is growing evidence to support that virion-
associated PGH domains facilitate infection under conditions where the cell wall is 
extensively cross-linked (for a recent review, see (55)). In the current study, we show 
that the M23 peptidase of Tal2009 possesses a D-Ala-D-Asp endopeptidase specificity. 
This tail-associated lytic activity facilitates phage infection by undoing the 
interpeptide cross-linkage of peptidoglycan glycan strands. As the majority of the 
sequenced P335-species lactococcal phages possess PGH domains associated with 
their tail proteins, the localized degradation of the bacterial cell wall is predicted to 
be an important step in the initial stages of infection by this species of phage. 
In this study, we clearly show that TP901-1erm-derived mutants defective in 
their tail-associated PGH activity are not completely deficient in phage infection, but 
display decreased infection efficiencies. This is consistent with the study of Moak 
and colleagues, who demonstrated that mutagenesis of T7’s virion-associated PGH 
domain did not inhibit, but merely delayed, infection (56). Furthermore, the reduced 
ability of TP901-1erm PGH mutants to infect stationary phase cells is in agreement 
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with the study of Puiri et al., where the tail fibre lytic domain of Mycobacterium 
phage TM4 was necessary for efficient infection of stationary phase cells (8). 
It was previously reported by Scholl and colleagues that phage K1-5 encodes 
and incorporates two different tail fibre proteins into its virion, adapting the phage to 
penetrating hosts with a different cell envelope composition (57). Phages Tuc2009 
and TP901-1 (and perhaps many other phages) have similarly evolved a novel 
strategy to generate a heterogeneous population. Through Tal proteolysis, the 
lactococcal phages Tuc2009 and TP901-1 generate two phage types; incorporating 
either a truncated Tal protein or incorporating a full length tail fibre with an 
associated lytic domain. Phages which feature in their virion a PGH domain are 
better adapted to infecting bacteria with a higher degree of cross-linkage in their cell 
wall. However, this evolutionary advantage appears to be a double-edged sword, as 
the fitness cost is at the expense of phage adsorption. 
The study of lactococcal phages pertains not only to their industrial 
significance, but their broader importance as model systems. The clear differences in 
the tail fibres and infection mechanisms of lactococcal phages show the multifaceted 
approach by phages to achieve infection. Studies characterizing these underlying 
molecular processes serve to better understand Siphoviridae, and their host 
interactions, in the biosphere. 
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Table 1. Bacteria, phages and plasmids used in this study. 
Strains, phages and plasmids Relevant features Source 
L. lactis   
 MG1363 Prototypical Lactococcus lactis strain (58) 
 NZ9000 MG1363 pepN::nisRK (36) 
 901-1erm Lysogenic host and source of TP901-1erm prophage (59, 60) 
 3107 Lytic host for phage TP901-1erm (52) 
 UC509 Lysogenic host and source of Tuc2009 prophage (61) 
 UC509.9 Lytic host for phage Tuc2009 (62) 
 NZ9700 Nisin over-producing strain (63) 
 NZ9000-TP901-1erm NZ9000 lysogenized with TP901-1erm prophage This study 
 NZ9000-TP901-1ermGly>Arg Glycine to arginine mutations in the proteolysis site of TP901-1erm prophage Tal901-1 protein This study 
 NZ9000-TP901-1ermHis892Ala Histidine to alanine mutation at amino acid position 892 of TP901-1erm prophage Tal901-1 protein This study 
 NZ9000-TP901-1ermGly603* Stop codon inserted in TP901-1 prophage Tal901-1 proteolysis site sequence mimicking natural truncation  This study 
Phage   
 TP901-1erm Temperate P335-species phage infecting 3107; contains erythromycin marker (59, 60) 
 Tuc2009 Temperate P335-species phage infecting UC509.9 (62) 
 TP901-1ermGly>Arg TP901-1 phage with glycine to arginine mutations in the proteolysis site of Tal901-1 protein This study 
 TP901-1ermHis892Ala TP901-1 phage with Tal901-1 histidine at position 892 mutated to alanine This study 
 TP901-1ermGly603* TP901-1 phage with stop codon inserted at the site of Tal901-1 proteolysis This study 
Plasmid   
 pNZ8048 Nisin-inducible protein expression vector (64) 
 pQE60 QIAGEN expression vector, N-terminal 6xHis tag QIAGEN 
 pREP4 QIAGEN vector supplying LacI QIAGEN 
 pJP005 pNZ8048 derivative expressing RecT protein (32) 
 pNZ9530 Nisin helper plasmid supplying NisRK genes for protein expression; erythromycin marker (65) 
 pTalM23-LysM pNZ8048 construct expressing TalM23-LysM recombinant protein This study 
 pTal2009-5ΔN pQE60 construct expressing terminal 501 bp of Tal2009 (31) 
 pTal901-1-5ΔN pQE60 construct expressing terminal 501 bp of Tal901-1 This study 
 pTal901-1-5ΔNHis892Ala pQE60 construct expressing terminal 501 bp of Tal901-1 from mutant TP901-1ermHis892Ala This study 
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Supplementary Table 1. Oligonucleotides used in this study. 
Primer name Primer sequence (5’ → 3’) Notes 
LysM-FP ACGACGCCATGGAACATCACCATCACCATCACGATTCTACAAGCCAGCCAACG NcoI 
LysM-RP GTCCGTTTAAATAATTTAGTGTTTGACCAGCGTA SOEing PCR overlapping oligo 
Tal2009M23-FP ACACTAAATTATTTAAACGGACACCCTGAACGTA SOEing PCR overlapping oligo 
Tal2009M23-RP ACGACGTCTAGATTAAAATTTGATATAATCCCTTGGATTCTTAAAGTG XbaI 
Tal901-1-5ΔN-FP ACGACGCCATGGGATTAAACGGACACCCTGAACGTAGT NcoI 
Tal901-1-5ΔN-RP ACGACGAGATCTAAATTTGATATAATCCCTTGGATTCTTAAAGTGAG BglII 
NZ-attB-Fw TGTGAAGGCTCTAATCATCG Forms PCR product with NZ-attB-
Rv primer using NZ9000 DNA as 
template 
NZ-attB-Rv ATGCTGATGAATGTTGGGAAC 
TP-attP-Fw GAGATAACTGATGAACTATGG Forms PCR product with NZ-attB-
Fw primer using NZ9000-TP901-
1erm DNA as template 
TP-attB-Rv CCTATTCTTGATACTTCGTCA 
oJP1161ᴪ C*T*T*C*T*GGTGGGTATTGACCATTCCAACCTGTATCACCTCGGCGTCTATTTCGGCCACCATTAGTA
TCAATTTTTGTTCCGTTGACATAG 
Gly>Arg-creating recombineering 
oligo 
oJP1162 ATTGAAGAATCTGATCATTTTCTTGTAGC Oligo screening Gly>Arg 
oJP1163
¥
 AACCTGTATCACCTCGGCGTCTA Oligo screening Gly>Arg 
oJP1164 TTGGAGCAATATAACCTCCGCC Oligo screening Gly>Arg 
oJP1168ᴪ G*A*T*G*A*TGGCCAATATTGGTCCATGAATTGGAAGTGCAGTGCCGGTCCAGTGACCGGACCAGTCG
CTCCCATAAGTCCAAT 
His892Ala-creating 
recombineering oligo 
oJP1169 ACAAAACGGCCAATGGATTGCG Oligo screening His892Ala 
oJP1170
¥
 ATGAATTGGAAGTGCAGTGCC Oligo screening His892Ala 
oJP1171 TCTTCAATATACTTATTAAAGATTCG Oligo screening His892Ala 
oJP1106ᴪ, § T*G*A*C*T*TCTGGTGGGTATTGACCATTCCAACCTGTATAGATCTAGCCAGAGTTTCCGCCACCATTA
GTATCAATTTTTGTT 
Gly603*-creating recombineering 
oligo 
oJP1110 ATCATTTTCTTGTAGCTAACTCAGAAGG Oligo screening Gly603* 
oJP1111 AACAAATTTGTTATACCATTCTTGGGCC Oligo screening Gly603* 
ᴪ Nucleotides of recombineering oligos which are designed to alter the base sequence of Tal901-1 are underlined. 
¥ Nucleotides of screening oligos which bind to mutating bases are similarly underlined. 
* Phosphorothioate linkages of recombineering oligos 
§ Novel BglII restriction site indicated in italics.  
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Supplementary Table 2. Proposed structures of muropeptides separated by RP-HPLC. 
 
a
Peak numbers refer to Fig. 3. 
b
Structures were deduced from MALDI-TOF MS analysis and according to the reference profile established by Courtin et al. (2006). Tri, disaccharide tripeptide (L-Ala-D-
iGln-L-Lys); Tetra, disaccharide tetrapeptide (L-Ala-D-iGln-L-Lys-D-Ala); Penta, disaccharide pentapeptide (L-Ala-D-iGln-L-Lys-D-Ala-D-Ala); disaccharide, GlcNAc-
MurNAc; D, D-Asp; N, D-Asn; (NH2), amidation; deAc, deacetylation; Ac, acetylation; iGln, α-amidated isoGlu (isoGln). 
c
Positions of N and D in either peptide chain are arbitrary. 
d
Position of amidation was not identified.  
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Figure 1. Comparative analysis of the TMP, Dit, and Tal proteins from P335-species phages. The locations of predicted peptidoglycan hydrolase 
domains are highlighted by coloured boxes, as indicated in the legend. The percentage amino acid identity between protein sequences was 
estimated by BLAST2p and is indicated in the shaded grey boxes.  
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Figure 2. Analysis of peptidoglycan hydrolase activity associated with M23 peptidase of Tal protein constructs. (A) Diagrammatic 
representation of Tal2009 tail fibre, and recombinant proteins Tal2009-5ΔN and TalM23-LysM. (B) Hydrolysis of L. lactis UC509.9 cell wall. The 
negative control (water) is marked as black diamonds, mutanolysin-only is marked with dark grey squares, mutanolysin and Tal2009-5ΔN is 
marked with white triangles, and mutanolysin and TalM23-LysM is marked with light grey circles. Error bars indicate standard deviation, while 
asterisks are located above statistically significant values (p-value < 0.001). (C) Diagram displaying Tal901-1 tail fibre and recombinant proteins 
Tal901-1-5ΔN and Tal901-1-5ΔNHis892Ala. The histidine or alanine amino acid at position 892 in the M23 peptidase catalytic site of constructs Tal901-
1-5ΔN and Tal901-1-5ΔNHis892Ala, respectively, is highlighted. (D) Hydrolysis of L. lactis 3107 cell wall. The negative control (water) is marked as 
black diamonds, mutanolysin-only is marked with dark grey squares, mutanolysin and Tal901-1-5ΔNHis892Ala is marked with white triangles, and 
mutanolysin and Tal901-1-5ΔN is marked with light grey circles. Error bars indicate standard deviation, while asterisks are located above 
statistically significant values (p-value < 0.001).  
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Figure 3. RP-HPLC separation of muropeptides obtained by digestion of L. lactis PG by (A) mutanolysin and (B) mutanolysin + TalM23-LysM. 
Peak numbers refer to structures identified by MALDI-TOF (Supplementary Table 2). 
A 
B 
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Figure 4. Western blots of TP901-1erm and mutant derivatives using anti-N-
terminal Tal2009 antibodies. Lanes 1 & 6, molecular weight ladder; lanes 2-5, TP901-
1erm, TP901-1Gly>Arg, TP901-1His892Ala and TP901-1Gly603*, respectively. 
 
Figure 3 
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Figure 5. Bar charts showing phage assays of TP901-1erm and mutant derivatives. TP901-1erm results are in solid grey, TP901-1ermGly>Arg are 
white with grey dots, TP901-1ermHis892Ala are grey and white checkers, and TP901-1ermGly603* are grey with white dots. Error bars indicate 
standard deviation, while asterisks indicate mutants that are statistical significance (p-value < 0.05). (A) Plaque assays of TP901-1erm and 
mutant derivatives. (B) Adsorption assays of TP901-1erm and mutant derivatives, measuring the percentage of bacterial-bound phage in 10 
minutes. (C) Efficiency of Centre of Infection (ECOI) formation by TP901-1erm and mutant derivatives. Each ECOI was calculated as the 
number of Centres of Infection (COIs) formed on stationary phase cells relative to the number of COIs formed on exponentially growing cells. 
(D) Competition assays between TP901-1ermGly>Arg and TP901-1ermGly603*, comparing their ability to form Centres of Infection (COIs) within 5 
minutes. TP901-1ermGly>Arg are white with grey dots, TP901-1ermGly603* are grey with white dots. Mutant phage TP901-1ermGly>Arg permanently 
retains the C-terminus of its tail fibre protein, which possesses the M23 peptidase domain, while mutant TP901-1ermGly603* incorporates only a 
truncated derivative of Tal901-1. 
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CHAPTER III 
 
Mutational and Molecular Analysis of Lactococcal Phage TP901-1 
 
 
Notes: 
Recombinant protein-expression constructs, their overproduction, and subsequent 
antibody generation was conducted by Dr. Barry Collins and Dr. François Douillard. 
Tuc2009 time-course infection assay and Western-blots were performed by Dr. 
Barry Collins. 
Electron micrographs were taken by Dr. Silvia Spinelli. 
 
 
This chapter is in preparations for publication as a research article: 
Stockdale, S. R., Collins, B., Spinelli, S., Douillard, F. P., Mahony, J., Cambillau, C., 
van Sinderen, D. Mutational and Molecular Analysis of Lactococcal Phage TP901-1. 
Manuscript in preparation. 
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ABSTRACT 
Members of the Siphoviridae family represent the most abundant viral 
morphology in the biosphere, yet many aspects of their virion structure and 
associated functions have yet to be determined. In this study, we present a 
comprehensive mutational and molecular analysis of lactococcal bacteriophage 
TP901-1. Inactivation of twelve genes located within the structural module of 
TP901-1 through the generation of non-sense mutations, and the introduction of two 
additional mutations causing aberrant protein production, allowed us to determine 
the essential nature of many of the corresponding gene products and to provide 
information on their functionality. Furthermore, in vitro and in vivo assembly of 
phage virions was assessed in this study. Based on the obtained information, we 
propose a functional model for the proteins that make up the TP901-1 virion. 
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INTRODUCTION 
Siphoviridae phages represent the dominant viral morphology, frequently 
outnumbering other viral morphotypes in environments such as the human gut and 
oceanic waters (1-4). Despite the prevalence of phages with long non-contractile 
tails, only a handful of Siphoviridae have been extensively studied at a structural 
level (for a review, see (5)). Extensive research in the field of dairy lactococci and 
their infecting phages has been undertaken since their discovery (6-9). Consequently, 
lactococcal phages have become one of the best characterized group of bacterial 
viruses that occupy a defined ecological niche and infect a single bacterial species 
(10). The prototypical and related phages TP901-1 and Tuc2009 infect the 
economically important dairy-starter bacterium Lactococcus lactis, and have been 
important in understanding lactococcal and other Gram-positive Siphoviridae due to 
the genetic accessibility of their Gram-positive hosts, the various molecular tools 
available for manipulating their genomes and the conserved nature of phage 
structural proteins. 
Recently, a composite model of the TP901-1 virion was constructed by 
single-particle electron microscopy (EM) analyses of the phage’s capsid, head-tail 
connector, tail-tube and baseplate regions (11). Several studies have focused on 
characterizing the structure and function of lactococcal phage baseplates, as these 
tail-tip structures possess receptor-binding proteins that are involved in the specific 
recognition of and initial interactions with their hosts (12-22). While the capsid, 
head-tail connector, and tail-tube assemblages of TP901-1 and Tuc2009 phages are 
not as well described, much can be predicted regarding these regions due to the 
evolutionary conserved nature of tailed phages and their structural proteins (23). 
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Morphogenesis of a typical icosahedral phage capsid requires three essential 
factors: the portal protein, also known as the connector protein; the major head 
protein (MHP); and a scaffolding protein, or a scaffolding domain associated with 
the MHP (5). The assembly of functional capsids, through an intermediate DNA-free 
procapsid structure, necessitates MHP subunits to assemble into 12 pentamers and 
often a variable number of hexamers, and incorporate a dodecamer portal protein 
complex into a unique capsid vertex (24). While scaffolding proteins or domains are 
not believed to be part of mature capsid structures (25), portal protein complexes and 
scaffolding proteins have been demonstrated to interact and are often proposed to 
initiate capsid morphogenesis (26-29). In a model of phage P22 capsid assembly, 
Prevelige and colleagues (1993) visualized incomplete capsid structures which 
showed scaffolding proteins and viral coat proteins sequentially added to the edges 
of the assembling procapsid shell (30, 31), suggesting a mechanism by which a 
single portal vertex nucleates capsid morphogenesis. Head-tail connector proteins of 
Siphoviridae phages associate with the portal protein-containing vertex of DNA 
packaged capsids and, as their name suggests, serve as an attachment site for the tail 
organelle (32). Head-tail connector protein gp16 of phage SPP1 also fulfils a capsid 
DNA-plug role (33). Finally, mature phage capsid structures can be decorated with 
various accessory proteins; previous studies have demonstrated that TP901-1 and 
several other lactococcal phages possess neck passage structure (NPS) proteins 
which may bind to a protein, or proteins, associated with the portal vertex (34). 
Siphoviridae tail assembly requires the tail tape measure protein or TMP, 
probably as a hexameric complex (35, 36), to dictate the length of the phage tail 
structure (37, 38). Two tail chaperone proteins, gpG and gpGT, are essential for the 
correct assembly of Siphoviridae tails. Chaperone gpGT is produced through a -1 
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ribosomal frame-shift during mRNA translation at a specific sequence corresponding 
to the 3’ end of gene gpG, which represents a genetic peculiarity conserved in many 
dsDNA tailed phages (39). Protein gpGT binds the hydrophobic TMP through the G 
domain and recruits the phage major tail protein (MTP) via its T domain (40, 41). 
Polymerization of MTP around and along the TMP to form the phage tail tube 
pauses when the end of the TMP is reached (42). Tail terminator proteins associate 
with the terminal hexameric ring of Siphoviridae tail tubes to complete MTP 
polymerization (43-46). In phage λ, tails also require activation through an unknown 
mechanism by protein gpZ before they can associate with phage capsids to produce 
complete virions (42). 
In the current study, we analysed the effect of fourteen mutations introduced 
into genes ORF32-44 of the structural module of TP901-1 on the efficiency of 
plaquing and on phage virion integrity, as determined by in vitro assembly, 
immunological detection and EM. This new data complements and significantly 
expands current knowledge on lactococcal Siphoviridae (34, 37, 47), allowing the 
formulation of a detailed molecular model describing the structure, function and 
assembly of the TP901-1 virion. 
  
 145 
MATERIALS AND METHODS 
Bioinformatic Analyses. DNA sequences were downloaded from NCBI 
GenBank (48). Inducible prophage t712 of NZ9000, described by Ventura et al. 
(2007) (49), was identified using the PHAge Search Tool (PHAST) (50). BLAST, 
Pfam and HHpred analyses were used for functional annotations of proteins (51-54). 
Putative promoter sequences of NZ9000 prophage t712 were identified using 
SoftBerry BPROM (http://www.softberry.com). Sequence percentage similarities 
between relevant TP901-1 and Tuc2009 proteins were calculated using LALIGN 
with default settings (55), and are listed in Table 1. ‘Dot plot’-like graphs comparing 
protein sequences were performed using PLALIGN (http://fasta.bioch.virginia.edu). 
The results of significant HHpred hits of TP901-1 and Tuc2009 structural module 
proteins are provided in Table 1, alongside Protein Data Bank (PDB) identification 
codes. Alignment of (multiple) amino acid sequences was performed using ClustalW 
(56). Protein secondary structure predictions and intrinsically disordered regions 
were detected using Quick2D (http://toolkit.tuebingen.mpg.de/) (57-61). 
Bacteria, Phages and Growth Conditions. Bacterial strains and phages used 
in this study are listed in Supplementary Table 1. Growth experiments of lactococcal 
strains and phage propagations were performed as described previously (62, 63). 
TP901-1erm and mutant derivatives were induced from corresponding lysogens of L. 
lactis NZ9000-Crot712 under the following conditions: the relevant strains were 
grown at 30 
o
C to an A600 of 0.3, at which point mitomycin C (Sigma) was added to a 
final concentration of 3 µg/ml with subsequent incubation at 20 
o
C until lysis 
occurred. NaCl, 1 M (w/v) final concentration, was added to the resultant phage 
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lysates followed by centrifugation in a Thermo Scientific SL16R centrifuge at 5580 
× g for 15 min and stored at 4 
o
C. 
Mutant Generation. Recombineering mutagenesis was performed as 
described previously (63-65). A detailed description of all TP901-1erm-derived 
mutants created in this study, and their nomenclature, is provided in Supplementary 
Table 2. Point mutations, creating a BamHI restriction site, were introduced in the 
deduced promoter sequence of the predicted anti-repressor-encoding gene (crot712) of 
prophage t712 of NZ9000 in order to prevent its induction during mitomycin C 
addition (generating strain NZ9000-Crot712) (66). Mutations in targeted ORFs of the 
TP901-1 structural module were generated so as to insert an in-frame stop codon, 
thereby terminating translation (mutant nomenclature ORFTP901-1::Ter), and where 
possible, introduce a restriction enzyme site. In order to prevent gpT production, an 
in-frame BamHI restriction site was introduced into the ‘slippery’ sequence 
(GGGAAAG) at the 3’ end of the TP901-1 gpG gene which is required for the 
sequence-specific -1 ribosomal frame-shift required for gpT translation (mutant 
termed gpTTP901-1::BamHI) (39). To further analyse the production and role of 
chaperone protein gpT, a single nucleotide insertion, coupled with several point 
mutations, was introduced into the gpG slippery sequence resulting in a direct 
translational fusion between the gpG and gpT gene sequences (the resulting mutant 
phage was designated gpGfsTTP901-1). Mismatch Amplification Mutation Assay 
(MAMA) PCRs and restriction digests were performed to identify TP901-1erm 
prophages containing the desired mutations. Oligonucleotides used for 
recombineering and MAMA PCR screening reactions were purchased from 
Integrated DNA Technologies (IDT, Belgium), and are listed in Supplementary 
Table 3. Mutations were confirmed by Sanger sequencing relevant PCR-amplified 
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regions using chromosomal DNA from the mutated TP901-1erm-containing L. lactis 
NZ9000-Crot712 lysogen as a template (sequencing performed by MWG, Germany). 
Phage Purification and Sucrose Gradients. Phage lysates were purified by 
sucrose gradient ultracentrifugation as follows: polyethylene glycol 8000 (PEG 
8000; 10 % w/v) was added to phage lysates and mixed gently at Room Temperature 
(RT) until completely dissolved. Phage samples were placed on ice for 3-4 hr before 
centrifugation in a 4 
o
C pre-chilled Thermo Scientific SL16R centrifuge at 5580 × g 
for 20 min. Pellets were air-dried, before resuspending in 1:50 initial volume of SM 
buffer (50 mM Tris-HCl, 100 mM NaCl, 10 mM MgSO4; pH 7.5). PEG 8000 was 
removed from phage samples by chloroform-extraction with an equal volume of 
chloroform, followed by vortexing for 30 sec and centrifugation at 1660 × g for 15 
min. The aqueous phase was extracted and applied to a sucrose gradient. 
Linear sucrose gradients, 20-70 % (w/v), were prepared using a Masterflex 
peristaltic pump (Thermo Scientific) in Beckman Thinwall Ultra-Clear centrifuge 
tubes (14 x 89 mm). Sucrose was added to all phage samples, at a final concentration 
of 14 % (w/v), before layering them on top of the prepared linear sucrose gradients. 
Samples were centrifuged for 1.5 hr at 250,000 × g in a Beckman SW40Ti 
ultracentrifuge rotor at 4 
o
C. Bands were extracted from the sucrose gradient and 
immediately dialysed against SM buffer (12-14 kDa MW cut-off; Medicell 
International Ltd., London, UK.). 
Phage Assays. Spot and plaque assays of TP901-1 and Tuc2009 were 
performed as described previously (67). In vitro assembly of TP901-1 structural 
module mutants was performed using sucrose gradient-purified bands of TP901-
1erm and mutant derivatives of this phage. Sucrose gradient-purified fractions of 
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mutant MHPTP901-1::Ter and mutant MTPTP901-1::Ter were used as either a phage tail 
or capsid donor, respectively. Briefly, 10 µl of purified TP901-1erm capsids or tails 
were mixed with 10 µl of purified TP901-1erm structural module mutant derivative 
fractions, and incubated for 16 hr at 30 
o
C. The phage mix was then tested for its 
ability to infect L. lactis 3107 by assessing the frequency of lysogeny, which was 
determined through acquisition of the adenine methylase gene present on the TP901-
1erm phage genome (or its mutant derivatives), conferring resistance to 5 µg/ml 
erythromycin (Erm5) (68, 69). This was performed by adding 50 µl of the phage mix 
to 450 µl of L. lactis 3107 at an A600 of ~0.3 and incubated at 30 
o
C for 1 hr before 
plating. Three technical replicates calculating the frequency of lysogeny were 
performed and results averaged. 
Protein Expression, Purification and Antibody Generation. Recombinant 
protein-expression constructs created during this study, and the oligonucleotides 
used to create them, are outlined in Supplementary Tables 1 and 3, respectively. 
Primers used for cloning were purchased from Eurofins MWG (Germany). KOD 
high-fidelity DNA polymerase (Novagen, UK) was used for PCR amplifications. For 
cloning reactions, restriction enzymes were supplied by Roche (Germany) and 
ligations were performed with T4 DNA ligase (Promega, USA). For genes cloned 
using pNZ8048, NcoI and SpeI were used, while for pTX8049, BamHI and SpeI 
were employed. In both cases, primers were used so as to facilitate the incorporation 
of a hexahistidine-tag at the C-terminus of the encoded protein, while pTX8049-
generated proteins also incorporate an N-terminally fused thioredoxin tag (70). 
Proteins were expressed and purified as outlined previously (70). Rabbit antibody 
production was carried out by Harlan laboratories (Leicester, UK.). Immunization 
was initially carried out with individual proteins supplemented with Freund’s 
 149 
adjuvant at a concentration of ~200 g/ml; this was followed by five booster 
injections over the 112 day protocol. 
Tuc2009 Protein Expression. Antibodies against Tuc2009 tail proteins were 
previously generated and proved successful in detecting the homo-immune structural 
proteins of Tuc2009 and TP901-1 (71). Therefore, the following Tuc2009 capsid 
proteins were overproduced and purified in L. lactis NZ9000: PortalTuc2009, 
MCP1Tuc2009, MCP2Tuc2009, SfpTuc2009, MHPTuc2009, MCP3Tuc2009, HTC1Tuc2009 and 
gpZTuc2009. Attempts to express recombinant proteins of HTC2Tuc2009 and gpUTuc2009 
were unsuccessful (data not shown). 
SDS-PAGE and Western Blotting. SDS-PAGE separation of proteins was 
performed using 12 % or 15 % (v/v) acrylamide gels following standard procedures 
(72). After protein separation by SDS-PAGE, the proteins were transferred to a 
nitrocellulose membrane by electro-blotting using 10 mM CAPS [3-
(cyclohexylamino)-1-propanesulfonic acid; pH 11], 10 % methanol transfer buffer. 
Membranes were blocked for 1 hr at RT with 50 % (v/v) Odyssey blocking buffer in 
PBS (Licor, USA). Optimal conditions for each rabbit polyclonal antibody were 
determined empirically (data not shown). Membranes were incubated with primary 
rabbit polyclonal antibodies, in a range from 1:500-1:15000, in blocking buffer 
containing 0.12-0.25 % (v/v) Tween-20 for 1 hr at RT or overnight at 4 C. 
Following 4 × 5 min washes in 0.1 % (v/v) Tween-20, the membranes were 
incubated in 1:7500 fluorescently labelled goat anti-rabbit IgG secondary antibody 
(Licor, USA) in blocking buffer containing 0.12-0.25 % Tween-20. Membranes were 
washed again and visualised on a Licor Odyssey imaging system (USA). 
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Tuc2009 Infection Assay. The Tuc2009 infection time-course assay was 
adapted from a previously described approach (71). L. lactis UC509.9 was grown to 
A600 of ~0.3 and infected with Tuc2009 to give a multiplicity of infection of 0.1. 
Aliquots of UC509.9 were taken 10 min before infection and every 10 min post-
infection for 70 min. Samples were rapidly frozen by immediately placing them in an 
alcohol dry ice bath. Samples were subsequently thawed on ice and the cells 
collected by centrifugation in a 4 
o
C pre-chilled Thermo Scientific SL16R centrifuge 
at 19,000 × g. Cell pellets were resuspended in ice-cold TBT buffer (10 mM Tris-
HCl, 300 mM NaCl, 50 mM CaCl2; pH 8), before acid-washed glass beads (≤ 106 
µm; Sigma) were added and then bead-beaten (Mini beadbeater-8, Biospec Products) 
for 10 × 1 min periods, with 1 min intervals on ice between each beat period. 
Clarified cellular extracts were prepared by centrifugation as described above and 
the protein concentration of these extracts were established using the Bio-Rad 
protein assay (73). Equal protein concentrations, 20 µg per well, were loaded into 
SDS-PAGE gel lanes. 
Electron Microscopy. For negative staining, 5 ul of each sample were applied 
onto glow-discharged carbon-coated grids (Agar Scientific) and incubated for 1 min. 
The grids were washed with 5 µl of deionized water before incubating for 30 sec in 
1% (w/v) of Uranyl Acetate (Agar Scientific, Stansted, UK.). CCD images were 
collected using a Tecnai Spirit operated at 120 Kv and a 2Kx2K CCD camera. 
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RESULTS 
Annotation of TP901-1 Structural Module. In order to predict the function(s) 
of TP901-1 structural module-encoded proteins, a detailed annotation was 
performed. Protein sequences of TP901-1 ORFs were subjected to BLAST non-
redundant database, Pfam and HHpred searches (51, 52, 74). Also, due to the 
conserved nature of phage structural proteins and genetic synteny of lambdoid-like 
phages (75, 76), TP901-1 was compared with the closely related lactococcal phage 
Tuc2009, Bacillus subtilis phage SPP1, and enterobacterial phage λ. The individual 
structural modules of TP901-1 and Tuc2009 are represented by polycistronic 
operons, each approximately 20 kb in length, transcribed from a promoter located 
upstream of the gene encoding their predicted small terminase subunits (77-79). The 
deduced structural module of TP901-1 encodes 22 proteins (Fig. 1) (77), while the 
structural module of phage Tuc2009 contains one additional gene, which specifies 
the host adsorption-enhancing baseplate protein BppA, and which is located between 
the baseplate-encoding genes bppUTuc2009 and bppLTuc2009 (78). 
The majority of TP901-1 and Tuc2009 structural proteins are conserved 
between these phages. Eleven of the twenty TP901-1 and Tuc2009 common proteins 
analysed in this study share > 90 % amino acid (aa) similarity, while a further six 
proteins share > 60 % aa similarity. As the GenBank ORF numbers assigned to 
TP901-1 and Tuc2009 differ, we have assigned, and will henceforth refer to, a 
common name to proteins that are presumed (based on their similarity, or other 
reasons, as outlined below) to fulfil similar functions (Table 1). 
Previous studies have determined the functions for several conserved TP901-
1 and Tuc2009 structural proteins (13, 16, 34, 37, 47, 63, 69, 80, 81). Due to the 
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conserved nature of phage structural proteins, it is possible to predict the functions of 
several other TP901-1 and Tuc2009 proteins based on well characterized phage 
proteins (33, 46, 82-84). However, a number of TP901-1 and Tuc2009 proteins do 
not exhibit significant similarity to known proteins and thus their function is as yet 
undefined. These proteins are: the Minor Capsid Protein 1 (MCP1), Minor Capsid 
Protein 2 (MCP2), Scaffolding-like protein (Sfp), Minor Capsid Protein 3 (MCP3) 
tail-activator protein (gpZ), and tail chaperone proteins (gpG and gpT), each of 
which will be discussed below. 
The N-terminal portion of MCP1TP901-1 and the complete MCP1Tuc2009 protein 
share a very high level (94.3 %) of aa similarity. However, MCP1TP901-1 has an 
approximate 28 kDa C-terminal extension, or an additional 248 aa, compared to 
MCP1Tuc2009. The initial ~100 aa of this 248 aa extension of MCP1TP901-1 appears to 
be due to a genetic duplication of the 5’-part of the MCP1TP901-1-encoding gene 
(Supplementary Fig. 1). The remaining C-terminally located 145 amino acids of 
MCP1TP901-1 are lacking in its equivalent in Tuc2009, and no significant function can 
be ascribed to this C-terminal region based on database searches. The genes 
specifying MCP1TP901-1 and MCP1Tuc2009, as well as SPP1 capsid protein gp7 
(gp7SPP1) all occur immediately downstream of the genes encoding their 
corresponding portal proteins, and have a strong positive charge (pI values of ~9.0), 
and are largely α-helical (data not shown). Furthermore, ClustalW alignment of 
MCP1TP901-1, MCP1Tuc2009 and gp7SPP1 was performed and revealed aa conservation, 
with the exception of the C-terminal extension of MCP1TP901-1 (Supplementary Fig. 
2). 
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MCP2TP901-1 and MCP2Tuc2009, though their corresponding genes are located 
at equivalent positions within the reciprocal TP901-1 and Tuc2009 genomes, do not 
share significant homology with LALIGN using default settings. Therefore, it is 
unknown if these phage proteins fulfil analogous functions. HHpred analysis of the 
MCP2Tuc2009 detected strong homology to the winged helix DNA-binding protein 
YjcQ of B. subtilis, p-value 1.1e-43. Winged helix DNA-binding proteins are part of 
a larger class of DNA binding helix-turn-helix proteins. While no known function is 
ascribed to these proteins, YjcQ homologues have previously been identified within 
prophage capsid-encoding regions (85). 
ORF35 of TP901-1 and ORF36 of Tuc2009 are annotated in this study as 
specifying putative scaffolding-like proteins (Sfp) based on their localization within 
the capsid-encoding structural module region and their predicted secondary structure. 
Scaffolding proteins are involved in assisting the correct assembly of viral capsid 
structures by ensuring specific protein-protein interactions, nucleating the assembly 
within cells, and preventing/excluding non-specific interactions between proteins 
during the molecular construction of phage capsids (25). SfpTP901-1 and SfpTuc2009 are 
predominantly α-helical and part of their structure is predicted to be intrinsically 
disordered (Supplementary Fig. 3), features commonly associated with phage 
scaffolding proteins (25). 
Significant similarity between MCP3TP901-1 and MCP3Tuc2009 could not be 
detected using the default settings of LALIGN. Therefore, these minor capsid 
proteins are putatively assigned a common protein name solely based on their 
genetic synteny, although they may not fulfil analogous biological functions. 
Interestingly, HHpred analysis of MCP3Tuc2009 revealed its relatedness to GP10 of a 
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T7-like Podoviridae phage infecting Prochlorococcus, with a p-value 1.5e-12, and 
also the major capsid protein gp5 of the well characterized phage HK97, with a p-
value 5.8e-05. MCP3Tuc2009 exhibits similarity to a 52 aa region located at the C-
terminus of HK97 gp5, corresponding to residues 332-384 of this viral procapsid 
protein. Amino acid Asn356 of gp5, conserved in MCP3Tuc2009, is involved in 
covalently bonding neighbouring HK97 capsid subunits via an isopeptide bond 
(Supplementary Fig. 4) (86). Covalent cross-linkage of capsid protein subunits has 
been previously observed for lactococcal phage r1t (87); however, it has not been 
documented to date for phages TP901-1 or Tuc2009. 
The gene products of ORF40 of TP901-1 and ORF43 of Tuc2009 share 66.7 
% aa similarity. Although no significant similarities to other proteins could be 
detected by means of database searches, the proteins are annotated in this study as 
tail-activator proteins (gpZ), based solely on their gene synteny with the structural 
module of phage λ (42). Similarly, the chaperone proteins gpG and gpT of TP901-1, 
while not returning significant structural similarity to characterized (phage) 
chaperone proteins through HHpred analysis, are expected to fulfil a similar role as 
phage λ gpG and gpT tail chaperone proteins based on genetic synteny with 
lambdoid-like phages and the presence of a conserved ‘slippery’ sequence that is 
associated with gpGT production (40, 41). 
Optimizing TP901-1erm host background. Several advances were made to 
optimize the host background for analysing mutations made in TP901-1erm. A 
lysogenized derivative of strain L. lactis NZ9000 had previously been isolated (63), 
allowing the use of an erythromycin marker present on the TP901-1erm genome (68, 
69). This lysogenized NZ9000 derivative offered an advantage over the original 
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TP901-1erm host, L. lactis 901-1erm, as the latter strain contains a second prophage 
similar in sequence to TP901-1 which may supply proteins in trans (Finn Vogensen, 
personal communication). In addition, NZ9000 contains an integrated copy of the 
NisRK cassette for protein expression using the nisin-inducible promotor system 
(88), which was used for the overproduction of RecT for recombineering 
mutagenesis (65). In order to further optimize NZ9000 as a background for analysing 
mutations in TP901-1erm, a BamHI restriction site was introduced into the deduced -
10 promoter sequence of the lysogenic/lytic switch of prophage t712 (thereby 
generating strain NZ9000-Crot712), aimed at causing ablation of this promoter, 
thereby preventing t712 prophage induction and virion production. Induction of 
prophage t712 was identified as a potential problem as; (i) t712 particle production 
would interfere with TP901-1 phage particle study, (ii) t712 induction would 
increase the metabolic burden on the host when only TP901-1 induction was desired, 
and (iii) it was deemed possible that, due to the conserved nature of Siphoviridae 
proteins, t712 may supply TP901-1 with structural proteins being analysed during 
this study in trans (66). In agreement with the potential problems posed by prophage 
t712 during this study, mutagenesis of the deduced promoter sequence for t712 Cro 
protein caused an approximate 100-fold increase in the TP901-1erm titre obtained 
following mitomycin C induction from the NZ9000-Crot712 background as compared 
to that obtained when strain NZ9000 was used (data not shown; indicator strain used 
for TP901-1erm titre determination was L. lactis 3107). 
Efficiency of Plaquing of TP901-1erm Mutants. The nomenclature assigned 
to TP901-1erm structural module mutants is based on the common name assigned to 
the phage open reading frames (Table 1), followed by a designation signifying the 
insertion of a translation terminating stop codon or restriction site (e.g. MCP1TP901-
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1::Ter or gpTTP901-1::BamHI, respectively). The mutant that carries a mutation 
causing the translation fusion of ORF gpG and gpT was termed gpGfsTTP901-1. 
TP901-1erm-derived structural module mutants were induced from their 
lysogenic host and then tested for their ability to infect host strain L. lactis 3107 by 
spot and plaque assays to determine which genes/proteins are essential for TP901-1 
phage assembly and/or infection. Of the 14 mutants created in the TP901-1erm 
structural module, only mutants carrying a non-sense mutation in the genes for 
MCP2TP901-1 or MCP3TP901-1 retained some residual infectious ability (Fig. 1). Plaque 
assays of three independently induced lysates of MCP2TP901-1::Ter and MCP3TP901-
1::Ter displayed reductions in Efficiency of Plaquing (EOP) of 1.8e-02 
+
/- 9.0e-04 
and 3.0e-04 
+
/- 4.0e-05, respectively, which are statistically significant compared to 
the TP901-1erm control (p-values < 0.01). Plaques formed by MCP2TP901-1::Ter and 
MCP3TP901-1::Ter were confirmed to possess the desired mutation by PCR and 
restriction digest using individual plaques as the template material. In addition, 
plaque sizes of TP901-1erm mutants MCP2TP901-1::Ter and MCP3TP901-1::Ter were 
visually smaller than the control wild-type phage (data not shown). 
In Vitro Assembly of TP901-1erm and Frequency of Lysogeny. Previous 
studies of phage λ has shown that capsids and tails can be produced independently, 
and following purification and subsequent combining, can assemble spontaneously 
in vitro (89). In order to determine if the capsid and tail structures of lactococcal 
phage TP901-1 are similarly capable of in vitro assembly, purified capsids and tails 
of TP901-1 were mixed and tested for the ability to lysogenize host strain L. lactis 
3107. Unable to establish lysogeny on their own, following the incubation of 
purified MHPTP901-1::Ter and MTPTP901-1::Ter, which donated phage tails and 
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capsids, respectively, infection and subsequent lysogenization of L. lactis 3107 
resulted in erythromycin resistant colonies (Table 2). This is indicative of lactococcal 
phage TP901-1erm capsids and tails assembling in vitro to form fully functional 
DNA-injecting virions. 
Sucrose gradient-purified samples of TP901-1erm, MCP2TP901-1::Ter and 
MCP3TP901-1::Ter phages, which represent the control and the only structural module 
mutants of TP901-1erm phage analysed in this study which retained their ability to 
form plaques on L. lactis 3107, lysogenized their host following infection and 
conferred erythromycin resistance as expected. The positive control, TP901-1erm, 
displayed the highest levels of lysogeny, yielding 7.51e06 
+
/- 4.25e05 Erm5 cfu/ml 
(or approximately 1.64 % Erm-resistant lysogens relative to total cfu/ml). 
By complementing TP901-1erm structural module mutants through the 
addition of either functional capsids or tails, it is possible to distinguish gene 
products required for functional capsid formation from those that are crucial for tail 
production. There is a clear distinction between TP901-1erm mutants that establish 
lysogeny at higher levels following in vitro assembly with either phage capsids or 
phage tails (shaded grey in Table 2). TP901-1erm derivatives carrying individual 
mutations targeting the portal protein-encoding gene through to the gene specifying 
the HTC2 protein were able to lysogenize L. lactis 3107 following incubation with 
purified capsids (donated from TP901-1erm MTP mutant, see Materials and 
Methods section) to a much higher level as compared to the mutant on its own or 
when mixed with purified tails. In contrast, TP901-1erm mutations in genes gpZ to 
gpT were significantly increased in their frequency of lysogeny following the 
addition of purified tails compared to lysogeny by the purified samples on their own 
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or mixed with purified capsids. Notably, mutant gpGfsTTP901-1 did not give an 
increase in its frequency of lysogeny following the addition of purified capsids or 
tails. 
TP901-1 and Tuc2009 Structural Protein Detection and Assembly. 
Polyclonal antibodies, generated against Tuc2009 structural proteins (see Materials 
and Methods section), were confirmed as reacting against Tuc2009 purified virions 
(Fig. 2, lane indicated as φ) and during an infection time-course assay (Fig. 2, lanes 
labelled ‘-10’ to ‘70’). All detected structural proteins of Tuc2009 appeared at 
molecular masses consistent with their calculated molecular weight. Immunoblots 
with the polyclonal antibodies directed against MCP3Tuc2009 and gpZTuc2009 did not 
result in a detectable immunological reaction using either whole phage particles or 
host cell extracts obtained during infection (data not shown), while the signal from 
MCP1Tuc2009 is obscured during the time-course assay by a non-specific cross 
reaction (i.e. present in -10 lane). 
Immunoblot detection was performed on chloroform-treated PEG 8000-
mediated precipitates of induced TP901-1erm mutants to determine the role of the 
different proteins during structural assembly (Fig. 3). The portal protein of TP901-1 
is detectable to some degree in all TP901-1erm mutants, and the purified phage 
controls, except for the lysate obtained from the TP901-1erm mutant that carried a 
non-sense mutation in the gene encoding the portal protein (Fig. 3). This result 
validated the recombineering mutagenesis strategy, confirming that the insertion of 
an in-frame stop codon successfully prevented its production. 
In addition to the absence of the portal protein in PEG-mediated precipitates 
of mutant PortalTP901-1::Ter, MCP1TP901-1 and HTC1TP901-1 are also undetectable in 
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Western blots of PortalTP901-1::Ter, while this being accompanied by a decreased 
amount of proteins SfpTP901-1 and MHPTP901-1. As expected, MCP1TP901-1 was not 
observed in Western blots using isolated virions of a TP901erm-derived mutant 
carrying an introduced translation terminating stop codon in the MCP1TP901-1-
specifying gene, while no noticeable effect was caused by this mutation in any of the 
additional proteins tested by Western blot. The translation terminating mutation in 
SfpTP901-1 resulted in a decreased amount of PortalTP901-1, and very little MHPTP901-1 
detected. The lysate of mutant MHPTP901-1 also resulted in a decrease in the level of 
PortalTP901-1 detected and a complete absence of SfpTP901-1. In addition to HTC1 
being absent, as expected, in mutant HTC1TP901-1::Ter, this predicted head-tail 
connector protein is also absent in PortalTP901-1::Ter, SfpTP901-1::Ter and MHPTP901-
1::Ter. 
Analysing the TP901-1erm mutants for the production of MTP showed that 
lysates of all presumed capsid mutants contained tail proteins, as expected. No MTP 
was detected in mutants of MTPTP901-1, gpGTP901-1 and gpTTP901-1. However, MTP 
was detected in the TP901-1 mutant permanently fusing gpG and gpT production 
together (gpGfsTTP901-1). In addition to detecting MTPTP901-1, Western blots were 
performed to detect the distal tail protein DitTP901-1 mutant lysates, as it is known to 
be crucial for the formation of functional phage tails (47). Interestingly, DitTP901-1 
was undetectable in all mutant virions where MTPTP901-1 was also absent. 
Electron Microscopy Analysis of TP901-1 Mutants. EM analysis of sucrose 
gradient-purified phage lysates of TP901-1erm mutants was performed to visualize 
the structural assemblages predicted through immunoblotting. In several instances, 
sucrose gradient-purification resulted in two distinct bands (Supplementary Fig. 5). 
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The appearance, and subsequent analysis, of the two bands obtained by sucrose 
gradient ultracentrifugation revealed the lower more dense band consisted of DNA-
packaged capsids and mature phage virions, while the upper less dense band 
contained free tail structures and capsids (which may have partially DNA-filled 
capsids). Where pertinent, EM images obtained from either an upper or lower 
sucrose gradient band are indicated. 
Purified fractions of PortalTP901-1::Ter showed only tail structures produced, 
and no visible capsid structures (Fig. 4B). EM images of MCP1TP901-1::Ter lower 
sucrose gradient band showed DNA-packaged capsids only, with no tails attached 
(Fig. 4C). A fully assembled phage virion was visualized for mutant MCP2TP901-
1::Ter; this was expected as this mutant phage was shown to be still capable of 
forming plaques on host L. lactis strain 3107 (Fig. 4D). Analysis of the lower 
sucrose gradient band of mutant HTC2TP901-1::Ter revealed DNA-packaged capsids 
(Fig. 4E). 
Individual DNA-packaged capsids and separate tails were visualized for the 
lower and upper sucrose gradient-purified fractions of mutant gpZTP90-1::Ter, 
respectively (Fig. 4F and 4G, respectively; Supplementary Fig. 5). Interestingly, EM 
images of gpUTP901-1::Ter showed DNA-packaged capsids in the lower sucrose 
gradient fraction in addition to long polytail structures formed by aberrant tail-tube 
polymerization in the upper sucrose gradient fraction (Fig. 4H and 4I, respectively). 
Mutagenesis of TP901-1erm MTP resulted, as expected, in the production of tail-less 
capsids (Fig. 4J). Notably, EM visualization of the TP901-1erm carrying the 
gpGTP901-1::Ter mutation revealed DNA-containing capsid and large disordered 
aggregates (Fig. 4K). We propose that these aggregates, not present in other phage 
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preparations, are hydrophobic TMP molecules incapable of remaining in solution in 
the absence of the chaperone protein gpG. Further EM analysis of all sucrose 
gradient bands of TP901-1erm structural module mutants is planned, which is 
predicted to identify the presence of full phage, detached capsid and detached phage 
tail structures that are predicted through Western blot and frequency of lysogeny 
assays (Supplementary Table 4). 
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DISCUSSION 
Despite advances in our understanding of Siphoviridae virions and their role 
for initiating the phage infection cycle, many aspects require further investigation. 
This is essential to ascertain the unique features of particular phages, while 
generating a unified model of characteristics distinct to Siphoviridae. 
Approximately half of the genome of TP901-1 is dedicated to creating the 
structural parts and efficient assembly of an infectious virion. In vitro assembly of 
TP901-1erm structural module mutants, assessed by monitoring the frequency of 
lysogeny, delineated the boundaries between the TP901-1 genetic modules 
associated with capsid and tail morphogenesis. The organization of the TP901-1 
genome co-locates all essential capsid protein-encoding genes at the beginning of the 
phage structural module, while gene products required for tail production begin at 
gpZ and continue as far as the host-specificity determining receptor binding protein-
encoding gene bppL (Fig. 1). This efficient and function-specific organization 
supports the modular theory of phage genome organization (90). 
Previous studies of phage λ showed that capsids and tails assemble 
independently, and that they can be joined together in vitro to form functional phages 
(89). In vitro assembly of TP901-1erm similarly demonstrated that the MHP mutant 
can produce functional tail structures, while the MTP mutant formed complete DNA-
packaged capsids. No additional host factors appear to be required for the assembly 
of phage capsids and tails, as these individual multiprotein complexes appear to be 
ready to assemble once formed. Lysogeny frequency of in vitro assembled TP901-
1erm virions, compared to that of identically prepared wild-type TP901-1erm phage 
control, tells us that the efficiency of assembly under the tested conditions is around 
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2.5-3.0 % (Table 2). The assembly of TP901-1erm capsids and tails is remarkably 
efficient, however, this is assuming that the MHP mutant (donating phage tails) and 
the MTP mutant (donating phage capsids) behave similarly to complete TP901-1erm 
virions during purification and contribute the necessary structures at a ratio of 1:1. 
Therefore, by optimizing the in vitro assembly parameters, the achievable efficiency 
of phage capsid and tail assembly may even be higher. 
Western blot detection of TP901-1 capsid proteins PortalTP901-1, SfpTP901-1 and 
MHPTP901-1 in various TP901-1erm mutants demonstrated that these proteins are 
essential for orchestrating the correct assembly and/or stabilization of capsid 
structures (Fig. 3). There is a pronounced lack of the SfpTP901-1 in mutant MHPTP901-
1::Ter, and vice versa, suggesting that these two proteins are closely connected 
during TP901-1 capsid assembly. The presence of SfpTP901-1 is markedly more 
affected than MHPTP901-1 in virion preparations of PortalTP901-1::Ter. This is 
consistent with other well-characterized phage systems where scaffolding proteins 
interact with the portal protein complex to initiate assembly (91). No procapsid 
structures were visualized following purification of PortalTP901-1::Ter, only tail 
structures (Fig. 4B), possibly due to the instability of capsid structures lacking 
packaged DNA. 
The portal protein of TP901-1 appears to act as a nucleus for capsid 
assembly. This is in agreement with the role of portal proteins in other viral 
assembly models (26-29). MCP1TP901-1, absent in PortalTP901-1::Ter, is a putative 
homologue of phage SPP1 capsid protein gp7 (see Results section). The SPP1 gp7 
protein has been identified as an internal virion protein that associates with the portal 
protein, being present at an estimated three copies per virion, and proposed to bind 
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DNA in a non-specific manner to limit the rate of genome ejection at the onset of 
infection (92-94). HTC1TP901-1, absent in PortalTP901-1::Ter, SfpTP901-1::Ter and 
MHPTP901-1::Ter, appears to be a functional analogue of SPP1 gp15; and can fit into 
the electron density map of the TP901-1 head-tail connector region during the 
pseudoatomic model construction of this phage (11, 33). Interestingly, SPP1 gp15 
only associates with its cognate portal protein once DNA packaging is complete 
(33); therefore, the detection of HTC1TP901-1 in MCP1TP901-1::Ter, MCP2TP901-1::Ter 
and MCP3TP901-1::Ter suggests that these mutants all produce DNA packaged 
capsids. Our EM analyses of MCP1TP901-1::Ter, showing DNA packaged capsids 
(Fig. 4C), and MCP2TP901-1::Ter, displaying complete phages with a DNA-packaged 
capsids (Fig. 4D), are in full agreement with this notion. 
Western blots aimed at detecting SfpTP901-1 and SfpTuc2009, using either crude 
lysates or purified phage virions, demonstrated the presence of these putative 
scaffolding-like proteins at expected full-lenght molecular weights (Fig. 2, Lane φ; 
Fig. 3). While in crude PEG-precipitated lysates visualization of SfpTP901-1 may be an 
artefact, the occurrence and clearly visible Western blot signal of Sfp proteins in 
purified phage preparations indicate that the putative scaffolding-like proteins of 
TP901-1 and Tuc2009 are part of the mature phage virions. Remarkably, previously 
characterized scaffolding proteins are reported to assist in phage assembly, yet are 
not associated with mature virions (25, 95, 96); therefore, the presence and precise 
function of the putative scaffolding proteins in mature TP901-1 and Tuc2009 virions 
will require further investigation. 
The experimental approach of PEG-precipitation of lysates containing 
TP901-1erm mutant virions coupled to immunoblotting also allowed us to putatively 
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eliminate possible protein interactions. For instance, the portal protein of TP901-1 is 
predicted to interact with both Sfp and MCP1. However, the proposed scaffolding 
protein mutant does not appear to significantly affect the levels of MCP1 detected, 
and vice versa. Therefore, these proteins may interact with distinct areas of the 
internal face of the presumed dodecameric portal complex during capsid assembly, 
explaining the observed results. 
Polyclonal antibodies were also used to observe the intracellular production 
of the capsid proteins during infection. MCP2Tuc2009 and SfpTuc2009 are the first 
proteins detected, produced 30 minutes post-infection. This result would agree with 
SfpTuc2009 acting as a scaffold-like protein, being produced in large quantities early in 
the infection cycle in order to orchestrate capsid assembly (Fig. 2). The detection of 
MCP2 early in the infection cycle, coupled with the observed similarity of 
MCP2Tuc2009 to DNA binding proteins, suggests that this small protein may localize 
within the phage capsid structure. 
Recent structural studies and biochemical investigations of tail chaperone 
proteins have provided a model of the roles of gpG and gpGT (39, 40, 97, 98). 
Preventing translation of TP901-1erm gpG or gpT (mutants gpGTP901-1::Ter and 
gpTTP901-1::BamHI, respectively) resulted in a failure to detect MTP or baseplate 
protein Dit. Interestingly, analysis of a mutation that mimicks the natural frame-shift 
occurring in gene gpG to produce protein gpGT (mutant gpGfsTTP901-1) showed that 
all tail proteins tested by Western blotting are present; however, no functional 
phages were produced. This confirms previous observations, whereby the ‘T’ 
domain is involved in binding to the phage MTP and the specific levels of gpG and 
gpGT produced are essential for forming functional tail structures (40, 41). 
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Immunoblots detecting MTPTP901-1 showed a significant increase in the 
amount of MTP observed for mutant gpUTP901-1::Ter (Fig. 3). In agreement, EM 
analysis highlighted the production of long tail structures for the mutant gpUTP901-
1::Ter. This corroborates previous studies, whereby mutations in the tail-terminator 
protein resulted in abnormally long polytail structures (42). As stated above, gpZ of 
TP901-1 could not be ascribed a function through database searches or by detecting 
homology to other well characterized phages. The nomenclature and proposed 
function of TP901-1 protein gpZ was based purely on synteny to phage λ tail 
module. By means of EM analysis, gpZTP901-1 appears to have a similar role to gpZλ 
in tail morphogenesis, as mutations in the encoding genes do not join their capsids 
and tails (42). 
Based on the current and previously obtained information, we present a 
model for the assembly and function of TP901-1 and Tuc2009 phage virion proteins 
(Fig. 5). Despite TP901-1 and Tuc2009 infecting the Gram-positive bacterium L. 
lactis, the assembly and function of their virion structural proteins demonstrate 
remarkable conservation with phages infecting divergent host organisms, indicating 
Siphoviridae have likely evolved from a common origin of efficient DNA-delivery 
machines. 
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Table 1. Comparative analysis of TP901-1 and Tuc2009 structural module proteins. *HHpred p-values shown are for TP901-1 protein 
sequences, except for Tuc2009 ORF35, ORF40, and ORF52. 
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Table 2. Lysogeny by TP901-1erm and structural module purified mutants mixed 
with phage capsids and tails. The lysogeny of purified samples resulting in the 
highest numbers of erythromycin resistant L. lactis 3107 colonies, either by 
purified sample on their own or mixed with phage capsids or tails, is highlighted in 
grey. The lack of erythromycin resistant colonies arising following lysogeny by 
gpGfsTTP901-1 on its own or mixed with capsids and tails suggests tail tube 
polymerization, but not tail assembly to capsids, is affected. 
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Supplementary Table 1. Bacterial strains, phages and plasmids used in this study. 
Strains, phages and plasmids Relevant features Source 
L. lactis   
 NZ9000 MG1363 pepN::nisRK (88) 
 NZ9000-Crot712 NZ9000 with point mutations inserting a BamHI site into prophage t712 anti-repressor (Cro) promotor sequence; contains plasmid pJP005 This study 
 NZ9000-Crot712-TP901-1erm NZ9000-Crot712 displaying t712
- phenotype lysogenized with TP901-1erm prophage; contains plasmid pJP005 This study 
 901-1erm Lysogenic host and source of TP901-1erm prophage (99) 
 3107 Lytic host for phage TP901-1erm (100) 
 UC509 Lysogenic host and source of Tuc2009 prophage (101) 
 UC509.9 Lytic host for phage Tuc2009 (102, 103) 
 NZ9700 Nisin over-producing strain (104) 
 NZ9000-Crot712-PortalTP901-1::Ter Translation termination codon insertion in TP901-1erm portal protein (ORF32) This study 
 NZ9000-Crot712-MCP1TP901-1::Ter Translation termination codon insertion in TP901-1erm MCP1 (ORF33) This study 
 NZ9000-Crot712-MCP2TP901-1::Ter Translation termination codon insertion in TP901-1erm MCP2 (ORF34) This study 
 NZ9000-Crot712-SfpTP901-1::Ter Translation termination codon insertion in TP901-1erm Sfp (ORF35) This study 
 NZ9000-Crot712-MHPTP901-1::Ter Translation termination codon insertion in TP901-1erm MHP (ORF36) This study 
 NZ9000-Crot712-MCP3TP901-1::Ter Translation termination codon insertion in TP901-1erm MCP3 (ORF37) This study 
 NZ9000-Crot712-HTC1TP901-1::Ter Translation termination codon insertion in TP901-1erm HTC1 (ORF38) This study 
 NZ9000-Crot712-HTC2TP901-1::Ter Translation termination codon insertion in TP901-1erm HTC2 (ORF39) This study 
 NZ9000-Crot712-gpZTP901-1::Ter Translation termination codon insertion in TP901-1erm gpZ (ORF40) This study 
 NZ9000-Crot712-gpUTP901-1::Ter Translation termination codon insertion in TP901-1erm gpU (ORF41) This study 
 NZ9000-Crot712-MTPTP901-1::Ter Translation termination codon insertion in TP901-1erm MTP (ORF42) This study 
 NZ9000-Crot712-gpGTP901-1::Ter Translation termination codon insertion in TP901-1erm gpG (ORF43) This study 
 NZ9000-Crot712-gpTTP901-1::BamHI Insertion mutation in TP901-1erm gpG (ORF43) disrupting gpT (ORF44) production This study 
 NZ9000-Crot712-gpGfsTTP901-1 Insertion and nucleotide altering mutation in TP901-1erm gpG (ORF43) causing a frameshift and permanently fusing it in frame to gpT (ORF44) This study 
   
Phages   
 TP901-1erm Temperate P335 species phage infecting 3107; contains erythromycin marker (69, 99, 105) 
 Tuc2009 Temperate P335 species phage infecting UC509.9 (102) 
   
Plasmids   
 pNZ8048 Nisin-inducible protein expression vector (106) 
 pTX8049 pNZ8048 derivative expression vector; recombinant N-terminal thioredoxin fusion (70) 
 pJP005 pNZ8048 derivative expressing RecT protein required for recombineering mutagenesis (65) 
 pNZ8048-PortalTuc2009 Tuc2009 Portal protein (ORF33) expression construct; Genbank coordinates 16486-17847 This study 
 pNZ8048-MCP1Tuc2009 Tuc2009 MCP1 (ORF34) expression construct; Genbank coordinates 17844-18884 This study 
 pTX8049-MCP2Tuc2009 Tuc2009 MCP2 (ORF35) expression construct; Genbank coordinates 18930-19262 This study 
 pNZ8048-SfpTuc2009 Tuc2009 Sfp (ORF36) expression construct; Genbank coordinates 19388-20050 This study 
 pTX8049-MHPTuc2009 Tuc2009 MHP (ORF37-39) expression construct; Genbank coordinates 20052-22183 This study 
 pTX8049-MCP3Tuc2009 Tuc2009 MCP3 (ORF40) expression construct; Genbank coordinates 22183-22383 This study 
 pTX8049-HTC1Tuc2009 Tuc2009 HTC1 (ORF41) expression construct; Genbank coordinates 22367-22699 This study 
 pTX8049-gpZTuc2009 Tuc2009 gpZ (ORF43) expression construct; Genbank coordinates 23004-23330 This study 
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Supplementary Table 2. Detailed description of mutations created in the various strains during this study, and their effects. 
Mutant strain and phages 
Accession numbers, ORF 
numbers and genomic 
coordinates of mutation region 
Original DNA sequence 
Original protein 
sequence1, 2 
DNA sequence following 
recombineering3 
Protein sequence following 
recombineering 
L. lactis NZ9000 NC_017949     
 NZ9000-Crot712 782805..782833 TTGACAAGTTGCAACGA
CGATGTTATAAT 
N/A TTGACAAGTTGCAACGA
CGATCAGGATCC 
N/A 
      
TP901-1 NC_002747     
 NZ9000-Crot712-PortalTP901-1::Ter ORF32; 15816..15839 AAACAAGAGCCTTTATT
TGCCGTG 
KQEPLFAV AAACAAGAGCCTTGAA
TTCTATTTGCCGTG 
KQEP*ILFAV 
 NZ9000-Crot712-MCP1TP901-1::Ter ORF33; 17151..17174 GGAATTCTTGGTTTAAG
CGTTCCA 
GILGLSVP GGAATTCTTGGTTGAAT
TCATAAGCGTTCCA 
GILG*IHKRS 
 NZ9000-Crot712-MCP2TP901-1::Ter ORF34; 18500..18523 TATCATTACTATTTTGA
CGGTGAT 
YHYYFDGD TATCATTACTATTGAAT
TCATTGACGGTGAT 
YHYY*IH*R* 
 NZ9000-Crot712-SfpTP901-1::Ter ORF35; 19028..19051 GTTAAAGAAAAATCTG
ACGAAGAA 
VKEKSDEE GTTAAAGAAAAATGAA
TTCCTGACGAAGAA 
VKEK*IPDEE 
 NZ9000-Crot712-MHPTP901-1::Ter ORF36; 19812..19835 GCTAAGACTACCTCTCA
AACTGTT 
AKTTSQTV GCTAAGACTACCTGAAT
TCGCTCAAACTGTT 
AKTT*IRSNC 
 NZ9000-Crot712-MCP3TP901-1::Ter ORF37; 20318..20341 GATGAACTAACGACGCT
TACCGTT 
DELTTLTV GATGAACTAACGTGAAT
TCACGCTTACCGTT 
DELT*IHAYR 
 NZ9000-Crot712-HTC1TP901-1::Ter ORF38; 20526..20549 CTTATTCTTGGTTCTGA
CATTAAA 
LILGSDIK CTTATTCTTGGTTGAAT
TCCTGACATTAAA 
LILG*IPDIK 
 NZ9000-Crot712-HTC2TP901-1::Ter ORF39; 20900..20923 AGTGTAGAAGTTTTTGG
AGATATT 
SVEVFGDI AGTGTAGAAGTTTAGAA
TTCTTGGAGATATT 
SVEV*NSWRY 
 NZ9000-Crot712-gpZTP901-1::Ter ORF40; 21107..21130 CTTGTAAAGCATTTGGA
TAAAGCA 
LVKHLDKA CTTGTAAAGCATTGAAT
TCTGGATAAAGCA 
LVKH*ILDKA 
 NZ9000-Crot712-gpUTP901-1::Ter ORF41; 21444..21467 TTCAAACGAATCCAAGC
TTTGGGG 
FKRIQALG TTCAAACGATGATGAGC
TTTGGGG 
FKR**ALG 
 NZ9000-Crot712-MTPTP901-1::Ter ORF42; 22061..22084 ATGCAGCAATTATTGAA
GTGTGGG 
MQQLLKCG ATGCAGCAATTATGAAT
TCATGAAGTGTGGG 
MQQL*IHEVW 
 NZ9000-Crot712-gpGTP901-1::Ter ORF43; 22579..22602 AACATTGCAACTTTATC
GAATGTA 
NIATLSNV AACATTGCAACTTGAAT
TCTATCGAATGTA 
NIAT*ILSNV 
 NZ9000-Crot712-gpTTP901-1::BamHI ORF44; 22731..22737 GAAAGCAATACGGGAA
AGTTAATC 
ESNTGKLI..[6 aa]..* GAAAGCAATACGGGAT
CCGGAAAGTTAATC 
ESNTGSGKLI..[6 aa]..* 
 NZ9000-Crot712-gpGfsTTP901-1 ORF43-44; 22731..22737 GAAAGCAATACGGGAA
AGTTAATC 
ESNTGKLI..[6 aa]..* GAAAGCAATACTGGTA
AAGCTGATC 
ESNTGKVN..[126 aa]..* 
1 The original protein sequence of NZ9000-Crot712-gpTTP901-1::Ter mutant shows only the amino acid sequence of gpG. Protein sequence of gpGT (produced through a -1 frame-shift in gpG DNA sequence 
GGGAAAG, fusing it to gpT) is not shown. 
2 The original protein sequence of NZ9000-Crot712-gpGfsTTP901-1 mutant shows only the amino acid sequence of gpG. 
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3 Introduced DNA bases causing mutations are underlined once, while introduced bases resulting in a novel restriction site are double underlined. 
N/A Not applicable 
* Translation terminating stop codon 
 188 
Supplementary Table 3. Oligonucleotides used in this study. 
Oligonucleotide name Oligonucleotide sequence (5’ → 3’) 
Recombineering primersᴪ  
 NZ9000-Crot712::BamHI C*T*C*C*A*TGATTGTTCGCTTGTTTGACTTTATGAGTTAGGATCCTGATCGTCGTTGCAACTTGTCAACCATTAAGGTTGTTTT 
 PortalTP901-1::Ter T*T*T*T*T*GTCCTCGTCAACACCATATCTCACGGCAAATAGAATTCAAGGCTCTTGTTTGACTGTATCGTCATAGACCATAAA 
 MCP1TP901-1::Ter T*C*A*A*C*TAAACTGTTATATCCTTCCTTTGGAACGCTTATGAATTCAACCAAGAATTCCGGCTTGTCTTTCAAATTCTGTGAG 
 MCP2TP901-1::Ter G*C*T*A*T*AATTTCTTCAACAACATTTCTATCACCGTCAATGAATTCAATAGTAATGATAGAATTTATTTTCTTTTTTAAAGATGA 
 SfpTP901-1::Ter T*T*A*G*C*TTTTTGAAGTTCGGCAGCTTTTTCTTCGTCAGGAATTCATTTTTCTTTAACTGACTTTTTGCCACCTTTTTCAAG 
 MHPTP901-1::Ter C*C*C*C*G*TCAACGTTTGCTTTAGTAGAAACAGTTTGAGCGAATTCAGGTAGTCTTAGCTGCGCTCAATAAGTCGTCATCGA 
 MCP3TP901-1::Ter T*A*G*T*T*TCAAGAAGCTCTTTTAGCTGATTAACGGTAAGCGTGAATTCACGTTAGTTCATCATTTTTCACTTGCTTGGTCGCATTTATG 
 HTC1TP901-1::Ter A*C*A*T*A*TTCTAGTTCTGGCGGTACTTCTTTAATGTCAGGAATTCAACCAAGAATAAGCAATAAACGGTCACGAGTGCGTTT 
 HTC2TP901-1::Ter T*C*A*T*T*CGCATGACTTTTGCCCCTTTTTTAATATCTCCAAAGAATTCAAACTTCTACACTTCTGTCAGTTCCAATATCAGTGATATTT 
 gpZTP901-1:: Ter G*T*T*G*A*ACACCCTTTAAAGATGCTGCTTTATCCAGAATTCAATGCTTTACAAGTTGGTCAATCCCTTTAAAAGATAAGCTA 
 gpUTP901-1::Ter T*C*A*T*T*GGCTTATAATCATAAACGGTATACCCCAAAGCTCATCATCGTTTGAACAATTCGTCAAAAATAGATTGGTCTCGAG 
 MTPTP901-1::Ter A*G*T*T*G*CTTTTTCTGCTTTATCAATTTCCCACACTTCATGAATTCATAATTGCTGCATCATCAAACGCTTTGTCCATTTCGT 
 gpGTP901-1::Ter G*T*T*T*C*TGTTCGATTTCCTAAAAATAATACATTCGATAGAATTCAAGTTGCAATGTTAGCCATTTCTAGTTCAGGAATGAT 
 gpTTP901-1::BamHI T*C*A*G*C*TATTTGGTCATTTTTGCTTTGATTAACTTTCCGGATCCCGTATTGCTTTCAGTAATTTCTTTCAAAACATCATCA 
 gpGfsTTP901-1 C*A*A*A*C*TTTTCAGCTATTTGGTCATTTTTGCTTTGATCAGCTTTACCAGTATTGCTTTCAGTAATTTCTTTCAAAACATCATCA 
  
Screening primers¥  
 Cro-t712-Fw CTTCAAGATATTCATCGCTCAGACGG 
 Cro-t712-MidFw TTGCAACGACGATCAGGATCC 
 Cro-t712-Rv TCGTAATCATCAAGCGCATGTTCC 
 Scrnseq-orf32-Fw GCAATGACAACTTATCAGCGTGA 
 Scrn-orf32-MidRv CACCATATCTCACGGCAAATAGAATTC 
 Seq-orf32-Rv ACTGGTAAATCTGGATATGGGTTG 
 Scrnseq-orf33-Fw GAGAAAGCTTGGCAAGAGCA 
 Scrn-orf33-MidRv CTTCCTTTGGAACGCTTATGAATTC 
 Seq-orf33-Rv ATGCATGTTTGGTGCATTAATACCA 
 Scrnseq-orf34-Fw CATTCAGTTTTAGGTTATGGGAACAT 
 Scrn-orf34-MidRv AACATTTCTATCACCGTCAATGAATTC 
 Seq-orf34-Rv TTCAGCCTGCTCTTTACCAA 
 Scrnseq-orf35-Fw GACGTGAAGAGAATCATTGTACCAGA 
 Scrn-orf35-MidRv GCAGCTTTTTCTTCGTCAGGAATTC 
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 Seq-orf35-Rv TTCATCAGCTTGACTGGTAATGT 
 Scrnseq-orf36-Fw GAATTGGTAAAGAGCAGGCTGA 
 Scrn-orf36-MidFw GCTTTAGTAGAAACAGTTTGAGGAATTCG 
 Seq-orf36-Rv GGCTTGTGCATCCTCATCAT 
 Scrnseq-orf37-Fw ACTGTTTCTACTAAAGCAAACGTTG 
 Scrn-orf37-MidRv TGATTAACGGTAAGCGTGAATTCA 
 Seq-orf37-Rv AACAGTTCTGGTAGGCTCCTT 
 Scrnseq-orf38-Fw ACGGAACTTACGCTGATGT 
 Scrn-orf38-MidRv CGGTACTTCTTTAATGTCAGGAATTC 
 Seq-orf38-Rv CTTCTTGTGAGTAGGACTGCAT 
 Scrnseq-orf39-Fw TTGCTTATGGCTATCACTGATGA 
 Scrn-orf39-MidRv CCCTTTTTTAATATCTCCAAAGAATTCA 
 Seq-orf39-Rv GGATTCGTTTGAACAATTCGTCA 
 Scrnseq-orf40-Fw GTAATCGAAAAACGCACTCGTG 
 Scrn-orf40-MidRv CTTTAAAGATGCTGCTTTATCCAGAATTC 
 Seq-orf40-Rv ACAAAAGGTTGAGCAGATTGA 
 Scrnseq-orf41-Fw TGATTTAGGCGAATGGGTTGA 
 Scrn-orf41-MidRv GGTATACCCCAAAGCTCATCA 
 Seq-orf41-Rv TGTATTTGTTGTTGTATCGTCCA 
 Scrnseq-orf42-Fw CACTTCAAATATGACAGCGAATATGCAG 
 Scrn-orf42-MidFw TTGATGATGCAGCAATTATGAATTCA 
 Seq-orf42-Rv CAATGTTAGCCATTTCTAGTTCAGGA 
 Scrnseq-orf43-Fw GGAAACTTGCATTCCAAACAGA 
 Scrn-orf43-MidRv CGATTTCCTAAAAATAATACATTCGATAGAATTC 
 Seq-orf43-Rv TTCGCATTCATCAATAAAATCATCAA 
 Scrnseq-orf44-Fw TCTCTTATGAACCTAACTCAGAAGATGCG 
 Scrn-orf44-MidRv CATTTTTGCTTTGATTAACTTTCCGGATCC 
 Seq-orf44-Rv AAGTTTTGAACTTGTTTAGCAGCGTC 
 Scrnseq-orf43-44-Fw ACTTGCTGTTAAAATCATTCCTGAACT 
 Scrn-orf43-44-MidRv ACTGAAAGCAATACTGGTAAAGCTG 
 Seq-orf43-44-Rv TTCTCTGGGCTTTCGATTCCTA 
  
Recombinant protein primersǂ, #  
 pNZ-orf33Tuc-Fw AGCAGCCCATGGTGAATTTGAAACCAATAAA 
 pNZ-orf33Tuc-Rv AGCAGCACTAGTTTAATGGTGATGGTGATGGTGCCCCTCATTTGTTTCATTCTC 
 pNZ-orf34Tuc-Fw AGCAGCCCATGGATTCATCTGATTACTGGAG 
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 pNZ-orf34Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGTCCTTTTCTTTTATTGC 
 pTX-orf35Tuc-Fw AGCAGCGGATCCATGGCTAAAGATGATTTCTT 
 pTX-orf35Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGAGTTCCTGGTATCCAGTCTTTT 
 pNZ-orf36Tuc-Fw AGCAGCCCATGGAACAAACAGAACTTTT 
 pNZ-orf36Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGATAGCCTCCTGTTAATTTT 
 pTX-orf37Tuc-Fw AGCAGCCCATGGCAAAACAAAAAACAACACTTAC 
 pTX-orf39Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGTACACCCGTAAATGTGATATTA 
 pTX-orf40Tuc-Fw AGCAGCGGATCCATGGGGCGGCTACTAAGTCG 
 pTX-orf40Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGTAAGTGATAGCCATAAGCAA 
 pTX-orf41Tuc-Fw AGCAGCGGATCCATGGCTATCACTTATGAAAT 
 pTX-orf41Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGATACAATCTGAACCTCCCTATCTTC 
 pTX-orf43Tuc-Fw AGCAGCGGATCCATGAAAATAACTGGAATTGA 
 pTX-orf43Tuc-Rv AGCAGCACTAGTTTAGTGATGGTGATGGTGATGTTTCGTCAACCTTTCTAA 
* Phosphorothioate linkages of recombineering oligos. 
ᴪ Nucleotides of recombineering oligos which are designed to introduce or alter the base sequence of TP901-1erm are underlined once, while introduced restriction enzyme sites are double underlined. 
¥ Nucleotides of screening oligos which bind to mutated bases are underlined. 
ǂ Restriction enzymes sites of recombinant protein construct oligos are double underlined. 
# Hexahistidine tags are indicated in bold. 
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Supplementary Table 4. Predicted and observed phenotypic properties of TP901-1erm structural module mutants. A selection of electron 
micrographs are available which confirm predicted structural assemblies formed by the specific mutants (Fig. 4). 
Sample analysed 
Predicted phenotypes of 
TP901-1erm structural mutants1 
Brief description for predicted phenotypes of TP901-1erm mutants; based 
on literature and, where required, experimental work 
EM observed phenotype2 
TP901-1erm N/A N/A Complete wild-type TP901-1 phage 
PortalTP901-1::Ter Tail structures Portal proteins are important for capsid morphogenesis (5) Tail structures (Fig. 4B) 
MCP1TP901-1::Ter Unknown SPP1 homologue has a role in capsid DNA packaging and/or ejection (93) LSGB - Capsids only, no attached tails (Fig. 4C) 
MCP2TP901-1::Ter Wild-type resembling phage Minor capsid protein of TP901-1 and Tuc2009, mutant still forms plaques Complete phage (Fig. 4D) 
SfpTP901-1::Ter Tail structures Scaffolding-like proteins are important for capsid morphogenesis (5) To be completed 
MHPTP901-1::Ter Tail structures Major capsid proteins are important for capsid morphogenesis (5) To be completed 
MCP3TP901-1::Ter Wild-type resembling phage Minor capsid protein of TP901-1 and Tuc2009, mutant still forms plaques To be completed 
HTC1TP901-1::Ter Detached capsid and tail structures Head-tail connector proteins required as an attachment site for phage tails (33) To be completed 
HTC2TP901-1::Ter Detached capsid and tail structures Head-tail connector proteins required as an attachment site for phage tails (33) LSGB - Capsids only, no attached tails (Fig. 4E) 
gpZTP901-1::Ter Detached capsid and tail structures Important for phage λ capsid-tail attachment (42) LSGB & USGB - Detached capsid and tail structures (Fig. 4F & G) 
gpUTP901-1::Ter Capsids and polytail structures Important for preventing aberrant MTP polymerization (42) LSGB & USGB - Capsids and polytails (Fig. 4H & I) 
MTPTP901-1::Ter Capsids Major tail proteins are essential for tail morphogenesis (89) Capsids (Fig. 4J) 
gpGTP901-1::Ter Capsids Chaperone gpG required to maintain hydrophobic TMP in solution (40, 41) Capsids and possibly insoluble TMP (Fig. 4K) 
gpTTP901-1::BamHI Capsids Chaperone gpGT require to recruit MTP to TMP for tail assembly (40, 41) To be completed 
gpGfsTTP901-1 Unknown Ratio of gpG and gpGT required for tail tube polymerization (40, 41) To be completed 
1 The predicted phenotypes of TP901-1erm structural module mutants are based on their ability to form plaques, Western blotting data, frequency of lysogeny following in vitro assembly and conservation of protein 
function amongst Siphoviridae. 
N/A Not applicable 
2 Lower sucrose gradient band (LSGB), upper sucrose gradient band (USGB) 
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Figure 1. Diagrammatic representation of the 22 annotated structural module genes of phage TP901-1. Mutagenesis of TP901-1 structural 
module has determined gene products essential (+) or non-essential (-) for creating infectious phage virions. The efficiency of plaquing is 
displayed for mutants of non-essential gene products. The genomic regions encoding capsid and tail morphogenesis proteins are depicted. 
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Figure 2. Western blot time-course detection of Tuc2009 capsid and head-tail 
connector proteins produced following infection of L. lactis UC509.9. A control lane 
containing purified phage virions, φ, shows the protein sizes as they are part of the 
mature virion. The protein detected by the primary polyclonal antibody is outlined to 
the right of the figure, with black-filled triangles highlighting the exact protein of 
interest. 
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Figure 3. Immunological detection of TP901-1erm structural proteins precipitated 
from phage lysates by PEG 8000. Negative control represents PEG 8000 
precipitation of mitomycin C induced strain NZ9000-Crot712. The protein detected by 
the primary antibody is depicted to the right of the image, with black-filled triangles 
highlighting protein sizes and a black-unfilled triangle indicating MCP1Tuc2009 
protein that is ~25 kDa smaller than MCP1TP901-1. 
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Figure 4. EM images of (A) TP901-1erm and (B-K) structural module mutant 
derivatives. Where relevant, black-filled triangles indicate free tail structures. (B) 
Tails, but no capsids, produced by mutant PortalTP901-1::Ter. (C) Capsids, without 
attached tails, visualised for mutant MCP1TP901-1::Ter. (D) Full phage particles 
produced following mutation MCP2TP901-1::Ter. (E) Capsids produced by HTC2TP901-
1::Ter. (F) Capsids isolated for mutant gpZTP901-1::Ter from lower sucrose gradient 
band (Supplementary Fig. 5). (G) Capsids and tails imaged for mutant gpZTP901-
1::Ter from upper sucrose gradient band (Supplementary Fig. 5). (H) Capsids of 
mutant gpUTP901-1::Ter observed in the lower sucrose gradient band (I) Capsids and 
polytails observed for mutant gpUTP901-1::Ter in the upper sucrose gradient band. (J) 
Capsids only are observed for mutant MTPTP901-1::Ter. (K) Capsids and insoluble 
aggregates, proposed to be the TMP, observed for mutant gpGTP901-1::Ter. Refer to 
text for a more detailed description characterizing each mutant. Scale bars indicating 
the EM magnification is displayed below each image. 
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Figure 5. Molecular model putatively depicting TP901-1 and Tuc2009 phage 
assembly. Capsid and tail structures are produced independently and spontaneously 
assemble. Portal protein initiates capsid assembly, as mutant PortalTP901-1::Ter fails to 
produce capsids. MCP1 is predicted to associate with the internal face of the portal 
protein complex. Due to MCP2Tuc2009 being similar to YjcQ DNA-binding proteins, 
it is depicted as an internal capsid protein. Scaffolding-like proteins SfpTP901-1 and 
SfpTuc2009 appear to be retained in their entirety in mature virions. Furthermore, Sfp 
and MHP appear to be added together to procapsids, as mutant MHPTP901-1::Ter 
negatively impacts on the addition of SfpTP901-1 to assembling capsid complexes. Due 
to weak conservation of MCP3 with capsid protein domains involved in covalently 
bonding capsid subunits, MCP3 may have a capsid stabilizing function. DNA 
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packaging by the terminase holoenzyme likely expands the capsids of TP901-1 and 
Tuc2009, creating more angular and stable structures. HTC1, and subsequently 
HTC2, are predicted to associate with capsids once DNA is packaged. TP901-1 and 
Tuc2009 phages contain non-essential NPS fibres associated with the portal vertex 
of capsids (34, 71). Tail assembly, illustrated as initiating with the TMP bound by 
chaperones gpG and gpGT, requires the C-terminus of the TMP, Dit and the N-
terminus of Tal protein to form an initiator complex (47). These interactions are 
likely rapid, possibly occurring simultaneously. However, the ‘G’ domains of the 
chaperones bind and maintain the hydrophobic TMP in solution, facilitating initiator 
complex formation, while the ‘T’ domain of gpGT recruits MTP for tail tube 
polymerization. These results are supported by the lack of Dit protein in gpGTP901-
1::Ter mutant. Polymerization of the phage tail tube is concluded by the addition of 
tail terminator protein gpU to the final MTP ring. Protein gpZ is possibly required 
for the attachment of tails to mature capsids. During tail assembly, proteins BppU 
and BppL associate with Dit to form a baseplate structure which functions as the 
phage host-recognising receptor-binding complex. 
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Supplementary Figure 1. Dot-plot analysis of MCP1TP901-1 and MCP1Tuc2009 using 
PLALIGN. The complete MCP1Tuc2009 protein is homologous to MCP1TP901-1 N-
terminus; however, MCP1TP901-1 possesses an approximately 28 kDa C-terminal 
extension (~250 aa). The initial ~100 amino acids of MCP1TP901-1 C-terminal 
extension show it is derived from a possible genetic duplication. 
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Supplementary Figure 2. ClustalW alignment of MCP1TP901-1, MCP1Tuc2009 and 
phage SPP1 capsid protein gp7. The three proteins share significant conservation, 
except for the approximate 28 kDa C-terminal extension present in MCPTP901-1. 
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Supplementary Figure 3. Secondary structure and intrinsically disordered-region predictions of (A) TP901-1, (B) Tuc2009, (C) phage 
λ and (D) phage SPP1 scaffolding, or scaffolding-like, proteins. SfpTP901-1, SfpTuc2009, gpNu3λ and gp11SPP1 are all predicted as largely α-
helical in structure (PSIPRED) and contain large regions of intrinsically disordered protein structure (IUPRED).  
(C) (D) 
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Supplementary Figure 4. Secondary structure comparison and ClustalW alignment of MCP3Tuc2009 and phage HK97 capsid protein 
gp5. Both MCP3Tuc2009 and gp5HK97 (A and B) show, albeit weakly, similar secondary structure (PSIPRED), and their ClustalW 
alignment (C) highlights several conserved amino acids. A conserved glutamic acid, highlighted by a black-filled triangle (C), is 
characterized in HK97 gp5 as involved in covalently crosslinking capsid subunits, and suggests a possible role for MCP3Tuc2009 in capsid 
stabilization. 
(A) 
(C) 
(B) 
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Supplementary Figure 5. Example of sucrose gradient purification (example shown is of 
TP901-1erm mutant gpZTP901-1::Ter). EM analysis of the bottom blue-grey band revealed 
phage capsids only, while the top yellow-grey band contained separate capsid and tail 
structures. Distinct bands, indicative of free capsids and tails, were analysed, where possible, 
separately.
Capsids 
Capsids and tails 
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CHAPTER IV 
 
Mutational Analysis of a Lactococcal Tape Measure Protein Reveals its Multi-
Functionality in Tail Morphology and DNA Injection 
 
 
 
 
 
 
 
 
This chapter is in preparation for publication as a research article: 
Mutational Analysis of a Lactococcal Tape Measure Protein Reveals its Multi-
Functionality in Tail Morphology and DNA Injection. 
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ABSTRACT 
The characteristic feature of Siphoviridae is their long non-contractile tail, which 
they use to efficiently recognise and initiate infection of their bacterial hosts. In this 
study, we examined the Tape Measure Protein (TMP) of the lactococcal phage 
TP901-1 in order to determine its role in assembling functional viral particles, in 
defining tail length, and in facilitating DNA injection into its host. Through the 
creation and analysis of 19 distinct deletion mutants in the TMP-encoding gene of 
TP901-1, we propose that TMP is located within the phage tail tube where its C- and 
N-terminal portion each possess distinct virion assembly functions at opposing ends 
of the tail. We furthermore identify repeats within the TMP primary sequence and 
propose their function is to determine the final phage tail length, while we also 
identify putative transmembrane-spanning regions located in the TMP and 
demonstrate their importance for the phage infection process.  
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INTRODUCTION 
Bacteriophages are the most abundant biological entities on Earth, with an 
estimated 10
31
 viruses in the biosphere (1, 2). Three morphologically distinct 
families of tailed phages are most frequently observed in biological samples: 
Myoviridae, members of which possess long contractile tails; Podoviridae, which 
have short non-contractile tails; and Siphoviridae, which exhibit long non-contractile 
tails (3). Siphoviridae phages are believed to represent the dominant viral 
morphology (4), perhaps because their long flexible tails facilitate efficient infection 
of their bacterial hosts. 
The length of a Siphoviridae tail is generally assumed to be dictated by the 
Tape Measure Protein (TMP) as in-frame deletions of, and insertions in, a 
Siphoviridae TMP-encoding gene proportionally decrease and increase, respectively, 
the length of the corresponding phage tail (5, 6). These findings suggest that the 
TMP acts as a molecular ruler, or scaffold, around which individual monomers of the 
major tail protein assemble to form the tail tube (7). 
Probably the best understood Siphoviridae tail assembly model is that of 
phage λ, which proposes that six copies of the TMP, represented by gene product H 
(gpH), associate to form an ‘initiator’ complex with gpI, gpJ, gpK and gpL (8). 
However, the inclusion of gpH to the initiator complex occurs with the aid of two 
chaperone proteins, gpG and gpGT (8, 9), whose functions include maintaining the 
hydrophobic TMP in solution during tail assembly (10). Recently, Xu et al. (2013) 
demonstrated that chaperone gpG binds across the complete length of gpH. 
Chaperone gpGT, produced through a conserved -1 ribosomal frame-shift during 
mRNA translation at a specific sequence corresponding to the 3’ end of gpG (11), 
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also binds to gpH through its N-terminal ‘G’ domain. However, gpGT also recruits 
Major Tail Protein (MTP or gpV) of phage λ to the assembling tail structure through 
its C-terminal ‘T’ domain, which is proposed to facilitate the assembly of the MTP-
composed tail tube around and along the TMP (9, 12). 
Polymerization of phage λ gpV into hexameric tail tube rings is proposed to 
pause when the end of gpH is reached (13, 14), at which point the tail terminator 
protein, gpU, associates with the last assembled gpV ring to terminate tail elongation 
(13, 15). Phage λ tails, being assembled independently of phage capsids (16), are 
then proposed to be activated by an unknown mechanism which involves the action 
of gpZ (13), and which facilitates subsequent association with individual phage 
capsids to produce fully functional infectious virions. 
In addition to important roles in dictating tail length and assembly, the TMP 
of Siphoviridae phages is believed to form a channel in the bacterial membrane for 
DNA entry into the bacterial cytoplasm. Several studies have demonstrated that the 
TMPs of Siphoviridae are ejected from the tail tube at the onset of infection (17-19) 
and that they subsequently localise with cell wall and membranous fractions of 
infected bacteria (20). For both phage λ and T5, DNA injection into liposomes 
containing their proteinaceous receptors, LamB and FhuA, respectively, have been 
documented (21, 22). In both instances, transmembrane (Tm) domains associated 
with phage λ and T5 TMPs have been proposed to form the channel for DNA entry 
into membranous vesicles. However, the TMP of phage T5, designated Pb2, more 
clearly implicates Siphoviridae TMPs as creating Tm channels, as it could be 
purified from phage virions and incubated with lipid bilayer membranes to form 
pores (18). 
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In this study, we examined various functional roles of the TMP of lactococcal 
phage TP901-1 using a series of in-frame deletion mutants of tmpTP901-1 targeting 
various domains and repeats. Based on the obtained results, we discuss the diverse 
roles of TMPTP901-1 in assembling the long tail organelle of this Siphoviridae, and its 
importance in initiating infection.  
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MATERIALS 
Bioinformatic Analysis. The TP901-1 genome sequence was downloaded 
from NCBI GenBank at accession number NC_002747 (23). The sequence of 
TMPTP901-1, corresponding to the product of ORF45, was manipulated using 
DNASTAR software package (fifth edition, 2006; DNASTAR Inc., Madison, WI). 
Repeat sequences in TMPTP901-1 were deduced by manually aligning Trp and Phe 
residues with 11 or 18 amino acid periodicity. Transmembrane domains were 
identified using TMHMM (24), while protein transmembrane topology was 
characterised using TOPO2 (25). The secondary structure of TMPTP901-1 was 
predicted using SABLE (26) and alignment of TMP amino acid sequences was 
performed using ClustalW (27). 
Bacterial Strains, Phages and Growth Conditions. Bacterial strains and 
phages used in this study are listed in Supplementary Table 1. Lactococcal strains 
were grown using standard conditions (28, 29). Phage lysates for the various 
biological characterisation assays were induced in an identical manner from three 
separate overnights of NZ9000-Crot712 lysogenized with TP901-1erm, or a particular 
mutant derivative, and stored as outlined previously (Stockdale et al., Chapter 3). 
Polyethylene glycol 8000 (PEG 8000) precipitation of phage particles (or tails and/or 
capsids) of the TP901-1erm phage or a particular mutant derivative, and their 
subsequent purification, was performed as described previously (Stockdale et al., 
Chapter 3). 
Mutant Generation and Screening. Recombineering mutagenesis was 
performed as described previously (29-31), with the following adjustments. Briefly, 
recombineering oligonucleotides designed to delete regions of tmpTP901-1, which are 
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listed in Supplementary Table 2, bound to approximately 40-45 nucleotides of 
TP901-1erm genomic DNA flanking each deletion. Genomic deletions created in 
this study were on average designed to be approximately 100 nucleotides, although 
sequences as short as 57 nucleotide bases (phage mutant ΔTm3) and as long as 153 
bases (mutant Δ1-9) were successfully removed in a single recombineering round. 
The corresponding amino acid sequences of TMPTP901-1 mutations created in this 
study are outlined in Supplementary Table 3. Following transformations involving 
recombineering oligonucleotides, cells were allowed to recover for approximately 30 
minutes before spread-plating the necessary dilutions on GM17 agar plates 
supplemented with 5 µg/ml erythromycin. Screening was performed by PCR 
amplification using NZ9000-Crot712-TP901-1erm colonies, or derivatives of this 
strain carrying the specific introduced mutations, as template DNA. Oligonucleotide 
pairs for screening were designed to generate an approximately 500 bp fragment for 
wild-type TP901-1erm genomic sequence, while generating an approximately 400 bp 
fragment following the successful deletion of a tmpTP901-1 region. The desired 
sequence of each introduced mutation in tmpTP901-1 was confirmed by Sanger 
sequencing the PCR product generated during screening (MWG Eurofins, Germany). 
Phage Assays. Plaque assays of TP901-1erm and TMPTP901-1 mutant 
derivatives were performed using standard protocols (32). The efficiency of plaquing 
(EOP) of TP901-1erm mutants, compared to the wild-type control, was calculated by 
dividing the plaque-forming units per millilitre (pfu/ml) of the particular TP901-
1erm mutant by the pfu/ml of the un-mutated TP901-1erm control. EOP assays were 
performed on three separate replicates over three successive days, and the results 
averaged. 
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Adsorption assays of TP901-1erm and derived mutants were conducted as 
follows: L. lactis 3107 was grown to an A600 of ~0.3 at which point CaCl2, 10 mM 
final concentration, was added to the culture. The L. lactis 3107 culture was 
dispensed into sterile eppendorfs in 450 µL aliqouts, before 50 µL TP901-1erm or a 
particular TMPTP901-1 plaque-forming mutant was added to the culture. Phages were 
allowed to adsorb for 30 seconds before 1 M (v/v) final concentration of NaCl was 
added, after which bacteria were pelleted by centrifugation at 16,800 × g for 1 
minute. The supernatant was aspirated into a fresh sterile eppendorf and tested for 
free phages to determine the final phage titre. In order to determine the initial titre of 
phages used for all adsorption assays, the protocol was conducted as described above 
using TP901-1erm and plaque-forming TMPTP901-1 mutant derivatives except phages 
were added to sterile GM17 media containing 10 mM CaCl2. The efficiency of phage 
adsorption, expressed as the percentage of phage adsorbing to their host in 30 
seconds, was calculated by [(initial phage titre-final phage titre)/initial phage 
titre]*100 (33). 
Frequency of lysogeny experiments were performed as described previously 
(Stockdale et al., Chapter 3), except that all assays were performed using Mitomycin 
C-induced phage lysates of TP901-1erm and TMPTP901-1 mutants rather than using 
sucrose gradient-purified fractions. The ability to measure frequency of lysogeny is 
based on bacterial acquisition of the adenine methylase gene present in the TP901-
1erm phage genome or its mutant derivatives, conferring resistance to 5 µg/ml 
erythromycin (Erm5) (34, 35). A full list of results from the various phage assays 
characterising TP901-1erm and TMPTP901-1 mutants is available in Table 1. 
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Protein Analysis. Separation of TP901-1erm or TP901-1erm-derivative 
virion proteins using 12 % polyacrylamide SDS-PAGE gels, their electro-blotting 
transfer to nitrocellulose membranes, and immunoblotting techniques were 
performed as described previously (Stockdale et al., Chapter 3). PEG 8000 
precipitates of TP901-1erm or derived mutant virions were subjected to Western 
blotting to determine the presence of Major Tail Protein (MTP) and Major Head 
Protein (MHP), indicative of tail tubes and capsids formed, respectively. A TP901-
1erm mutant of the MTP-encoding gene (Stockdale et al., Chapter 3) was used as a 
negative control for tail tube/MTP-detecting Western blots, while a MHP mutant of 
TP901-1erm (Stockdale et al., Chapter 3) was used as a negative control for Western 
blots checking the production of phage capsids/MHP.  
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RESULTS 
Characterisation of TMPTP901-1. It has long been known that the TMPs of 
Siphoviridae control the length of their assembled tail structures, with deletions and 
insertions resulting in proportionally shorter and longer tails, respectively (5, 6). 
Katsura and Hendrix (1984) proposed that TMP proteins adopt a coiled-coil α-helical 
structure, with each amino acid of the TMP template protein roughly corresponding 
to 0.15 nm of the phage tail’s final length (5). Secondary structure prediction of 
TMPTP901-1 revealed, as expected, a largely α-helical content (Fig. 1). However, the 
C-terminal extremity of TMPTP901-1 possesses a short coiled and β-sheet region, the 
potential significance of which is discussed below. 
Bioinformatic programmes aimed at detecting repeat sequences within 
TMPTP901-1 did not identify any strong candidates for repeating units within this 
protein (results not shown). Therefore, manual examination of the amino acid 
sequence of TMPTP901-1 was conducted. Analysis was based on the characterisation 
of TMP proteins by Belcaid et al. (2011), who suggested specific repeat sequences in 
TMP proteins had a periodicity of 11 and 18 amino acids, and also by Siponen et al. 
(2009), who described repeating aromatic amino acids in the proposed TMP of 
lactococcal phage p2 (10, 36). 
Manual alignment of Trp and Phe residues, spaced 11 or 18 amino acids 
apart, resulted in the identification of 29 aromatic-residue-containing repeat 
sequences (Fig. 2). Four of the deduced repeat sequences measured 18 amino acids 
in length, with each of these repeats beginning with a Trp residue. The remaining 25 
repeats of TMPTP901-1 are proposed to be 11 amino acids in length. While the 
majority of the twenty-five shorter repeats in TMPTP901-1 are predicted to begin with 
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a Trp residue, four repeats commence with a Phe. Four of the 11 amino acid-long 
repeats begin with neither a tryptophan nor phenylalanine residue; however, these 
were still considered repeat sequences as the periodicity of aromatic amino acids 
continued following these repeats. 
Analysis of TMPTP901-1 revealed the presence of two Tm-containing domains, 
each with three Tm-spanning regions (Fig. 3). Interestingly, the carboxy-proximal 
Tm domain occurs within the deduced aromatic-residue-containing repeat sequences. 
The predicted topology of TMPTP901-1, as it may occur following the protein’s 
ejection from the tail tube, implicates both Tm domains as being inserted into the 
bacterial membrane (Fig. 4). In addition, the topological prediction of TMPTP901-1 
suggests that the stretch of 129 amino acids between the two Tm domains is located 
within the bacterial cytoplasm, while the N- and C-terminal extremities of TMPTP901-
1 are situated extracellularly. 
Comparative analysis of the TMPTP901-1 with its closely related homolog of 
lactococcal phage Tuc2009, TMPTuc2009, revealed that TMPTP901-1 had suffered a 
deletion or that a duplication had occurred in TMPTuc2009 (Fig. 5). In either case, the 
difference between TMPTuc2009 and TMPTP901-1 corresponds to 88 amino acids, 
immediately following the carboxy-proximal Tm-spanning domain. The differential 
88 amino acids obey the characteristics identified in TMPTP901-1 repeats, with 
aromatic residues occurring periodically at intervals of 11 amino acids (Fig. 5). In 
addition, studies examining TP901-1 and Tuc2009 tail structures proposed their tail 
tube lengths are 135 and 144 nm long, respectively, corresponding to TMPTP901-1 
(937 aa) being slightly smaller than TMPTuc2009 (1,025 aa) (6, 37). 
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Efficiency of plaquing. Mutations were introduced into the gene encoding 
TMPTP901-1 in order to distinguish the various functions associated with this protein, 
and also to discover functionalities associated with particular regions of TMPTP901-1. 
Deletions within the TMPTP901-1-encoding gene, causing corresponding ablations of 
various aromatic residue-containing repeat sequences within TMPTP901-1, were 
performed to presumably shorten the length of TP901-1erm tail. Such mutants are 
denoted by the symbol ‘Δ’ followed by the number assigned to the particular 
removed aromatic-residue-containing repeat sequences (Fig. 2). Deletions 
corresponding to the removal of Tm domain regions were carried out to determine 
their important in the phage infection process, as they are presumed to insert into the 
bacterial membrane following TMP ejection from the tail tube. These mutants were 
designated ‘ΔTm’, followed by the number given to individual Tm spanning regions 
of TMPTP901-1 (Fig. 3B). Deletions affecting the N- or C-terminus of TMPTP901-1, and 
named ΔN-terminus and ΔC-terminus, respectively, were conducted to investigate if 
the observed phenotype would be consistent with their respective presumed roles in 
either associating with capsid components or forming a tail-assembly initiator 
complex. 
Lysates produced from mitomycin C-induced NZ9000-Crot712-TP901-1erm 
and derived strains each harbouring a TP901-1erm prophage carrying a particular 
mutation in the TMP-encoding gene were tested for their ability to form plaques on 
L. lactis 3107. Of the nineteen TMP-mutants created, only eight mutants displayed 
an Efficiency of Plaquing (EOP) at levels comparable to the wild-type TP901-1erm 
control (Fig. 6; Table 1). The eight TMPTP901-1 mutants with EOPs comparable to 
TP901-1erm represent deletion mutants removing complete aromatic-residue-
containing repeating units of 11 or 18 amino acids (Fig. 2). Interestingly, mutant Δ1-
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7.5, in which one of the TMPTP901-1 repeat sequences had partially been removed, 
formed no plaques (data not shown), whereas mutants Δ1-5 and Δ1-8, in which 
repeat sequences had been removed in full, exhibited EOPs of 1.96 
+
/- 0.22 and 2.43 
+
/- 0.26, respectively. TMP mutant Δ24-29 also formed plaques on host L. lactis 
3107; however, its EOP was dramatically reduced (to an approximate EOP of 3.20e-
4 relative to wild-type TP901-1erm). The possible reason for the dramatic decrease 
in EOP observed for Δ24-29 is discussed below. Analysis of the TMPTP901-1 mutants 
which were shown to form plaques highlighted that only the EOP of mutant Δ1-2, 
which carries the smallest of the TMP repeat deletions (removing 29 amino acids; 
supplementary Table 3), was not statistically different from that of the wild-type 
TP901-1erm control. The EOP values obtained for all other TMP repeat deletion 
mutants were statistically different from that of the wild-type TP901-1erm, with p-
values < 0.01. 
Surprisingly, TMPTP901-1 mutants Δ1-5, Δ1-8, Δ1-9, Δ24-26 and Δ20-26 
displayed an increase in their EOP relative to that obtained for the TP901-1erm 
control. Mutant Δ20-26 yielded the highest EOP, approximately 12.5-fold higher 
than that obtained for TP901-1erm. Plaque sizes of TMP mutants that were capable 
of infecting host L. lactis 3107 displayed considerable variation (Fig. 7). The plaque 
sizes of TMP mutants Δ1-2, Δ1-5, Δ1-8 and Δ1-9 exhibited a gradual decrease in 
size compared to that produced by the TP901-1erm control, whereas plaques of TMP 
mutants Δ24-26 and Δ20-26 were similar in size to that of TP901-1erm. TMP 
mutants Δ1-5+24-26 and Δ1-9+20-26 formed pinprick plaques on their host. 
Possible reasons for the altered plaque morphologies are discussed below. 
Adsorption Assays. In order to determine if the adsorption efficiency of 
TP901-1erm and TMPTP901-1 mutants with predicted shorter tails differed, adsorption 
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assays were conducted (Fig. 8; Table 1). Phage adsorption to their lytic host, L. lactis 
3107, is expressed as percentage of phage bound at 30 
o
C within 30 seconds. The 
adsorption of TP901-1erm control measured 34.05 
+
/- 1.76 % (Fig. 8; Table 1). 
TMPTP901-1 mutants Δ1-2, Δ1-5, Δ1-8 and Δ1-9, which steadily increase in their EOP 
with a presumed concomitant decrease in tail length (Fig. 6; Table 1), display a 
gradual decline in adsorption assay efficiency. Mutant Δ1-9, which represents the 
tmpTP901-1 mutant removing the most DNA between the two encoded Tm-spanning 
domains, displayed an adsorption efficiency of 20.77 
+
/- 1.57 %. In addition, 
TMPTP901-1 deletion mutants Δ24-26 and Δ20-26, which exhibit a dramatically higher 
EOP than TP901-1erm, also displayed a substantial drop in their ability to adsorb to 
host L. lactis 3107; only 8.81 
+
/- 0.18 % of the phages present in lysates of mutant 
Δ20-26 adsorbed under tested conditions. Mutants Δ1-5+24-26 and Δ1-9+20-26, 
which are predicted to produce the shortest TP901-1erm tail structures, while still 
forming visible plaques, display the lowest adsorption efficiencies, with just 5.09 
+
/- 
0.09 % of TMPTP901-1 mutant Δ1-9+20-26 adsorbing to its host in 30 seconds at 30 
o
C. 
Frequency of lysogeny. TP901-1erm and plaque forming TMPTP901-1 mutant 
derivatives were tested for their ability to inject DNA into their hosts by performing 
frequency of lysogeny assays (Fig. 9A; Table 1). In addition, TMPTP901-1 mutants 
which were shown to be unable to form plaques on their host were tested for their 
ability to inject DNA into a host bacterium following in vitro assembly with donated 
phage tails, in case the TMP mutation causes the formation of unattached capsids 
and tails, or a failure to produce tails. The infection-defective phenotype of such 
TMP mutants, as determined by frequency of lysogeny, can sometimes be rescued by 
in vitro assembly experiments (Fig. 9B; Table 1) (Stockdale et al., Chapter 3). 
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While TP901-1erm control lysogenized its host at levels of 6.03e03 
+
/- 
5.24e2 Erm5 cfu/ml, TMPTP901-1 mutants Δ1-2, Δ1-5, Δ1-8 and Δ1-9 steadily 
increased in their frequency of lysogeny (Fig. 9A; Table 1). TMPTP901-1 mutants Δ1-
5, Δ1-8 and Δ1-9, Δ24-26 and Δ20-26 displayed frequencies of lysogeny that were 
significantly higher than the TP901-1erm control (p-value < 0.01), with mutant Δ20-
26 yielding 3.05e05 
+
/- 4.23e04 Erm5 cfu/ml lysogenized cells under the same 
conditions as the control. Combinatorial TMPTP901-1 mutants, including Δ1-9+24-26 
whose plaques are too small to accurately count, demonstrated that the frequency of 
lysogeny steadily decreased for mutants Δ1-5+24-26, Δ1-9+24-26 and Δ1-9+20-26. 
This is in agreement with the EOP results for mutants Δ1-5+24-26 and Δ1-9+20-26, 
and expected EOP results for TMP mutant Δ1-9+24-26, with the shortest predicted 
tail produced by Δ1-9+20-26 lysogenizing its host at a frequency of 3.17e04 +/- 
6.19e03 Erm5 cfu/ml. 
Lysates of non-plaque forming TMPTP901-1 mutants were tested for their 
ability to lysogenize host L lactis 3107 on their own or following incubation with 
free phage tails (Fig. 9B), donated from MHPTP901-1::Ter mutant (Stockdale et al., 
Chapter 3). TMPTP901-1 ΔN-terminus and ΔC-terminus yielded no erythromycin 
resistant colonies following incubation of the host strain with lysates of these 
mutants. However, frequency of lysogeny assays for TMPTP901-1 mutants ΔN-
terminus and ΔC-terminus following in vitro assembly with phage tails resulted in 
erythromycin colonies. Analysis of TMPTP901-1 Tm spanning region mutants resulted 
in a few erythromycin resistant colonies observed on the undiluted plate for mutant 
ΔTm3, while no such colonies were observed for mutant ΔTm2-3. Lysogens of L. 
lactis 3107 were detected for ΔTm3 and ΔTm2-3 lysates mixed with phage tails 
donated from MTPTP901-1::Ter; the possible reason for this observation is discussed 
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below. Unexpectedly, erythromycin resistant colonies, at a level statistically similar 
to the TP901-1erm control (p-value > 0.01), were observed for mutant ΔTm4 
following the frequency of lysogeny assay. Furthermore, the subsequent incubation 
of TMPTP901-1 mutant ΔTm4 with donated tail structures did not statistically result in 
an increase in its frequency of lysogeny compared to ΔTm4 lysates on their own (p-
value > 0.01). A putative explanation for the behavioural phenotype of ΔTm4 is 
provided in the discussion. 
TP901-1 immunoblotting. Western blots detecting TP901-1 MTP were 
conducted against PEG 8000 precipitated lysates of TP901-1erm and TMPTP901-1 
mutant derivatives which were unable to form plaques, as an indication of tail tubes 
produced (Fig. 10). MTP was clearly detectable in all TMPTP901-1 mutants, but only 
weakly visible in mutant Δ1-7.5, while apparently absent for mutant ΔC-terminus. 
Western blots against the MHP of TP901-1erm TMP mutants was performed to 
confirm phage capsid proteins were present, signifying correct preparation of phage 
samples. The capsid protein was detectable for all TMP mutants, except for the 
negative control representing a mutant in the MHP (results not shown).  
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DISCUSSION 
Bacteriophages, dominated by tailed phages of the order Caudovirales, are 
estimated to outnumber bacteria by about 10-fold (2). Detailed molecular models 
outlining the initiation of infection by Myoviridae and Podoviridae virions have 
previously been described (38, 39), yet a detailed model of how Siphoviridae adsorb, 
penetrate and inject DNA into their hosts is still lacking. In this study, we have 
examined the TMP of lactococcal phage TP901-1, in order to build a more detailed 
picture of this protein’s role in assembly and length determination of the long non-
contractile Siphoviridae tail organelle, while also to increase our understanding of 
how TMP proteins may facilitate DNA injection into their host. 
TMPTP901-1 is predicted as largely α-helical (Fig. 1), in agreement with the 
proposed coiled-coil secondary structure of TMP proteins (5). The C-terminus of 
TMPTP901-1 contains a short region predicted to be less α-helical in structure, which is 
consistent with secondary structure predictions of phage λ TMP and also anticipated 
in the model of λ tail assembly to interact with various proteins to form an initiator 
complex for tail assembly (7). In the current study, removing the terminal 30 amino 
acids at the C-terminus of TMPTP901-1 in mutant ΔC-terminus, appears to block tail 
formation as no MTP could be detected by means of Western blot analysis (Fig. 10). 
This finding corroborates the role of the TMPTP901-1 C-terminus in forming an 
initiator-type complex for tail assembly (37, 40, 41) and also indicates that the C-
terminal end of TMP within Siphoviridae tail structures is located distal to the 
capsid. 
If the TMP C-terminus is located at the tip of Siphoviridae phage tails, the 
corresponding N-terminus is expected to be located proximal to phage capsids within 
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tail structures. TMPTP901-1 mutant ΔN-terminus, removing 30 amino acids 
immediately downstream of the initiating methionine, produced tail proteins and 
capsid components as detected through Western blotting (Fig. 10). Frequency of 
lysogeny assays showed no infection of L. lactis by TMPTP901-1 ΔN-terminus lysates; 
however, following the mixing of ΔN-terminus with a TP901-1erm mutant donating 
functional phage tails (Stockdale et al., Chapter 3), erythromycin resistant lysogens 
of L. lactis 3107 were obtained (Fig. 9B; Table 1). This suggests that the N-terminus 
of TMPTP901-1 is involved in phage head-tail connection, through either direct contact 
with capsid proteins or indirectly via an interaction with the tail-terminator protein 
which attaches to the terminal hexameric ring of the MTP tail tube (13, 15, 42).  
While the TMP of Siphoviridae phages are known to dictate the final length 
of their tail structures (5, 6), to the best of our knowledge, no studies have 
specifically tried to shorten the length of Siphoviridae phage tails while maintaining 
their functionality. The identification of regularly occurring aromatic repeat 
sequences represented an opportunity to test the effect of shortening a Siphoviridae 
phage tail, while preserving the phage’s infectivity, and understand why they possess 
such long tail organelles. Interestingly, deletions in tmpTP901-1, presumed to shorten 
the final length of the phage’s tail, result in an increase in the observed phage EOP 
and frequency of lysogeny, while simultaneously decreasing the phage’s adsorption 
efficiency. Two possible factors which may explain the observed increase in titre of 
TMPTP901-1 mutants with presumably shorter tails is: (i) recombinant TP901-1 phage, 
TP901-1erm, contains an additional adenine methylase gene for erythromycin 
resistance that may reduce the optimal packaging size of its genome within capsids; 
or (ii) due to their decreased adsorption efficiency, fewer TMPTP901-1 mutants bind to 
cellular debris following lysis and become inactivated. However, combinatorial 
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mutations removing larger sections of tmpTP901-1, while continuing to decrease in 
their adsorption efficiencies, also results in the gradual decrease in mutant EOPs. 
These results suggest the efficiency of adsorption, and subsequent optimal efficiency 
at which phage establishing infection, is linked with the length of Siphoviridae phage 
tails. 
In order to confirm the nature of specific aromatic-residue-containing repeat 
sequences in assembling and determining the length of phage tails, TMPTP901-1 
mutant Δ1-7.5, out of sync with the 11 and 18 amino acid periodicity of tryptophan 
and phenylalanine residues, was created. Western blot detection of MTP present in 
Δ1-7.5 highlighted little MTP precipitated from phage lysates. In addition, the 
combination of Δ1-7.5 lysates with tails donated from MHPTP901-1::Ter mutant 
resulted in substantially more erythromycin colonies during frequency of lysogeny 
assays, compared to lysogeny by TMPTP901-1 Δ1-7.5 mutant on its own, signifying 
inefficient tail assembly for mutant Δ1-7.5. Potential reasons for the decreased 
production of tails with mutant Δ1-7.5 include the requirement of chaperone proteins 
gpG and gpGT to efficiently encompass the TMP during tail assembly. This is 
supported by structural studies of tail assembly chaperone proteins which 
demonstrated they form spiral structures in solution (10, 43), with chaperone ORF12 
of lactococcal phage p2 containing regularly spaced hydrophobic patches along the 
inside of its chaperone spiral structure which is anticipated to coincide with the 
positions of aromatic residues along the phage TMP α-helical structure (10). 
In addition to TMPTP901-1 mutant Δ1-7.5, several TP901-1erm TMP mutants 
displayed a dramatic increase in their frequency of lysogeny following incubation 
with tails donated from mutant MHPTP901-1::Ter. This indicates these mutants 
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inefficiently produce tail structures following induction from their host. All mutants 
created in this study analysing the annotated repeats 27-29, despite deletions obeying 
the 11 amino acid periodicity of repeat sequences, displayed either a dramatic 
reduction in EOP or low frequency of lysogeny. Two potential reasons for these 
observations are; (i) repeats 28 and 29 are in fact not repeat sequences, as they do not 
start with a tryptophan or phenylalanine amino acid; or (ii) repeat 29 is eighteen 
rather than eleven amino acids long, as a tryptophan residue occurs seven amino 
acids following the residue which was deemed to represent the end of this particular 
repeat sequence. However, without a better understanding of structure of TMP 
proteins as they occur within phage virions, including how repeats contribute to tail 
assembly and why they can be of different length (36), it is hard to predict 
phenotypes of particular mutants which do not assembly tails as efficiently as the 
wild-type phage. 
Mutations in Tm spanning regions of TMPTP901-1 substantiate the presumed 
importance of these domains for DNA injection into their host. Mutants ΔTm3 and 
ΔTm2-3, which are expected to produce phages with connected capsids and tails, 
yielded very few and zero erythromycin resistant colonies, respectively, following 
frequency of lysogeny experiments (Fig. 9B; Table 1). These findings support the 
presumed role of the N-terminal proximal Tm domain of TMPTP901-1 in facilitating 
DNA injection into its host. However, frequency of lysogeny assays of ΔTm3 and 
ΔTm2-3 following incubation with functional tails yielded erythromycin resistant 
colonies, highlighting that, to a limited degree, these mutants inefficiently produced 
tail structures. This is in agreement with other TMPTP901-1 mutants, as ΔTm3 and 
ΔTm2-3 do remove amino acids with a denomination of 11 or 18 residues 
(Supplementary Table 3). 
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Unexpectedly, TMPTP901-1 mutant ΔTm4 lysogenized L. lactis 3107 at levels 
comparable to wild-type TP901-1erm during frequency of lysogeny assays (Fig. 9B; 
Table 1), despite not forming plaques on its host. Without structural data on the 
nature of the predicted Tm pores formed by TMPs during Siphoviridae DNA 
injecting into their hosts, it is hard to draw a conclusion on the role(s) of the C-
terminal proximal Tm domain of TP901-1. However, from results obtained in this 
study, it seems that the C-terminal proximal Tm domain of TMPTP901-1 is not 
essential for DNA injection into its host. In addition, the distance between the N-
terminal and C-terminal proximal Tm domains is predicted as important for phage 
DNA injection and/or replication. Plaques produced by mutants Δ1-2, Δ1-5, Δ1-8 
and Δ1-9 decrease in size when the intervening gap between the two Tm domains is 
decreased, and plaques are abolished for mutant Δ1-10 which overlaps with the start 
of the forth predicted Tm spanning region. 
In order to confirm the predicted phenotypes of TMPTP901-1 phage mutants 
produced in this study, electron microscopy (EM) images are required. Based on the 
biological characterization assays of TMPTP90-1 mutants, EM analysis, which is 
currently underway, is predicted to visualize: detached capsids and tail structures for 
mutant ΔN-terminus; capsids only for ΔC-terminus, excess capsid structures for 
mutants which remove sections of tmpTP901-1 out of sync with 11 or 18 amino acid 
periodicity, due to inefficient tail production; and TP901-1erm with shorter tails for 
mutants deleting aromatic-residue-containing repeating units in the TMPTP901-1-
encoding gene. 
In conclusion, several distinct functions of the TMP of lactococcal phage 
TP901-1 have been demonstrated in this study, including; (i) the role of the N- and 
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C-terminal regions of TMPTP901-1 in tail assembly, (ii) the potential role of aromatic-
residue-containing repeat sequences in controlling phage tail length, (iii) the 
necessity of repeats of specific length for efficient tail production, and (iv) the role of 
certain TMPTP901-1 Tm spanning regions for DNA injection into a host bacterium. 
While this studies adds to the knowledge of Siphoviridae TMP tail assembly and 
function, more biological and, if possible, structural studies are required to further 
disentangle the complicated multi-functionality of Siphoviridae TMPs and their 
essential role during host infection.  
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Table 1. Results of biological assays analysing TP901-1erm and TMPTP901-1 mutants. 
TP901-1erm or TMPTP901-1 Tested Result Average Standard Deviation   TP901-1erm or TMPTP901-1 Tested Result Average Standard Deviation 
Efficiency of Plaquing (EOP)     Frequency of Lysogeny (Erm5 cfu/ml) (Erm5 cfu/ml) 
  TP901-1erm 1.00 +/- 0.046     ΔN-terminus 0.00 +/- 0.00 
  Δ1-2 0.67 +/- 0.067     ΔN-terminus + Tails 1.19e04 +/- 3.47e03 
  Δ1-5 1.96 +/- 0.224     ΔC-terminus 0.00 +/- 0.00 
  Δ1-8 2.43 +/- 0.258     ΔC-terminus + Tails 3.23e03 +/- 1.30e03 
  Δ1-9 2.89 +/- 0.266     ΔTm3 1.25e00 +/- 5.00e-01 
  Δ24-26 7.04 +/- 0.298     ΔTm3 + Tails 9.32e02 +/- 1.47e02 
  Δ20-26 12.52 +/- 1.483     ΔTm2-3 0.00 +/- 0.00 
  Δ1-5+24-26 0.44 +/- 0.066     ΔTm2-3 + Tails 2.28e03 +/- 2.06e02 
  Δ1-9+24-26 N/A N/A     ΔTm4 1.01e04 +/- 1.52e03 
  Δ1-9+20-26 0.35 +/- 0.008     ΔTm4 + Tails 1.58e04 +/- 3.54e03 
       Δ1-7.5 4.95e01 +/- 9.88e00 
Percentage Phage Adsorption (%) (%)     Δ1-7.5 + Tails 2.14e04 +/- 5.53e03 
  TP901-1erm 34.05 +/- 1.76     Δ1-10 8.25e01 +/- 3.87e00 
  Δ1-2 27.84 +/- 5.60     Δ1-10 + Tails 1.63e04 +/- 2.27e03 
  Δ1-5 26.37 +/- 1.82     Δ24-29 1.01e02 +/- 1.99e01 
  Δ1-8 21.98 +/- 2.40     Δ24-29 + Tails 2.06e04 +/- 4.16e03 
  Δ1-9 20.77 +/- 1.57     Δ1-9+20-29 2.53e02 +/- 3.50e01 
  Δ24-26 11.49 +/- 1.39     Δ1-9+20-29 + Tails 1.40e04 +/- 3.06e03 
  Δ20-26 8.81 +/- 0.18      
  Δ1-5+24-26 8.63 +/- 0.19      
  Δ1-9+20-26 5.09 +/- 0.09      
        
Frequency of Lysogeny (Erm5 cfu/ml) (Erm5 cfu/ml)      
  TP901-1erm 6.03e03 +/- 5.24e02      
  Δ1-2 8.43e03 +/- 3.33e02      
  Δ1-5 3.20e04 +/- 2.90e03      
  Δ1-8 4.62e04 +/- 3.31e03      
  Δ1-9 6.08e04 +/- 3.76e03      
  Δ24-26 1.34e05 +/- 9.07e03      
  Δ20-26 3.05e05 +/- 4.32e04      
  Δ1-5+24-26 7.27e04 +/- 1.00e04      
  Δ1-9+24-26 5.73e04 +/- 3.67e03      
  Δ1-9+20-26 3.17e04 +/- 6.19e03      
N/A   Not applicable 
Erm5 cfu/ml  5 µg/ml erythromycin-resistant colony forming units per millilitre  
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Supplementary Table 1. Bacterial strains, phages and plasmids used in this study. 
Strains, phages and plasmids Relevant features Source 
Lactococcal strains   
 3107 L. lactis strain sensitive to infection by phage TP901-1erm  
 NZ9000-Crot712-TP901-1erm L. lactis NZ9000 derivative with mutation in prophage t712 deduced anti-repressor (Cro) promotor sequence and lysogenized with TP901-1erm; contains 
plasmid pJP005 
(Stockdale et al., 
Chapter 3) 
   
Phages   
 TP901-1erm Temperate P335 species phage infecting L. lactis strain 3107; contains erythromycin marker (35, 44, 45) 
 TP901-TMPΔ1-2 Deletion mutation in tmpTP901-1 removing repeats #1 and #2 (see Fig. 2) This study 
 TP901-TMPΔ1-5 Deletion mutation in tmpTP901-1 removing repeats #1 to #5; derived from sequential mutation of TMPTP901--1 mutant Δ1-2 This study 
 TP901-TMPΔ1-7.5 Deletion mutation in tmpTP901-1 removing repeats #1 to #7, and 9 out of the 18 amino acids of repeat #8; derived from sequential mutation of TMPTP901--1 
mutant Δ1-5 
This study 
 TP901-TMPΔ1-8 Deletion mutation in tmpTP901-1 removing repeats #1 to #8; derived from sequential mutation of TMPTP901--1 mutant Δ1-5 This study 
 TP901-TMPΔ1-9 Deletion mutation in tmpTP901-1 removing repeats #1 to #9; derived from sequential mutation of TMPTP901--1 mutant Δ1-5 This study 
 TP901-TMPΔ1-10 Deletion mutation in tmpTP901-1 removing repeats #1 to #10; derived from sequential mutation of TMPTP901--1 mutant Δ1-8 This study 
 TP901-TMPΔ24-26 Deletion mutation in tmpTP901-1 removing repeats #24 to #26 This study 
 TP901-TMPΔ20-26 Deletion mutation in tmpTP901-1 removing repeats #20 to #26; derived from sequential mutation of TMPTP901--1 mutant Δ24-26 This study 
 TP901-TMPΔ24-29 Deletion mutation in tmpTP901-1 removing repeats #24 to #29; derived from sequential mutation of TMPTP901--1 mutant Δ24-26 This study 
 TP901-TMPΔ1-5+24-26 Deletion mutation in tmpTP901-1 removing repeats #1 to #5 and #24 to #26; derived from sequential mutation of TMPTP901--1 mutant Δ1-5 This study 
 TP901-TMPΔ1-9+24-26 Deletion mutation in tmpTP901-1 removing repeats #1 to #9 and #24 to #26; derived from sequential mutation of TMPTP901--1 mutant Δ1-5+24-26 This study 
 TP901-TMPΔ1-9+20-26 Deletion mutation in tmpTP901-1 removing repeats #1 to #9 and #20 to #26; derived from sequential mutation of TMPTP901--1 mutant Δ1-9+24-26 This study 
 TP901-TMPΔ1-9+24-29 Deletion mutation in tmpTP901-1 removing repeats #1 to #9 and #24 to #29; derived from sequential mutation of TMPTP901--1 mutant Δ1-9+24-26 This study 
 TP901-TMPΔ1-9+20-29 Deletion mutation in tmpTP901-1 removing repeats #1 to #9 and #20 to #29; derived from sequential mutation of TMPTP901--1 mutant Δ1-9+20-26 This study 
 TP901-TMPΔTm3 Deletion mutation in tmpTP901-1 removing the third annotated transmembrane domain (Fig. 3) This study 
 TP901-TMPΔTm2-3 Deletion mutation in tmpTP901-1 removing the second and third transmembrane domains This study 
 TP901-TMPΔTm4 Deletion mutation in tmpTP901-1 removing the fourth transmembrane domain This study 
 TP901-TMPΔN-term Deletion mutation in tmpTP901-1 removing 30 amino acids, following the inaugural methionine, from the N-terminal-encoding region of tmpTP901-1 This study 
 TP901-TMPΔC-term Deletion mutation in tmpTP901-1 removing 30 amino acids from the C-terminal-encoding region of tmpTP901-1 This study 
   
Plasmids   
 pJP005 pNZ8048 derivative expressing RecT protein required for recombineering mutagenesis (31) 
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Supplementary Table 2. Recombineering and screening oligonucleotides used in this study to create TP901-1erm TMP mutants. 
Oligonucleotide name Prerequisite Oligonucleotide sequence (5’ → 3’) 
Recombineering primers   
 Δ1-2 None A*A*T*G*T*TGTTCCAGGTATCAGAGAACCATTGGGTAATATCTCCCCAATTTTTATAAACTAAAATTCCTATAGCTATAACAGCCGCTATGGC 
 Δ1-5 Δ1-2 C*G*T*A*C*CTTTCCAAAGATTAGTGAACCACTCCTTAATGCCATTCCAATTTTTATAAACTAAAATTCCTATAGCTATAACAGCCGCTATGGC 
 Δ1-7.5 Δ1-5 A*T*C*A*A*GAATTGGTTGAAAGATTGTTTTGATTGTCTCAACAAATGGATTTTTATAAACTAAAATTCCTATAGCTATAACAGCCGCTATGGC 
 Δ1-8 Δ1-5 G*A*C*T*T*GCCCCCATAATCCGCTAAAGAAATCAAGAATTGGTTGAAAATTTTTATAAACTAAAATTCCTATAGCTATAACAGCCGCTATGGC 
 Δ1-9 Δ1-5 T*C*T*C*C*CAAGCTGAACCAAAGATAGTTTGGACTTGCCCCCAATTTTTATAAACTAAAATTCCTATAGCTATAACAGCCGCT 
 Δ1-10 Δ1-8 G*A*G*T*A*ACAAAACTGGTCCCATAACAACCGTCTTAATAATCTCCCAATTTTTATAAACTAAAATTCCTATAGCTATAACAGCCGCTATGGC 
 Δ24-26 None T*A*C*C*A*ATATCTAGCAAGTTTATATTTTTTAGATTGTTAAAACCTTGTTTGACTCCATTCACAATAGCATTGGCAGAATCA 
 Δ20-26 Δ24-26 G*G*C*T*T*TACCAATATCTAGCAAGTTTATATTTTTTAGATTGTTAAAACCATTAACAATTCCGTCAACAATAGACTTGGCCATATTAATGAC 
 Δ24-29 Δ24-26 T*G*G*C*C*CTTTATGCTTCCGAATCCAATCGCCAATCCCGCTAATGAAACCTTGTTTGACTCCATTCACAATAGCATTGGCAGAATCAACGAC 
 Δ20-29 Δ20-26 T*G*G*C*C*CTTTATGCTTCCGAATCCAATCGCCAATCCCGCTAATGAAACCATTAACAATTCCGTCAACAATAGACTTGGCCATATTAATGAC 
 ΔTm3 None A*T*A*C*T*TCTTTCCCGAATTTAGAAATTTTATCCCAATTTTTTGGTAAAGAAATAGCAGTAAAACTTCCTCCTATTAGAGCA 
 ΔTm2-3 ΔTm3 T*G*C*C*C*ATACTTCTTTCCCGAATTTAGAAATTTTATCCCAATTTTTTACTCTTTGTAGAGTAACAACAGCTTGCCCAAATATTACTAATAA 
 ΔTm4 None G*C*A*T*C*GCAAAATCTTTTTTGAATTGGTTAAAGTCCCCAGTGATAGTTTGGACTTGCCCCCATAATCCGCTAAAGAAATCA 
 ΔN-term None C*T*T*T*C*CCTACTGTAGACATCGTACTATTAGTGTTCTTTTCCATATTTTCCTCCTTTCCTAGTTATTTGCTTTTTTCATGA 
 ΔC-term None G*T*T*T*T*GTCGTATCTCTAAACTTGTACATTTCTACCTCCTAGAATGAAGCCGGCTGTTTTCCTTGGTTAAGATTCACATCA 
   
Screening primers   
 Del1-10-Fw  GCAGTTAGGAAAGTTGCTGA 
 Del1-10-Rv  GTCCCATAACAACCGTCTT 
 N-term-Del-Fw  CGAAGAAGAATTCATTTATGAACAAGC 
 N-term-Del-Rv  GCTTGTTGTCTAAGTTCTTCG 
 C-term-Del-Fw  GCTTGTTGTCTAAGTTCTTCG 
 C-term-Del-Rv  ACATTAGTGATCACACCTCC 
 Tm2-3-Del-Fw  AGTTGCTGATTCAATTTCAGGAT 
 Tm2-3-Del-Rv  ATTTTTGGCACCTTGGACTG 
 Tm4-Del-Fw  AGAAATTTGCGTCCGATGCA 
 Tm4-Del-Rv  TGTTTGCCAGAGCATCGCA 
 Del24-26-Fw  TTCTAATATCTGGACGACAGT 
 Del24-26-Rv  CCAATATCCACAGAATAGTCA 
 Del20-29-Fw  TTCTAATATCTGGACGACAGTTGT 
 Del20-29-Rv  CCTTGGTTAAGATTCACATCATGAG 
* Phosphorothioate linkages of recombineering oligos. 
 246 
Supplementary Table 3. Resultant amino acid sequences of TP901-1erm TMP 
mutants following recombineering mutagenesis. 
Mutant name Number of amino 
acids deleted 
Resultant amino acid sequence of TP901-1 TMP mutants
1, 2
 
 Δ1-2 29 AIAAVIAIGILVYKN / WGDITQWFSDTWNNI 
 Δ1-5 69 AIAAVIAIGILVYKN / WNGIKEWFTNLWKGT 
 Δ1-7.5 100 AIAAVIAIGILVYKN / PFVETIKTIFQPILD 
 Δ1-8 109 AIAAVIAIGILVYKN / FQPILDFFSGLWGQV 
 Δ1-9 120 AIAAVIAIGILVYKN / WGQVQTIFGSAWEII 
 Δ1-10 131 AIAAVIAIGILVYKN / WEIIKTVVMGPVLLL 
 Δ24-26 40 VVDSANAIVNGVKQG / FNNLKNINLLDIGKA 
 Δ20-26 84 VINMAKSIVDGIVNG / FNNLKNINLLDIGKA 
 Δ24-29 73 VVDSANAIVNGVKQG / FISGIGDWIRKHKGP 
 Δ20-29 117 VINMAKSIVDGIVNG / FISGIGDWIRKHKGP 
 ΔTm3 19 GLALIGGSFTAISLP / KNWDKISKFGKEVWA 
 ΔTm2-3 43 LLVIFGQAVVTLQRV / KNWDKISKFGKEVWA 
 ΔTm4 23 ILDFFSGLWGQVQTI / TGDFNQFKKDFAMLW 
 ΔN-terminus 30 M / EKNTNSTMSTVGKVA 
 ΔC-terminus 30 SHDVNLNQGKQPASF / * 
1 Site of deletion is indicated by a forward-slash (/) 
2 Stop codon represented by an asterisks symbol (*) 
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Figure 1. SABLE secondary structure prediction of TMPTP901-1. The protein’s 
secondary structure is predominately α-helical, in red. The C-terminal extremity has 
a short coiled section, indicated in blue, and a predicted β-sheet, indicated in green, 
before ending with more α-helices.  
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>TMPTP901-1 
MESFSVQAYLKATDNNFVSTFKDAAKQVQNFEKNTNSTMSTVGKVATSTGKTLTKAVTVPIIGIGVAA
AKIGGDFESQMSRVKAISGATGSSFEELRQQAIDLGAKTAFSAKESASGMENLASAGFNAKEIMEAMP
GLLDLAAVSGGDVALASENAATALRGFNLDASQSGHVANVFAKAAADTNAEVGDMGEAMKYIAPVANS
MGLSIEEVSAAIGIMSDAGIKGSQAGTSLRGALSRLADPTDAMQAKMDELGLSFYDSEGKMKPLKDQI
GMLKDAFKGLTPEQQQNALVTLYGQESLSGMMALIDKGPDKLGKLTESLKNSDGAADKMAKTMQDNMN
SSLEQMMGAFESAAIVVQKILAPAVRKVADSISGLVDKFVSAPEPVQKMIVTIGLIVAAIGPLLVIFG
QAVVTLQRVKVGFLALRSGLALIGGSFTAISLPVLGIIAAIAAVIAIGILVYKN 
1. WDKISKFGKEV 
2. WANVKKFASDAAEVIKEK 
3. WGDITQWFSDT 
4. WNNIKNGAKGL 
5. WDGTVQGAKNAVDSVKNA 
6. WNGIKEWFTNL 
7. WKGTTSGLSSA 
8. WDSVTTTLAPFVETIKTI 
9. FQPILDFFSGL 
10. WGQVQTIFGSA 
11. WEIIKTVVMGP 
12. VLLLIDLITGD 
13. FNQFKKDFAML 
14. WQTLFTNIQTL 
15. VTTYVQIVVGF 
16. FTAWGQTVSNI 
17. WTTVVNTIQSL 
18. WGAFTTWVINM 
19. AKSIVDGIVNG 
20. WNSFKQGTVDL 
21. WNATVQWVKDT 
22. WASFKQWVVDS 
23. ANAIVNGVKQG 
24. WENLKQGTIDL 
25. WNGMINGLKGI 
26. WDGLKQSVRNLIDNVKTT 
27. FNNLKNINLLD 
28. IGKAIIDGLVK 
29. GLKKKWEDGMK 
FISGIGDWIRKHKGPIRKDRKLLIPAGKAIMTGLNSGLTGGFRNVQSNVSGMGDMIANAINSDYSVDI
GANVAAANRSISSQVSHDVNLNQGKQPASFTVKLGNQIFKAFVDDISNAQGQAINLNMGF 
 
Figure 2. Analysis of TMPTP901-1 amino acid sequence. Twenty-nine aromatic-
residue-containing repeat sequences were putatively deduced by manually aligning 
tryptophan (W) and phenylalanine (F) amino acids with 11 or 18 spaced periodicity. 
All tryptophan amino acids in TP901-1 TMP sequence are highlighted in yellow, and 
phenylalanine amino acids within the putative repeat sequences’ region are 
highlighted in red. Transmembrane spanning regions are underlined once and twice, 
alternatively (see Fig. 3).  
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(B) 
>TMPTP901-1 
MESFSVQAYLKATDNNFVSTFKDAAKQVQNFEKNTNSTMSTVGKVATSTGKTLTKAVTVPIIGIGVAA
AKIGGDFESQMSRVKAISGATGSSFEELRQQAIDLGAKTAFSAKESASGMENLASAGFNAKEIMEAMP
GLLDLAAVSGGDVALASENAATALRGFNLDASQSGHVANVFAKAAADTNAEVGDMGEAMKYIAPVANS
MGLSIEEVSAAIGIMSDAGIKGSQAGTSLRGALSRLADPTDAMQAKMDELGLSFYDSEGKMKPLKDQI
GMLKDAFKGLTPEQQQNALVTLYGQESLSGMMALIDKGPDKLGKLTESLKNSDGAADKMAKTMQDNMN
SSLEQMMGAFESAAIVVQKILAPAVRKVADSISGLVDKFVSAPEPVQKM 
 
1. IVTIGLIVAAIGPLLVIFGQAVVTLQRVK 
2. VGFLALRSGLALIGGSFTAISLP 
3. VLGIIAAIAAVIAIGILVY 
 
KNWDKISKFGKEVWANVKKFASDAAEVIKEKWGDITQWFSDTWNNIKNGAKGLWDGTVQGAKNAVDSV
KNAWNGIKEWFTNLWKGTTSGLSSAWDSVTTTLAPFVETIKTIFQPILDFFSGLWGQVQTI 
 
4. FGSAWEIIKTVVMGPVLLLIDLITGDFNQFKKDFAML 
5. WQTLFTNIQTLVTTYVQIVVGFFTAWGQT 
6. VSNIWTTVVNTIQSLWGAFTTWV 
 
INMAKSIVDGIVNGWNSFKQGTVDLWNATVQWVKDTWASFKQWVVDSANAIVNGVKQGWENLKQGTID
LWNGMINGLKGIWDGLKQSVRNLIDNVKTTFNNLKNINLLDIGKAIIDGLVKGLKKKWEDGMKFISGI
GDWIRKHKGPIRKDRKLLIPAGKAIMTGLNSGLTGGFRNVQSNVSGMGDMIANAINSDYSVDIGANVA
AANRSISSQVSHDVNLNQGKQPASFTVKLGNQIFKAFVDDISNAQGQAINLNMGF 
 
Figure 3. TMPTP901-1 transmembrane (Tm) spanning region predictions. (A) 
TMHMM analysis of TP901-1 TMP putatively predicts six Tm spanning regions. 
(B) Amino acids of the Tm spanning regions predicted inside or outside the bacterial 
cytoplasm are highlighted yellow and red, respectively.  
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   (D)    (E) 
 
 
 
 
 
 
Figure 4. Predicted Transmembrane (Tm) topology of (A) TMPTP901-1 and (B-E) 
mutant derivatives which were forecast by TOPO2 to adopt an altered Tm topology. 
(B) TMP repeat deletion mutant Δ1-10 displays altered Tm topology, as the end of 
the tenth annotated repeat sequence overlaps with the start of the forth Tm spanning 
region (see Fig. 2). (C) TMP deletion of the annotated third Tm spanning region, 
ΔTm3, results in a dramatically altered transmembrane topology. (D) TMP deletion 
ΔTm2-3 was created to restore transmembrane topology of ΔTm3; however, this 
mutation does not restore the mutant’s plaque forming ability. (E) Deletion of the 
forth annotated Tm spanning region, ΔTm4, displays an altered transmembrane 
topology. 
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TP901-1_TMP      MESFSVQAYLKATDNNFVSTFKDAAKQVQNFEKNTNSTMSTVGKVATSTGKTLTKAVTVP 60 
TuC2009_TMP      MESFSVQAYLKATDNNFVSTFKDAAKQVQNFQNNTNSTMSTVGQVSKSTGKKLSKAVTVP 60 
                 *******************************::**********:*:.****.*:****** 
 
TP901-1_TMP      IIGIGVAAAKIGGDFESQMSRVKAISGATGSSFEELRQQAIDLGAKTAFSAKESASGMEN 120 
TuC2009_TMP      IIGIGVAAAKIGGDFESQMSRVKAISGATGSSFEELRQQAIDLGAKTAFSAKESASGMEN 120 
                 ************************************************************ 
 
TP901-1_TMP      LASAGFNAKEIMEAMPGLLDLAAVSGGDVALASENAATALRGFNLDASQSGHVANVFAKA 180 
TuC2009_TMP      LASAGFNAKEIMEAMPGLLDLAAVSGGDVGLASENAATALRGFNLDASQSGHVANVFAKA 180 
                 *****************************.****************************** 
 
TP901-1_TMP      AADTNAEVGDMGEAMKYIAPVANSMGLSIEEVSAAIGIMSDAGIKGSQAGTSLRGALSRL 240 
TuC2009_TMP      AANTNAEVGDMGEAMKYIAPVANSMGLSIEEVSAAIGIMSDAGIKGSQAGTSLRGALSRL 240 
                 **:********************************************************* 
 
TP901-1_TMP      ADPTDAMQAKMDELGLSFYDSEGKMKPLKDQIGMLKDAFKGLTPEQQQNALVTLYGQESL 300 
TuC2009_TMP      AKPTDAMQAKMDELGLSFYDSEGKMKPLKDQIGMLKDAFKGLTPEQQQNALVTLYGQESL 300 
                 *.********************************************************** 
 
TP901-1_TMP      SGMMALIDKGPDKLGKLTESLKNSDGAADKMAKTMQDNMNSSLEQMMGAFESAAIVVQKI 360 
TuC2009_TMP      SGMIALIDKGPDKLGKLTESLKNSDGAADKMAKTMQDNMNSSLEQMMGALESAAIVVQKI 360 
                 ***:*********************************************:********** 
 
TP901-1_TMP      LAPAVRKVADSISGLVDKFVSAPEPVQKMIVTIGLIVAAIGPLLVIFGQAVVTLQRVKVG 420 
TuC2009_TMP      LAPAVRKVADSISGLVDKFVSAPEPVQKMIVTIGLIVAAIGPLLVIFGQAVLVLQRVKVG 420 
                 ***************************************************:.******* 
 
TP901-1_TMP      FLALRSGLALIGGSFTAISLPVLGIIAAIAAVIAIGILVYKNWDKISKFGKEVWANVKKF 480 
TuC2009_TMP      FLALRSGLALIGGSFTAISLPVLGIIAAIAAVIAIGILVYKNWDKISKFGKEVWANVKKF 480 
                 ************************************************************ 
 
TP901-1_TMP      ASDAAEVIKEKWGDITQWFSDTWNNIKNGAKGLWDGTVQGAKNAVDSVKNAWNGIKEWFT 540 
TuC2009_TMP      ASDAAEVIKEKWGDITQWFSDTWKSIKEGAKGLWNGTIQGAKDAVDSVKNAWNGIKEWFA 540 
                 ***********************:.**:******:**:****:****************: 
 
TP901-1_TMP      NLWKGTTSGLSSAWDSVTTTLAPFVETIKTIFQPILDFFSGLWGQVQTIFGSAWEIIKTV 600 
TuC2009_TMP      NLWKGTTSGLSSAWDSVTTTLAPFVETIKTIFQPMLDFFSGLWGQVKTIFGSAWEIIKTV 600 
                 **********************************:***********:************* 
 
TP901-1_TMP      VMGPVLLLIDLITGDFNQFKKDFAMLWQTLFTNIQTLVTTYVQIVVGFFTAWGQTVSNIW 660 
TuC2009_TMP      VMGPVLLLIDLITGDFNQFKEDFGMLWQTLATAIQTIVQTFVNIVVGLYSSFFQTVVNIW 660 
                 ********************:**.****** * ***:* *:*:****::::: *** *** 
 
TP901-1_TMP      TTVVNTIQSLWGAFTTWVINMAKSIVDGIVN----------------------------- 691 
TuC2009_TMP      TTIVNTIQSLWGAFTTWVVNMAKSIVDGIVNGWNSFKQGTVDLWNATIQWVKDTWASFKQ 720 
                 **:***************:************                              
 
TP901-1_TMP      -----------------------------------------------------------G 692 
TuC2009_TMP      WVVNMAKSIVDGIVNGWNSFKQGTVDLWNATIQWVKDTWASFKQWVVNMAKSIVDGIVNG 780 
                                                                            * 
 
TP901-1_TMP      WNSFKQGTVDLWNATVQWVKDTWASFKQWVVDSANAIVNGVKQGWENLKQGTIDLWNGMI 752 
TuC2009_TMP      WNSFKQGTVDLWNATIQWVKDTWASFKQWVVDSANAIVNGVKQGWKNLKQGTIDLWKGMI 840 
                 ***************:*****************************:**********:*** 
 
TP901-1_TMP      NGLKGIWDGLKQSVRNLIDNVKTTFNNLKNINLLDIGKAIIDGLVKGLKKKWEDGMKFIS 812 
TuC2009_TMP      NGLKGIWDGLKQSVSDLIDNVKTTFNNLKNINLLDIGKAIIDGFVKGLKQKWEDGMKFIS 900 
                 ************** :***************************:*****:********** 
 
TP901-1_TMP      GIGDWIRKHKGPIRKDRKLLIPAGKAIMTGLNSGLTGGFRNVQSNVSGMGDMIANAINSD 872 
TuC2009_TMP      GIGDWIREHKGPIRVDRKLLTPAGNAIMNGLNSGLTGGFRDVQSNVSGMGDMIANAINSD 960 
                 *******:****** ***** ***:***.***********:******************* 
 
TP901-1_TMP      YSVDIGANVAAANRSISSQVSHDVNLNQGKQPASFTVKLGNQIFKAFVDDISNAQGQAIN 932 
TuC2009_TMP      YSVDIGANVAAANRSISSQVSHDVNLNQGKQPASFTVKLGNQNFKAFVDDISNAQGQAIN 1020 
                 ****************************************** ***************** 
 
TP901-1_TMP      LNMGF 937 
TuC2009_TMP      LNMGF 1025 
                 ***** 
 
Figure 5. ClustalW alignment of lactococcal phage TP901-1 and Tuc2009 TMP sequences. 
Tuc2009 TMP, relative to TP901-1, has an addition 88 amino acids which obeys the 11 
amino acid periodicity of the aromatic-residue-containing repeat sequences (highlighted 
yellow); however, two of TMPTuc2009’s additional repeats appear to begin with an alanine. 
ClustalW conserved amino acids are coloured: red, small/hydrophobic; blue, acidic; 
magenta, basic; green, hydroxyl/sulfhydryl/amine.  
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Figure 6. Efficiency of Plaquing (EOP) of TP901-1erm and TMP mutant derivatives 
which form plaques. Plaques for TP901-1erm TMP mutant Δ1-9+24-26 were 
detectable when the bacterial lawn was challenged with a presumed high titre of 
phages, but plaques in isolation were too small to accurately count. Results are 
summarized in Table 1. 
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Scale bar represents 2mm 
(A) (B) (C) (D) (E) 
(F) (G) (H) (I) 
 
 
 
 
 
 
 
Figure 7. Photographs of plaques formed by (A) TP901-1erm and (B-I) TMPTP901-1 
mutant derivatives. (A) Wild-type phage TP901-1erm forms on average the largest 
plaques, while plaques decrease in size for mutants (B) Δ1-2, (C) Δ1-5, (D) Δ1-8 
and (E) Δ1-9. Plaque sizes of mutants (F) Δ24-26 and (G) Δ20-26 are comparable to 
the wild-type plaque size. However, mutant (H) Δ1-5+24-26 forms extremely small 
plaques, while mutant (I) Δ1-9+20-26 are barely visible (examples of several 
plaques indicated by black-filled triangles). Images were standardised with each 
scale bar representing 2 mm. 
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Figure 8. Adsorption assays of TP901-1erm and TMPTP901-1 mutants which form 
countable plaques. Results are summarized in Table 1. 
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(B) 
 
Figure 9. Frequency of lysogeny of TP901-1erm and TMPTP901-1 mutant derivatives. (A) Frequency of lysogeny of TP901-1erm and plaque 
forming TMPTP901-1 mutants. (B) Frequency of lysogeny of non-plaque forming TMPTP901-1 mutants, with and without the donation of phage 
tails. Results are summarized in Table 1. 
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Figure 10. Western blot detection of TP901-1 major tail protein (MTP) for TP901-1erm TMP mutants which produced no plaques. MTPTP901-
1::Ter and MHPTP901-1::Ter served as a negative and positive control for the detection of TP901-1 MTP, and vice versa for the detection of 
TP901-1 Major Head Protein (MHP; results not shown). Very little MTP was present in the PEG 8000 precipitate of mutant Δ1-7.5 while no 
MTP was detected for ΔC-terminus, suggesting aberrant tail production. All other non-plaque forming mutants of TP901-1 TMP showed the 
presence of MTP, indicative of functional tails produced. 
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CHAPTER V 
 
General Discussion 
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The main aim of this PhD study was to investigate Siphoviridae structural 
proteins, and primarily proteins comprising their tail apparatus, in order to 
characterize their role in commencing infection of their bacterial host. The chapters 
of thesis describe; (i) the Tail-Associated Lysin (Tal) proteins of lactococcal-
infecting TP901-1 and Tuc2009 phages, and their pertinence to degrading the 
bacterial cell wall for infection; (ii) the structural module-encoded proteins of 
TP901-1 and their assembly and importance in creating an infectious virion; and (iii) 
the Tape Measure Protein (TMP) of TP901-1 and its multifaceted role in creating a 
functional tail and in facilitating DNA injection into a host bacterium. 
 
An important, yet often overlooked, aspect of the phage infection cycle is 
their ability to overcome the bacterial cell wall. Gram-negative bacteria often possess 
only a single-layer Peptidoglycan (PG) sacculus (1), yet many of their infecting 
phages encode Virion-Associated Peptidoglycan Hydrolase (VAPGH) enzymes to 
overcome this obstacle (2-5). Consequently, one would almost expect all phages 
infecting Gram-positive bacteria to possess VAPGHs to surmount the thicker Gram-
positive cell wall; however, this is not the case. 
 
The characterization of the Tal proteins of TP901-1 and Tuc2009 yielded 
results consistent with findings by Molineux et al. (2001) and Piuri et al. (2006) (6, 
7): VAPGH enzymes enhance phage infection during environmental and 
physiological conditions which result in greater cross-linkage of the bacterial cell 
wall. Thus, TP901-1 and Tuc2009 virions, which possess a lytic domain associated 
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with their Tal proteins, are primed to infect lactococcal cells with increased cross-
linkage of their peptidoglycan as they enter stationary phase growth. 
 
TP901-1 and Tuc2009 may also produce tails with a truncated tail fibre 
protein lacking the C-terminal M23 peptidase domain which is required for lytic 
activity. By analysing a mutant of TP901-1 which exclusively incorporates a 
truncated form of its Tal protein into their virion, and a mutant that produced only 
full length Tal proteins, it became apparent that under optimal growth conditions the 
TP901-1 mutant lacking the lytic domain adsorbed to its host more efficiently 
compared to the TP901-1 Tal mutant with the lytic domain. Similarly, by reversing 
conditions, the TP901-1 Tal mutant incorporating full length-only Tal proteins into 
its virion was better at initiating infection of bacteria with increased PG cross-
linkage. From these results, we speculate that TP901-1 naturally produces two 
alternate forms of its tail fibre protein to create a mixture of virions specialized at 
efficiently infecting its host regardless of the bacterium’s cell wall cross-linkage 
status. 
 
There are several aspects of TP901-1 and Tuc2009 Tal proteins which should 
be further investigated to generate a more comprehensive molecular model of 
Siphoviridae PG degradation and host penetration at the onset of infection. At 
approximately the same time Chapter 2 of this thesis was published, a research 
article by Harada et al. was published which detailed a metal-binding capacity for 
phage Mu tail spike protein. In brief, this aforementioned research demonstrated that 
calcium ions present at the tip of phage Mu’s tail spike, gp45, directed the phage’s 
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cell penetrating needle towards the bacterial cell membrane (8). Despite phage Mu 
exhibiting Myoviridae morphology, HHPred structural analysis of TP901-1 and 
Tuc2009 Tal protein revealed a putative similarity to the calcium-binding domain of 
Mu gp45 (structure 3VTO_A; p-value 0.0041). Indeed, comparative analysis of Mu 
gp45 and Tal901-1 and Tal2009 at the amino acid sequence-level revealed conserved 
amino acids which are important in Mu gp45 calcium binding. The region of TP901-
1 and Tuc2009 Tal protein similar to the calcium binding domain of Mu gp45 
immediately precedes the proteolysis site of Tal901-1 and Tal2009 that is responsible 
for generating the truncated form of their Tal proteins (9). This is interesting as 
regardless of TP901-1 and Tuc2009’s strategy to produce full-length and truncated 
tail fibre proteins, calcium ions immediately preceding the proteolysis site may help 
to direct the phage’s tail tip perpendicular to the bacterial membrane. Therefore, 
mutations in Tal901-1 amino acid residues Asp600 and Ser601, utilising previous 
TP901-1 mutants which incorporate into their virions the full length only and the 
truncated form of the Tal protein, may further our understanding of the host-
penetration mechanism utilised by lactococcal-infecting phages as a prerequisite to 
efficient genome ejection. 
 
Virions of lactococcal Siphoviridae phages represent complex quaternary 
structures assembled from multiple proteins and subunits thereof. The assembly of 
infectious viral particles occurs within the bacterial cell and, like a machine, phage 
progeny are designed and programmed to adsorb to, and initiate infection of a new 
host following lysis. The complexity of phage virions is indicative of a common 
evolutionary origin; and in agreement with this, the genomic organisation and 
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predicted structures of TP901-1 proteins constituting its virion were found to be 
conserved with phages infecting both Gram-positive and Gram-negative bacteria. 
 
Chapter 3 of this thesis takes a broad experimental look at the presumed 
structural module of phages TP901-1 and Tuc2009. However, there is a lot more to 
learn by mutational probing the structural module-encoded proteins at the amino acid 
level. In addition, now that the exact boundaries of the capsid and tail-encoding 
regions of TP901-1 and Tuc2009 have been determined, and each of these found to 
be < 10 kb in length, it may be possible to separately clone these regions into a 
plasmid and overexpress these structures, as has been done for phage λ (10, 11). For 
example, the overexpression of complete TP901-1 tail structures, without the added 
physiological stress on the host bacterium to replicate the phage’s genome and 
capsid components, may facilitate increased production and subsequent purification 
of tails for further analyses. An alternative strategy to produce and consequently 
purify TP901-1 capsid and tail structures, without the physiological stress of 
replicating a complete infectious phage, is achievable through recombineering 
mutagenesis of TP901-1 genome. Via such a recombineering methodology, it should 
be possible to introduce the necessary genetic sequence, at the N- or C-terminus of 
phage encoded-proteins, to tag proteins with 6 histidine residues for Ni-NTA 
column-affinity purification. For example, by introducing a non-sense mutation into 
TP901-1 Major Capsid Protein (MCP), and adding a hexa-histidine tag to the Major 
Tail Protein (MTP), this may offer a novel mechanism to generate pure and 
functional tail structures. 
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Analysis of the TP901-1 and Tuc2009 genomes revealed that almost half of 
their genomes encode proteins required for the assembly of their respective virion 
structures. Mutational analysis of the TP901-1 genome highlighted that virtually all 
targeted genes within the presumed structural module are required to form a fully 
functional infectious particle. As TP901-1 and Tuc2009 genomes appear to contain 
very little ‘junk’ DNA, combined with the knowledge that the genomic order of 
functionally analogous structural genes is conserved despite sequence divergence, 
this makes TP901-1 and Tuc2009 ideal models to annotate and assign functions to 
genes in newly sequenced phage genomes which do not necessarily infect lactococci. 
 
Enterobacterial phage λ continues to serve as a prototypical model to enhance 
our understanding of Siphoviridae. The efficient recombineering mutagenesis 
strategy, as applicable to TP901-1 (12, 13), has demonstrated that many features of 
phage λ are conserved between this Gram-negative-infecting phage and TP901-1. 
For instance, the programmed ribosomal translational frame-shift required to 
produce chaperone proteins gpG and gpGT is now experimentally proven as 
conserved between these phages (14). In addition, the independent production of, 
and subsequent ability to assembly in vitro, Siphoviridae phage capsids and tails, 
previously reported for phage λ (15), has now been documented for a Gram-positive 
infecting phage. 
 
There are three familial classifications of Caudovirales, yet the Siphoviridae 
family is the only morphology for which a detailed molecular model for DNA 
injection into a host bacterium is lacking (16, 17). Several studies have indicated a 
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role of the TMP in creating a channel from the phage tail-tube tip to the bacterial 
cytoplasm (18-21); however, this model does not appear to be widely accepted or 
referenced in the literature. Previous analyses of Siphoviridae TMP proteins 
(including TP901-1) have shown how the TMP dictates the length of phage tails and 
acts as a scaffold for the assembly of the MTP rings which form the tail tube. 
However, these studies did not appear to focus on maintaining fully functional tails. 
Finally, the TMPs of Siphoviridae phages are a central component of the tail 
structures, and in all studied instances, essential for creating functional tails. Chapter 
4 of this thesis tries to dissect the various roles of the TMP, including; (i) its roles in 
the assembly process of the phage tail structure, (ii) its role in dictating the length of 
the Siphoviridae phage tail, and (iii) the hypothesized role of TMP in creating a 
channel that covers the distance from the phage tail tip and across the membrane to 
reach the host’s cytoplasm. 
 
The TMP of phage TP901-1 was shown as one of three essential proteins 
required to assemble tail structures, the other two proteins being the Distal Tail 
protein (Dit) and the N-terminus of the Tal protein (22). During mutational analysis 
of TP901-1 TMP carried out in Chapter 4 of this thesis, we identified the orientation 
of the TMP in the complete tail tube structure. To the best of our knowledge, this has 
previously not been shown for a Siphoviridae phage, likely proving difficult as the 
TMP is not an exposed protein within complete virions. However, mutagenesis of 
TP901-1 TMP N-terminus produced free phage tails structures, presumably due to 
the lack of an interaction between the phage TMP and head-tail connector proteins 
associated with the phage capsid. A deletion in the C-terminus of TP901-1 TMP did 
not yield assembled phage tail structures, indicating the lack of an initiator complex 
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formed of TMP-Dit-Tal, which, as mentioned, is a key requisite for phage tail 
assembly. 
 
The ground-breaking research by Katsura (1984), who demonstrated that the 
TMP of lambda dictates the length of a Siphoviridae tail, also showed shortening of 
lambda tails from 29 Major Tail Protein (MTP) rings to 13 MTP rings (23). 
However, these phage mutants were incapable of infecting their host. Successive 
mutations in TP901-1 TMP protein, outlined in Chapter 4 of this thesis, 
demonstrated how specific aromatic-residue-containing repeating units of 11 and 18 
amino acids dictate the final length of the tail, and that the distance between 
repeating aromatic residues is important for tail function. Methods to generate the 
shortest possible functional tail of TP901-1 has so far indicated that 16 aromatic-
residue-containing repeating units from TP901-1’s TMP, out of 29 annotated 
repeats, can be removed without drastically altering the efficiency of plaquing of 
TP901-1 TMP mutants. 
 
Potentially the tail of TP901-1 may be shortened further by additional 
deletions; however, additional work is required to determine if this is possible. 
Specifically, should this work be revisited, the annotated 29
th
 repeat of the TP901-1 
TMP should be subjected to investigation. During the manual annotation of repeat 
sequences with either a tryptophan or phenylalanine spaced 11 or 18 amino acids 
apart, the 29
th
 repeat of TP901-1 TMP was annotated as an 11 amino acid repeat. 
This was performed as 11 amino acid repeats seem to occur far more frequently than 
the 18 amino acids repeats, the reason for which is currently unknown, and a 
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phenylalanine residue occurred exactly 11 amino acids from the start of the 
annotated 29
th
 repeat, potentially marking the end-boundary of repeating units. 
However, results for mutants with deletions in repeats 27-29 were dramatically 
affected in their efficiency of plaquing. The 29
th
 TP901-1 TMP aromatic-containing 
repeat sequence therefore may be a longer repeating unit than initially annotated, as a 
tryptophan is 18 amino acids following the beginning of the 29
th
 repeating unit of 
TP901-1 TMP. If this is indeed the case, this raises an interesting question as to why 
the 7 extra amino acids of an 18 residue repeat cannot join to an 11 amino acid 
repeating unit and once again form an 18 amino acid repeating unit. This suggests 
the sequence of specific individual repeats, or the exact sequence of 11 and 18 amino 
acid repeats, differs and are important for functional tails. 
 
The numerical superiority of Siphoviridae in environmental samples analysed 
is indicative of their successful replication strategy, which involves their long non-
contractile tail appendages. However, there is sparse evidence to support the role of 
Siphoviridae TMP proteins tails in creating a channel for DNA ejection. The 
strongest argument in support of TMP proteins forming a channel for DNA injection 
is based on experiments conducted on phage T5. Böhm and colleagues (2001) 
demonstrated phage T5 could inject DNA into proteoliposomes containing the 
phage’s proteinaceous receptor, FhuA (19). Combined with analyses showing T5’s 
TMP, Pb2, contains transmembrane helices and inserts into black-lipid bilayer 
membranes, the TMP was suggested by Böhm et al. as the candidate protein 
responsible for creating a channel into bacterial membranes. Additional support for 
the TMP of Siphoviridae in forming a channel for DNA entry into a host bacterium 
is provided by the Podoviridae phage T7. The recent study by Hu et al. (2013) 
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demonstrated how phage T7 ejected proteins from its virion, like the TMP of 
Siphoviridae, and that the ejected proteins underwent extensive structural 
rearrangements to form a channel in the bacterial membrane, directing and protecting 
the phage genome from the phage tail-tip into the bacterial cytosol (16). In Chapter 4 
of this thesis, our results support the TMP of Siphoviridae in creating a channel for 
DNA injection into host bacterium. Mutants deleting specific transmembrane 
helices, possessed MTP which is indicative of tail tubes forming; however, they 
were incapable of injecting their DNA into host bacteria. In order to verify the 
normal production of phages tails for TP901-1 TMP transmembrane mutants, and 
confirm the predicted effects of numerous TP901-1 structural mutants, electron 
micrograph (EM) images are required. Purification of TP901-1, and its mutant 
derivatives, for EM analysis is currently still underway as a prerequisite to 
publishing Chapters 3 and 4 of this thesis as research articles. 
 
Further experiments are required to prove the TMP of Siphoviridae is 
responsible, beyond any doubt, for creating a channel in the bacterial cell membrane 
during phage DNA injection. Ideally, structural studies of TMP would provide the 
most comprehensive proof of this concept. However, as this large protein requires 
chaperones for its correct folding and incorporation into phage virions, as it is 
presumed a largely hydrophobic protein, alternative methods may be required. Using 
antibodies against the N-terminal region of TP901-1 TMP, which are currently under 
production (Collins et al., unpublished results), it may be possible to detect the TMP 
in cell wall and membranous fractions of TP901-1’s host bacterium following phage 
infection. A detailed molecular model of all the various steps of a Siphoviridae 
initiating infection, from adsorption to penetration and DNA injection, is currently 
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not available, and many of these important questions can potentially be answer using 
TP901-1 and Tuc2009 as prototypical models. 
 
1. Gan L, Chen S, Jensen GJ. 2008. Molecular organization of Gram-negative 
peptidoglycan. Proc Natl Acad Sci U S A 105:18953-18957. 
2. Coburn DL. 2011. The Role of Bacteriophage Lambda gpK in Tail 
Assembly and Host Cell Entry. Ph.D. Thesis. University of Toronto. 
3. Boulanger P, Jacquot P, Plancon L, Chami M, Engel A, Parquet C, 
Herbeuval C, Letellier L. 2008. Phage T5 straight tail fiber is a 
multifunctional protein acting as a tape measure and carrying fusogenic and 
muralytic activities. J Biol Chem 283:13556-13564. 
4. Briers Y, Miroshnikov K, Chertkov O, Nekrasov A, Mesyanzhinov V, 
Volckaert G, Lavigne R. 2008. The structural peptidoglycan hydrolase 
gp181 of bacteriophage phiKZ. Biochem Biophys Res Commun 374:747-
751. 
5. Kanamaru S, Leiman PG, Kostyuchenko VA, Chipman PR, 
Mesyanzhinov VV, Arisaka F, Rossmann MG. 2002. Structure of the cell-
puncturing device of bacteriophage T4. Nature 415:553-557. 
6. Molineux IJ. 2001. No syringes please, ejection of phage T7 DNA from the 
virion is enzyme driven. Mol Microbiol 40:1-8. 
7. Piuri M, Hatfull GF. 2006. A peptidoglycan hydrolase motif within the 
mycobacteriophage TM4 tape measure protein promotes efficient infection of 
stationary phase cells. Mol Microbiol 62:1569-1585. 
8. Harada K, Yamashita E, Nakagawa A, Miyafusa T, Tsumoto K, Ueno T, 
Toyama Y, Takeda S. 2013. Crystal structure of the C-terminal domain of 
 269 
Mu phage central spike and functions of bound calcium ion. Biochim 
Biophys Acta 1834:284-291. 
9. Kenny JG, McGrath S, Fitzgerald GF, van Sinderen D. 2004. 
Bacteriophage Tuc2009 encodes a tail-associated cell wall-degrading 
activity. J Bacteriol 186:3480-3491. 
10. Xu J, Hendrix RW, Duda RL. 2013. Chaperone-Protein Interactions That 
Mediate Assembly of the Bacteriophage Lambda Tail to the Correct Length. 
J Mol Biol 426:1004-1018. 
11. Xu J, Hendrix RW, Duda RL. 2013. A Balanced Ratio of Proteins from 
Gene G and Frameshift-Extended Gene GT Is Required for Phage Lambda 
Tail Assembly. J Mol Biol 425:3476-3487. 
12. van Pijkeren JP, Britton RA. 2012. High efficiency recombineering in 
lactic acid bacteria. Nucleic Acids Res 40:e76. 
13. van Pijkeren JP, Neoh KM, Sirias D, Findley AS, Britton RA. 2012. 
Exploring optimization parameters to increase ssDNA recombineering in 
Lactococcus lactis and Lactobacillus reuteri. Bioengineered 3:209-217. 
14. Xu J, Hendrix RW, Duda RL. 2004. Conserved translational frameshift in 
dsDNA bacteriophage tail assembly genes. Mol Cell 16:11-21. 
15. Weigle J. 1966. Assembly of phage lambda in vitro. Proc Natl Acad Sci U S 
A 55:1462-1466. 
16. Hu B, Margolin W, Molineux IJ, Liu J. 2013. The bacteriophage T7 virion 
undergoes extensive structural remodeling during infection. Science 339:576-
579. 
 270 
17. Kostyuchenko VA, Chipman PR, Leiman PG, Arisaka F, Mesyanzhinov 
VV, Rossmann MG. 2005. The tail structure of bacteriophage T4 and its 
mechanism of contraction. Nat Struct Mol Biol 12:810-813. 
18. Marinelli LJ. 2008. Characterization of the role of the Rpf motif in 
mycobacteriophage tape measure proteins. Ph.D. Thesis. University of 
Pittsburgh. 
19. Bohm J, Lambert O, Frangakis AS, Letellier L, Baumeister W, Rigaud 
JL. 2001. FhuA-mediated phage genome transfer into liposomes: a cryo-
electron tomography study. Curr Biol 11:1168-1175. 
20. Roessner CA, Ihler GM. 1986. Formation of transmembrane channels in 
liposomes during injection of lambda DNA. J Biol Chem 261:386-390. 
21. Feucht A, Schmid A, Benz R, Schwarz H, Heller KJ. 1990. Pore formation 
associated with the tail-tip protein pb2 of bacteriophage T5. J Biol Chem 
265:18561-18567. 
22. Vegge CS, Brondsted L, Neve H, Mc Grath S, van Sinderen D, Vogensen 
FK. 2005. Structural characterization and assembly of the distal tail structure 
of the temperate lactococcal bacteriophage TP901-1. J Bacteriol 187:4187-
4197. 
23. Katsura I. 1987. Determination of bacteriophage lambda tail length by a 
protein ruler. Nature 327:73-75. 
 
 271 
 
 
ACKNOWLEDGEMENTS 
  
 272 
Simply put, without the help and support of a great number of people this 
thesis would have been near impossible. 
 
First of all, I would like to thank Douwe. Thank you for the opportunity to 
conduct a PhD in phage biology; thank you for all your help, patience, and guidance 
through-out; and thank you for responding to all the emails I bombarded you with 
towards the end. You will be glad to know, due to a lack of recent publications, ‘The 
Journal of Inexplicable Results’ has been discontinued. 
 
Next, I would like to thank all the postdocs and staff around the department 
who answered numerous – and often repetitive – questions; without this help, the 
more difficult techniques during the PhD would still be undone. Although there are 
too many postdocs/staff to name (and I would likely forget a few), I would just like 
to thank Jenn in particular. Your help in getting me started in the lab, and continually 
sparing time to help with everything and anything, has been amazing. 
 
One of the highlights of the PhD has been the friends made throughout. The 
hours necessary to finish the PhD, ‘half-days’ included, would have been so much 
more difficult without your support. There are just so many friends, associated with 
so many great memories, that I would like to go into detail to thank; but as I want to 
get this thesis written, I cannot list them all. Therefore, I would just like to say thank 
you – I am sure you know who you are – for being great friends throughout the PhD, 
and hopefully long into the future. 
 273 
Very briefly, I would like to thank some friends in particular. Thanks to Stu, 
despite spending more time in the lab with you over the last four years than I have 
spent time with my own fiancée, it was always good craic (although I don’t think I 
could tolerate getting hit with that Disney pen one more time!). Thanks to James, for 
some of the funniest moments and more than a few phrases that I must now unlearn 
– ‘could you face that’. Thanks to Phil, despite being the newest lab member, you 
settled into the general lab humour very quickly and always made it a good laugh. 
Amy wasn’t too pleased with ‘scone breaks’, but they were needed. Finally, thanks 
to Annaleen and Joanna, and many others, for the general banter which made the 
days enjoyable. 
 
To my parents, for your unwavering support in everything I do, thank you so 
much. Despite endless rants, on topics I am sure you have no clue, you always 
listened and that was often all that was needed. I have no idea how I will ever repay 
everything you have done, but when the time comes, I promise I will pick you a nice 
retirement home. 
 
Finally, to Amy, how can I even thank and praise you enough for everything? 
Never once have you complained of the long hours, my general lack of contribution 
to housework, and many, MANY other things which I have neglected in order to 
finish the PhD. Luckily, I know there are many years ahead during which I can 
return the favour – which I cannot wait for. I simply could not have asked for more 
from someone – ‘I mo do’. 
